EP3544681A1 - Monitoring and treating pain with epidermal electronics - Google Patents
Monitoring and treating pain with epidermal electronicsInfo
- Publication number
- EP3544681A1 EP3544681A1 EP17875036.0A EP17875036A EP3544681A1 EP 3544681 A1 EP3544681 A1 EP 3544681A1 EP 17875036 A EP17875036 A EP 17875036A EP 3544681 A1 EP3544681 A1 EP 3544681A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- body portion
- sensor
- movement
- pain
- processor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 253
- 230000036407 pain Effects 0.000 title claims abstract description 230
- 238000012544 monitoring process Methods 0.000 title abstract description 19
- 230000033001 locomotion Effects 0.000 claims abstract description 468
- 239000012636 effector Substances 0.000 claims abstract description 145
- 238000000034 method Methods 0.000 claims abstract description 111
- 239000000758 substrate Substances 0.000 claims abstract description 102
- 230000035790 physiological processes and functions Effects 0.000 claims abstract description 28
- 238000001514 detection method Methods 0.000 claims abstract description 21
- 238000004891 communication Methods 0.000 claims description 135
- 238000002604 ultrasonography Methods 0.000 claims description 95
- 238000011282 treatment Methods 0.000 claims description 60
- 230000003287 optical effect Effects 0.000 claims description 48
- 210000003205 muscle Anatomy 0.000 claims description 46
- 239000000126 substance Substances 0.000 claims description 32
- 210000005036 nerve Anatomy 0.000 claims description 31
- 210000000707 wrist Anatomy 0.000 claims description 26
- 230000009471 action Effects 0.000 claims description 23
- 206010003246 arthritis Diseases 0.000 claims description 22
- 230000004913 activation Effects 0.000 claims description 17
- 210000001519 tissue Anatomy 0.000 claims description 17
- 210000003423 ankle Anatomy 0.000 claims description 16
- 238000011269 treatment regimen Methods 0.000 claims description 16
- 210000004243 sweat Anatomy 0.000 claims description 15
- 210000002414 leg Anatomy 0.000 claims description 9
- 208000004296 neuralgia Diseases 0.000 claims description 9
- 208000000112 Myalgia Diseases 0.000 claims description 8
- 239000012491 analyte Substances 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 208000006820 Arthralgia Diseases 0.000 claims description 7
- 206010043255 Tendonitis Diseases 0.000 claims description 6
- 210000002683 foot Anatomy 0.000 claims description 5
- 210000001624 hip Anatomy 0.000 claims description 5
- 210000003127 knee Anatomy 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 206010019233 Headaches Diseases 0.000 claims description 4
- 208000020947 enthesitis Diseases 0.000 claims description 4
- 239000000416 hydrocolloid Substances 0.000 claims description 3
- 208000001640 Fibromyalgia Diseases 0.000 claims description 2
- 210000002808 connective tissue Anatomy 0.000 claims description 2
- 230000002035 prolonged effect Effects 0.000 claims description 2
- 210000003131 sacroiliac joint Anatomy 0.000 claims description 2
- 230000000472 traumatic effect Effects 0.000 claims description 2
- 201000002481 Myositis Diseases 0.000 claims 1
- 206010029240 Neuritis Diseases 0.000 claims 1
- 239000000090 biomarker Substances 0.000 claims 1
- 238000002570 electrooculography Methods 0.000 claims 1
- 238000012545 processing Methods 0.000 description 97
- 230000001133 acceleration Effects 0.000 description 84
- 230000003993 interaction Effects 0.000 description 76
- 238000005259 measurement Methods 0.000 description 67
- 210000004027 cell Anatomy 0.000 description 52
- 208000012514 Cumulative Trauma disease Diseases 0.000 description 51
- 239000000463 material Substances 0.000 description 41
- 230000004888 barrier function Effects 0.000 description 39
- 230000015654 memory Effects 0.000 description 37
- 230000000694 effects Effects 0.000 description 34
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 24
- 230000008569 process Effects 0.000 description 24
- 230000006378 damage Effects 0.000 description 23
- 230000006870 function Effects 0.000 description 23
- 229910052710 silicon Inorganic materials 0.000 description 22
- 239000010703 silicon Substances 0.000 description 22
- 230000001939 inductive effect Effects 0.000 description 20
- 230000007830 nerve conduction Effects 0.000 description 20
- 230000008859 change Effects 0.000 description 19
- 239000000835 fiber Substances 0.000 description 19
- 230000004044 response Effects 0.000 description 19
- 238000004422 calculation algorithm Methods 0.000 description 18
- 208000014674 injury Diseases 0.000 description 18
- 208000027418 Wounds and injury Diseases 0.000 description 17
- 230000036544 posture Effects 0.000 description 17
- 230000000638 stimulation Effects 0.000 description 16
- 238000004364 calculation method Methods 0.000 description 14
- -1 polydimethylsiloxane Polymers 0.000 description 14
- 230000001627 detrimental effect Effects 0.000 description 13
- 230000004962 physiological condition Effects 0.000 description 13
- 208000001294 Nociceptive Pain Diseases 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 238000004590 computer program Methods 0.000 description 11
- 238000012377 drug delivery Methods 0.000 description 11
- 208000000094 Chronic Pain Diseases 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 238000012986 modification Methods 0.000 description 10
- 239000004753 textile Substances 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- 239000010931 gold Substances 0.000 description 9
- 239000007769 metal material Substances 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 208000005298 acute pain Diseases 0.000 description 8
- 238000005452 bending Methods 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 8
- 230000000007 visual effect Effects 0.000 description 8
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 7
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 7
- 230000001070 adhesive effect Effects 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000003491 array Methods 0.000 description 7
- 230000005540 biological transmission Effects 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 239000010408 film Substances 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 239000002121 nanofiber Substances 0.000 description 7
- 239000003981 vehicle Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 206010038584 Repetitive strain injury Diseases 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000004744 fabric Substances 0.000 description 6
- 230000005021 gait Effects 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 229910052737 gold Inorganic materials 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 208000021722 neuropathic pain Diseases 0.000 description 6
- 210000000929 nociceptor Anatomy 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 239000004065 semiconductor Substances 0.000 description 6
- 230000008093 supporting effect Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 208000005392 Spasm Diseases 0.000 description 5
- 230000009910 autonomic response Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000000151 deposition Methods 0.000 description 5
- 230000008021 deposition Effects 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 229910021389 graphene Inorganic materials 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000004118 muscle contraction Effects 0.000 description 5
- 239000002074 nanoribbon Substances 0.000 description 5
- 238000006213 oxygenation reaction Methods 0.000 description 5
- 108020003175 receptors Proteins 0.000 description 5
- 230000003252 repetitive effect Effects 0.000 description 5
- 230000000241 respiratory effect Effects 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 230000035807 sensation Effects 0.000 description 5
- 230000004936 stimulating effect Effects 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 5
- 101800004538 Bradykinin Proteins 0.000 description 4
- 102400000967 Bradykinin Human genes 0.000 description 4
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 4
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 4
- 206010011985 Decubitus ulcer Diseases 0.000 description 4
- 108010015776 Glucose oxidase Proteins 0.000 description 4
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 208000004210 Pressure Ulcer Diseases 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 208000003443 Unconsciousness Diseases 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 230000004075 alteration Effects 0.000 description 4
- 210000003403 autonomic nervous system Anatomy 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 230000000763 evoking effect Effects 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 201000008482 osteoarthritis Diseases 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 208000000003 Breakthrough pain Diseases 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 208000007101 Muscle Cramp Diseases 0.000 description 3
- 201000001263 Psoriatic Arthritis Diseases 0.000 description 3
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 3
- 229960002986 dinoprostone Drugs 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 210000001097 facial muscle Anatomy 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 230000000917 hyperalgesic effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 229910052451 lead zirconate titanate Inorganic materials 0.000 description 3
- 210000003041 ligament Anatomy 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000007659 motor function Effects 0.000 description 3
- 210000004126 nerve fiber Anatomy 0.000 description 3
- 230000005693 optoelectronics Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000002496 oximetry Methods 0.000 description 3
- 238000002638 palliative care Methods 0.000 description 3
- 230000010254 physiological adaptation Effects 0.000 description 3
- 229920000052 poly(p-xylylene) Polymers 0.000 description 3
- 230000000770 proinflammatory effect Effects 0.000 description 3
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 3
- 230000001107 psychogenic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000011514 reflex Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 208000009935 visceral pain Diseases 0.000 description 3
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 2
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 2
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 101800000414 Corticotropin Proteins 0.000 description 2
- 206010061991 Grimacing Diseases 0.000 description 2
- 208000004454 Hyperalgesia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 208000003456 Juvenile Arthritis Diseases 0.000 description 2
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 description 2
- 206010029174 Nerve compression Diseases 0.000 description 2
- 102400000064 Neuropeptide Y Human genes 0.000 description 2
- 108090000189 Neuropeptides Proteins 0.000 description 2
- 208000000114 Pain Threshold Diseases 0.000 description 2
- 101000669494 Pelophylax ridibundus Ranakinin Proteins 0.000 description 2
- 101710183734 Peptide YY-like Proteins 0.000 description 2
- ORNBQBCIOKFOEO-YQUGOWONSA-N Pregnenolone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC3)C[C@@H](O)CC4)CC2)CC1 ORNBQBCIOKFOEO-YQUGOWONSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102400000096 Substance P Human genes 0.000 description 2
- 108700012920 TNF Proteins 0.000 description 2
- 208000000491 Tendinopathy Diseases 0.000 description 2
- 208000004760 Tenosynovitis Diseases 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- MCEWYIDBDVPMES-UHFFFAOYSA-N [60]pcbm Chemical compound C123C(C4=C5C6=C7C8=C9C%10=C%11C%12=C%13C%14=C%15C%16=C%17C%18=C(C=%19C=%20C%18=C%18C%16=C%13C%13=C%11C9=C9C7=C(C=%20C9=C%13%18)C(C7=%19)=C96)C6=C%11C%17=C%15C%13=C%15C%14=C%12C%12=C%10C%10=C85)=C9C7=C6C2=C%11C%13=C2C%15=C%12C%10=C4C23C1(CCCC(=O)OC)C1=CC=CC=C1 MCEWYIDBDVPMES-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002730 additional effect Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000010485 coping Effects 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 2
- 229960000258 corticotropin Drugs 0.000 description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 208000004967 femoral neuropathy Diseases 0.000 description 2
- 230000005669 field effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 208000018875 hypoxemia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 description 2
- HFGPZNIAWCZYJU-UHFFFAOYSA-N lead zirconate titanate Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Zr+4].[Pb+2] HFGPZNIAWCZYJU-UHFFFAOYSA-N 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 210000004705 lumbosacral region Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 208000032184 meralgia paresthetica Diseases 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 238000010295 mobile communication Methods 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 208000019382 nerve compression syndrome Diseases 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 230000006855 networking Effects 0.000 description 2
- 108091008700 nociceptors Proteins 0.000 description 2
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229940124583 pain medication Drugs 0.000 description 2
- 230000037040 pain threshold Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000301 poly(3-hexylthiophene-2,5-diyl) polymer Polymers 0.000 description 2
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229960000249 pregnenolone Drugs 0.000 description 2
- ORNBQBCIOKFOEO-QGVNFLHTSA-N pregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 ORNBQBCIOKFOEO-QGVNFLHTSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 2
- 229960003351 prussian blue Drugs 0.000 description 2
- 239000013225 prussian blue Substances 0.000 description 2
- 208000009873 radial neuropathy Diseases 0.000 description 2
- 230000026416 response to pain Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000004092 somatosensory cortex Anatomy 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 201000004415 tendinitis Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 238000012876 topography Methods 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- GKWLILHTTGWKLQ-UHFFFAOYSA-N 2,3-dihydrothieno[3,4-b][1,4]dioxine Chemical compound O1CCOC2=CSC=C21 GKWLILHTTGWKLQ-UHFFFAOYSA-N 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000035154 Hyperesthesia Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010061951 Methemoglobin Proteins 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010049565 Muscle fatigue Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000030858 Myofascial Pain Syndromes Diseases 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 206010036313 Post-traumatic headache Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 239000002042 Silver nanowire Substances 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010043269 Tension headache Diseases 0.000 description 1
- 208000008548 Tension-Type Headache Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 206010053552 allodynia Diseases 0.000 description 1
- JNDMLEXHDPKVFC-UHFFFAOYSA-N aluminum;oxygen(2-);yttrium(3+) Chemical compound [O-2].[O-2].[O-2].[Al+3].[Y+3] JNDMLEXHDPKVFC-UHFFFAOYSA-N 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000002717 carbon nanostructure Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 208000003295 carpal tunnel syndrome Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- KVEAILYLMGOETO-UHFFFAOYSA-H dicalcium magnesium diphosphate Chemical compound P(=O)([O-])([O-])[O-].[Mg+2].[Ca+2].[Ca+2].P(=O)([O-])([O-])[O-] KVEAILYLMGOETO-UHFFFAOYSA-H 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 210000005153 frontal cortex Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229920000592 inorganic polymer Polymers 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000000412 mechanoreceptor Anatomy 0.000 description 1
- 108091008704 mechanoreceptors Proteins 0.000 description 1
- 210000001617 median nerve Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 210000004237 neck muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000002981 neuropathic effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003040 nociceptive effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000037325 pain tolerance Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000004796 pathophysiological change Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000307 polymer substrate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001144 postural effect Effects 0.000 description 1
- 210000002442 prefrontal cortex Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108091008706 proprioceptors Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000001303 quality assessment method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000000029 referred pain Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000020341 sensory perception of pain Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 125000006839 xylylene group Chemical group 0.000 description 1
- 229910019901 yttrium aluminum garnet Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4824—Touch or pain perception evaluation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
- A61B2562/0214—Capacitive electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0219—Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/06—Arrangements of multiple sensors of different types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/164—Details of sensor housings or probes; Details of structural supports for sensors the sensor is mounted in or on a conformable substrate or carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/026—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1121—Determining geometric values, e.g. centre of rotation or angular range of movement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36003—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of motor muscles, e.g. for walking assistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Definitions
- a pain therapy device includes, but is not limited to, a deformable substrate configured to interface with a skin surface of a body portion of an individual subject; a sensor assembly coupled to the deformable substrate, the sensor assembly including a motion sensor and a physiological sensor, the sensor assembly configured to generate one or more sense signals based on detection of a movement of the body portion by the motion sensor and a physiological parameter of the body portion by the physiological sensor; a processor operably coupled to the sensor assembly and configured to receive the one or more sense signals, the processor including circuitry configured to identify at least one physiological state, including a pain state of the individual subject based on at least one of the movement of the body portion or the physiological parameter; and an effector operably coupled to the processor and configured to affect the body portion responsive to control by the processor upon identification of the pain state of the individual subject based on at least one of the movement of the body portion or the physiological parameter.
- a method includes, but is not limited to, detecting, via an epidermal electronic device, a movement of a body portion and a physiological parameter of the body portion; generating one or more sense signals based on detection of the movement of the body portion and the physiological parameter of the body portion; receiving the one of more sense signals with a computer processor; identifying at least one pain state of the individual subject based on at least one of the movement of the body portion or the physiological parameter; and transmitting a control signal to activate an effector to act on the body portion upon identification of the at least one pain state of the individual subject based on at least one of the movement of the body portion or the physiological parameter.
- FIG. 1 A is a schematic view of an embodiment of an epidermal electronics device showing individual cells of the device.
- FIG. 1 B is a schematic cross section view of an embodiment of an epidermal electronics device showing individual cells of the device.
- FIG. 2A is a schematic view of an embodiment of an epidermal electronics device showing cells configured to measure orientation using accelerometers.
- FIG. 2B is a schematic view of an embodiment of the epidermal electronics device showing cells configured to measure orientation using inclinometers and/or gyroscopes.
- FIG. 2C is an illustration of a sensor configuration according to one embodiment of the epidermal electronics device.
- FIG. 3A is an exploded schematic view of an embodiment of the epidermal electronics device showing greater detail.
- FIG. 3B is a schematic view of an embodiment of the epidermal electronics device showing greater detail of the electronics assembly.
- FIG. 4A is a schematic view of an additional embodiment of the epidermal electronics device.
- FIG. 4B is a schematic view of the electronics layer of an additional embodiment of the epidermal electronics device.
- FIG. 5 is a schematic view of two embodiments of the epidermal electronics device in communication with each other.
- FIG. 6 is a schematic view of an embodiment the epidermal electronics device as used to measure orientation relative to several body parts.
- FIG. 7 is a flow chart detailing operation of one embodiment of the epidermal electronics device.
- FIG. 8 is a flow chart with additional detail showing the operation on an embodiment of the epidermal electronics device.
- FIG. 9 is a schematic of a system for monitoring, treating, and preventing a repetitive stress injury, arthritis or other medical condition.
- FIG. 10 is a schematic of an embodiment of a system such as shown in
- FIG. 11 is a schematic of an embodiment of a system such as shown in
- FIG. 12 is a schematic of an embodiment of a system such as shown in
- FIG. 13 is a schematic of an embodiment of a system such as shown in FIG. 9.
- FIG. 14 is a schematic of an embodiment of a system such as shown in
- FIG. 15A is a schematic of an embodiment of a system such as shown in
- FIG. 15B is a schematic of an embodiment of a system such as shown in
- FIG. 16 is a schematic of a system for monitoring, treating, and preventing a repetitive stress injury, arthritis or other medical condition.
- FIG. 17 is a flowchart of a method of monitoring, preventing, and treating a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- FIG. 18 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 19 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 20 is a flowchart illustrating aspects of a method such as shown in FIG. 19.
- FIG. 21 is a flowchart illustrating aspects of a method such as shown in FIG. 19.
- FIG. 22 is a flowchart illustrating aspects of a method such as shown in
- FIG. 23 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 24 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 25 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 26 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 27 is a flowchart illustrating aspects of a method such as shown in FIG. 26.
- FIG. 28 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 29 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 30 is a flowchart illustrating aspects of a method such as shown in FIG. 17.
- FIG. 31 is a schematic of a system for monitoring and treating a physiological condition of an individual subject, including but not limited to monitoring and treating a pain state of the individual subject.
- FIG. 32 is a schematic of an embodiment of a system such as shown in FIG. 31 .
- FIG. 33 is a schematic of an embodiment of a system such as shown in FIG. 31 .
- FIG. 34 is a schematic of an embodiment of a system such as shown in FIG. 31 .
- FIG. 35 is a schematic of an embodiment of a system such as shown in FIG. 31 .
- FIG. 36 is a schematic of an embodiment of a system such as shown in FIG. 31 .
- an epidermal electronics device may include a thin layer of electronic circuits. This thin layer is supported by a barrier layer and optionally encapsulated by a substrate layer.
- the device is configured to attach to or otherwise engage skin or other tissue, such as by being affixed to the skin via an adhesive material, held in place by an external pressure, such as pressure provided by a material wrapped around or about a body portion (e.g. , a fabric, a garment, a glove, a bandage, etc.), affixed in a textile, fabric, garment, accessory (e.g. , a glove, a sock, a finger cot, etc.), or so forth.
- the device is also configured to allow the electronic circuits to flex without being damaged.
- the epidermal electronics device includes electronics for measuring various parameters. In general, an epidermal electronics device may be used for a variety of medical applications.
- epidermal electronics device 100 is shown to include substrate layer 105.
- Epidermal electronics device 100 further includes electronics layer 107 located between substrate layer 105 and barrier layer 109. Electronics layer 107 is shown through substrate layer 105 with view 1 10. Included within electronics layer 107 are cells 120. Epidermal electronics device 100 is illustrated as attached to attachment surface 103.
- Substrate layer 105 facilitates the transfer of epidermal electronics device 100 to attachment surface 103.
- substrate layer 105 may provide a backing which is used to transfer electronics layer 107 to attachment surface 103.
- Substrate layer 105 may then peel away from electronics layer 107 leaving electronics layer 107 attached to attachment surface 103 via barrier layer 109.
- Substrate layer 107 may also provide protection to electronics layer 107 during the handling of epidermal electronics device 100.
- Substrate layer 105 also provides support for electronics layer 107.
- Barrier layer 109 can be an elastomer or polymer suited for use in contact with organic tissue. In some embodiments, the barrier layer 109 is a bio compatible or otherwise inert material.
- barrier layer 109 may have a low elastic modulus, e.g. , one which is significantly lower (e.g. , less than half) of the elastic modulus of attachment surface 103.
- barrier layer 109 may comprise a low modulus polymeric material such as PDMS or BASF.
- the substrate layer 105 may be a rubber or silicone material.
- substrate layer 105 may be water soluble.
- Substrate layer 105 may be dissolved following transfer of the epidermal electronics device 100 onto the attachment surface 103.
- substrate layer 105 need not be biocompatible as it is removed completely or partially following the transfer of epidermal electronics device 100 onto the attachment surface 103.
- Substrate layer 105 provides protection to electronics layer 107 from external sources of damage. External sources of damage may include moisture, physical damage (e.g. , from a user touching epidermal electronics device 100), electrical interference, magnetic interference, etc.
- attachment surface 103 is the skin of a user. In other embodiments, attachment surface 103 includes other organs. For example, attachment surface 103 may be bone, muscle tissue, the heart, the lungs, etc. In some embodiments, attachment surface 103 is a bandage attached or to be attached to the skin or other organ. In some embodiments, attachment surface 103 is a covering such as a glove, finger cot, or the like.
- Epidermal electronics device 100 is held in contact with attachment surface
- epidermal electronics device 100 is held in contact with attachment surface 103 through close-contact atomic forces or van der Waals interactions. In other embodiments, epidermal electronics device 100 is held in contact with attachment surface 103 through the use of an adhesive.
- the adhesive may be applied after the epidermal electronics device 100 is placed on attachment surface 103.
- the adhesive may be a spray on bandage or may be adhesive tape.
- the adhesive may also be included as a component of barrier layer 109.
- barrier layer 109 at least partially
- barrier layer 109 encompasses the entirety of epidermal electronics layer 107. In other words,
- barrier layer 109 only coats electronics layer 107 on the surface opposite substrate layer 105. Barrier layer 109 may also partially coat electronics layer 107 to allow for contact between elements or cells of electronics layer 107 and the attachment surface 103.
- electronics layer 107 is located between substrate layer 105 and barrier layer 109. Barrier layer 109 and/or substrate layer 105 provides support for the elements of electronics layer 107.
- electronics layer 107 includes an array of cells 120.
- Cells 120 contain individual sensors or components. Cells 120 are also in communication with other components in electronics layer 107.
- cells 120 may be in communication with each other or a subset of other cells 120 within epidermal electronics device 100. Cells 120 may also be in communication with other elements. For example, cells 120 may be in
- Cells 120 may also contain connections to allow power delivery to the component in the cell, input/output to and from the component in the cell, and/or multiplexing circuitry.
- cells 120 may contain sensors such as accelerometers, inclinometers, magnetometers, or gyroscopes. These sensors may be of the micro electro-mechanical systems (MEMS) type, given the small scale of epidermal electronics device 100 and associated components; MEMS accelerometers, gyroscopes, and inclinometers are commercially available from multiple vendors. The sensors may also be part of or supported by integrated circuits or systems on a chip (SOCs).
- MEMS micro electro-mechanical systems
- Cells 120 may also contain interaction devices such as drug delivery systems, electrodes, motion capture markers, etc. Interaction devices may also be MEMS, part of or supported by integrated circuits, or SOCs. According to various alternative embodiments, cells 120 may include circuitry facilitating multiplexing of sensor output, transformers, amplifiers, circuitry for processing data and control signals, one or more transistors, etc.
- FIG. 1 B illustrates a cross section schematic view of one embodiment of epidermal electronics device 100.
- Substrate layer 105 is the topmost layer relative to attachment surface 103 and protects electronics layer 107 from the external environment.
- Barrier layer 109 is in contact with attachment surface 103 and protects electronics layer 107 from attachment surface 103.
- Electronics layer 107 is between barrier layer 109 and substrate layer 105.
- Electronics layer 107 is shown with cells 120 located therein.
- attachment surface 103 may be the skin of a user.
- Barrier layer 109 attaches epidermal electronics device 100 to attachment surface 103.
- Barrier layer 109 also protects electronic components of epidermal electronics device 100 from damage caused by attachment surface 103.
- Electronics layer 107 which includes electronic components of epidermal electronics device 100, is coupled to barrier layer 109.
- substrate layer 105 is coupled to electronics layer 107.
- Substrate layer 105 may provide a surface on which epidermal electronics device 100 is constructed, further protects the electronics components of epidermal electronics device 100, and/or facilitates the attachment of epidermal electronics device 100 to attachment surface 103 (e.g. , provides a peel away surface which may be grasped while attaching epidermal electronics device 100.
- epidermal electronics device may include a subset of the layers described above.
- epidermal electronics device 100 may include only barrier layer 109 and the electronic components described herein.
- Barrier layer 109 may protect the electronic components, attach epidermal electronics device 100 to attachment surface 103, and provide a surface on which epidermal electronics device 100 is constructed.
- Substrate layer 105 is an optional component of epidermal electronics device 100.
- FIG. 2A illustrates a schematic view of a portion of epidermal electronics device 100 according to one embodiment and shows sensors and sensor combinations which may be used.
- epidermal electronics device 100 includes one or more single-axis accelerometers 700.
- accelerometer is located within one of cells 120.
- Single-axis accelerometers 700 may be positioned at angles such as first angle 720 and second angle 730.
- Some embodiments of epidermal electronics device 100 include multi-axis
- epidermal electronics device 100 includes two or more single-axis accelerometers 700. Each accelerometer is part of a single cell 120. Cell 120 facilitates communication between the single-axis accelerometer 700 and other components of the electronics layer 107. Cell 120 may include one or more transistors. As is shown with view 1 10, illustrated with a dashed line, the single- axis accelerometers 700 are part of electronics layer 107. Single-axis
- accelerometer 700 is a MEMS accelerometer measuring acceleration along a single axis.
- One single-axis accelerometer 700 is shown oriented at a first angle 720.
- Another single-axis accelerometer 700 is shown oriented at a second angle 730.
- the rotation and orientation of the epidermal electronics device 100 may be determined from the sensor outputs.
- the different angles 720 and 730 may result in the single-axis accelerometers being oriented along different planes.
- the single-axis accelerometers may be slightly or fully opposed.
- Some embodiments of the epidermal electronics device 100 include multi-axis accelerometer 710.
- FIG. 2B illustrates additional sensors which may be included in an embodiment of epidermal electronics device 100.
- These additional sensors may include one or more of single-axis inclinometers 703, multi-axis inclinometers 713, single-axis gyroscopes 705, and multi-axis gyroscopes 715.
- Inclinometers may be used to measure an orientation of epidermal electronics device 100 relative to the direction of gravity.
- One single-axis inclinometer 703 may be oriented at first angle 723.
- Another single-axis inclinometer 703 may be oriented at second angle 733.
- two components of the orientation of epidermal electronics device 100 relative to the direction of gravity may be determined from the sensor outputs.
- the different angles 720 and 730 may result in the single-axis inclinometers being oriented along different axes.
- Single-axis inclinometers may be used to measure pitch or roll relative to the direction of gravity.
- Some embodiments of epidermal electronics device 100 include a multi-axis inclinometer 713, i.e. , to measure both pitch and roll.
- electronics layer 107 includes one or more gyroscopes to measure an angular velocity of epidermal electronics device 100.
- electronics layer 107 includes one or more single-axis gyroscopes 705 (e.g. , a MEMS vibrating structure gyroscope).
- One single-axis gyroscope 705 may be oriented at first angle 725.
- Another single-axis gyroscope 705 may be oriented at second angle 735.
- two components of the angular velocity of epidermal electronics device 100 may be determined from the sensor outputs.
- the different angles 725 and 735 may result in the single-axis
- epidermal electronics device 100 includes a multi-axis gyroscope 715.
- FIG. 2C illustrates an embodiment of epidermal electronics device 100 in which two sensors are arranged to measure the motion (angular and/or
- Single-axis accelerometer 704 is shown positioned with its axis of measurement parallel to and along the Z axis of a three dimensional space.
- Single-axis accelerometer 704 has first angle 720 defining a zero degree angle with axis Z.
- Second single-axis accelerometer 706 is shown with its axis of measurement not in alignment with the axis Z.
- Second accelerometer 706 has an axis of measurement defined by second angle 730 from the Z axis. This angle may be greater than zero degrees.
- the measurement axis of second single-axis accelerometer 706 is further defined by angle 731 which defines the measurement axis relative to the X-Y plane.
- single-axis accelerometers 704 and 706 are configured to be slightly opposed (e.g. , single-axis accelerometer 704 is aligned with the Z axis and second single-axis accelerometer 706 is positioned with second angle 730 of thirty degrees and angle 731 of fifteen degrees).
- multiple single-axis accelerometers 703 are configured to measure acceleration along the X, Y, and Z axes.
- additional single-axis gyroscopes are configured to measure rotation about the X, Y, and Z axes in addition to
- one or more single-axis inclinometers are substituted for one or more accelerometers or gyroscopes. Single-axis inclinometers may also be used to provide redundant measurements. In some embodiments, the measurements provided by one or more inclinometers are used to verify the orientation of the epidermal electronics device as determined using other data. In some embodiments, single-axis gyroscopes are substituted for one or more accelerometers. Single-axis gyroscopes may also be used to provide redundant measurements.
- the accelerometers, inclinometers, and/or gyroscopes include multi-axis accelerometers, multi-axis inclinometers, and/or multi-axis gyroscopes.
- single-axis accelerometer 704 is positioned on an axis.
- Second single single-axis accelerometer 706 is positioned along the same axis but laterally displaced from accelerometer 704.
- Single-axis accelerometer 704 and second single single-axis accelerometer 706 are poisoned to measure acceleration along the same axis but with opposite signs. Acceleration along the axis will read as positive acceleration to one of the two accelerometers and negative acceleration to the other of the two accelerometers.
- the sum of the acceleration measured by single-axis accelerometer 704 and second single single-axis accelerometer 706 will be zero or approximately zero (e.g. , approximately zero accounting for measurement error, etc.). Rotation which is measured by the two accelerometers will result in a net acceleration measured by the two accelerometers. Therefore, two displaced single-axis accelerometers oppositely aligned along the same axis may detect or measure rotation, i.e. , angular velocity and/or angular acceleration.
- sensors e.g. , accelerometers, inclinometers, gyroscopes, etc.
- epidermal electronics device 100 may be configured to measure the orientation and/or angular motion of the device and therefore the attachment surface 103 to which the epidermal electronics device 100 is attached (e.g. , a body part such as a limb, etc.).
- a plurality of single-axis sensors are used to measure the orientation of epidermal electronics device 100.
- six single-axis accelerometers 103 may be used to measure a total of six degrees of freedom.
- the six single-axis accelerometers may measure X axis acceleration, Y axis acceleration, and Z axis acceleration along with pitch, roll, and yaw angular accelerations about those axes.
- combinations of multiple sensor types are used to achieve the same functionality.
- three single-axis accelerometers may be configured to measure X axis acceleration, Y axis acceleration, and Z axis acceleration with an additional three single-axis gyroscopes configured to measure pitch, roll, and yaw angular velocities about those axes.
- Other sensors may also be used to measure the orientation, rotation, and/or position of the epidermal electronics device 100 and attachment surface 103.
- a multi-axis accelerometer measuring X axis acceleration, Y axis acceleration, and Z axis acceleration may be used in conjunction with a multi- axis gyroscope to measure pitch, roll, and yaw angular velocities about those axes.
- FIG. 3A illustrates an exploded schematic view of one embodiment of epidermal electronics device 100.
- This embodiment includes substrate layer 105, electronics layer 107 including layer of material 1 1 1 , and barrier layer 109.
- barrier layer 109 Further included within barrier layer 109 are barrier openings 1 19.
- Substrate layer 105 may provide physical support for electronics layer 107. Substrate layer 105 may also facilitate attachment of the epidermal electronics device 100, including electronics layer 107 and barrier layer 109, to the
- substrate layer 105 may be discarded or dissolved after the epidermal electronics device 100 has been attached to attachment surface 103.
- Electronics layer 107 is illustrated as including components on a layer of material 1 1 1 .
- Layer 1 1 1 may be used to provide mechanical support to the components of electronics layer 107. It may also be used to facilitate
- electronics layer 107 is made up only of the electronic components therein (e.g. , there is no supporting layer of material). In such a case, electronics layer 107 may be manufactured on substrate layer 105 or barrier layer 109. Substrate layer 105 or barrier layer 109 provides the mechanical support necessary to make and use epidermal electronics device 100.
- Substrate layer 105 provides protection to the components of the
- Substrate layer 105 may prevent external forces and elements from interfering with the functions of electronics layer 107. For example, substrate layer 105 may prevent moisture from reaching electronics layer 107. In some embodiments, substrate layer 105 may also prevent physical damage to the components of electronics layer 107. Substrate layer 105 may also shield electronics layer 107 from outside sources of radiation, magnetic fields, light, etc.
- barrier layer 109 is permeable or semipermeable. For example, barrier layer 109 may be semipermeable to allow the transfer of drugs through barrier layer 109. Barrier layer 109, as depicted, may include one or more barrier openings 1 19. In one embodiment, barrier openings 1 19 correspond to a particular cell or group of cells 120.
- the barrier openings 1 19 allows for elements of electronics layer 107 to have direct contact with attachment surface 103.
- a sensor 770 may have direct contact with attachment surface 103 through barrier opening 1 19.
- epidermal electronics device 100 may be configured with barrier openings 1 19 in order to better facilitate operation of one or more sensors 770. For example, allowing direct contact with attachment surface 103 may improve the accuracy of an orientation sensor such as an accelerometer. Likewise, a sensor such as a moisture sensor may have improved readings if in contact with attachment surface 103.
- Barrier openings 1 19 also facilitate the operation of interaction devices 780. Interaction devices 780 may operate more efficiently if in direct contact with attachment surface 103
- FIG. 3B illustrates electronics assembly 1 13 according to one embodiment.
- Electronics assembly 1 13 includes components which are located in electronics layer 107. As depicted, electronics assembly 1 13 and the components therein may not be supported by an additional layer of material 1 1 1 (e.g. , electronics assembly 1 13 may include only circuits and components without a supporting material or substrate). In some embodiments, electronics assembly 1 13 is produced on substrate layer 105 (not pictured in FIG. 3B). Electronics assembly 1 13 may include cells 120, sensors 770, interaction devices 780, power source 740 connected to other components via power connection 741 , communications device 750 connected to other components via communications connection 753, control circuit 760, and input/output connection 751 . In some embodiments, control circuit 760 further includes memory 761 , processor 763, and multiplexer 765.
- Interaction device 780 allows epidermal electronics device 100 to interact with attachment surface 103.
- Interaction device 780 may be configured to provide stimulation to the attachment surface in the form of applied voltage and/or drug delivery.
- interaction device 780 may be a MEMS drug delivery system.
- interaction device 780 may be an electrode for delivering an applied voltage to the attachment surface.
- Interaction device 780 also allows external devices to interact with the epidermal electronics device 100.
- a camera or motion capture system may monitor the position of the epidermal electronics device.
- Interaction device 780 may be a passive motion capture marker.
- Interaction device 780 may also be an active motion capture marker.
- interaction device 780 is a light emitting diode (LED) controlled by control circuit 760.
- LED light emitting diode
- the LED may be illuminated intermittently to allow a motion capture system to record the orientation and/or movement of epidermal electronics device 100. This data may be used to calibrate epidermal electronics device 100. It may also be used as a constraint when estimating the orientation and movement of the epidermal electronics device from data gathered by sensors 770. For example, the orientation data from a motion capture system may be used as a boundary or limit when calculating the orientation of a body part using epidermal electronics device 100 (e.g. , if a motion capture system
- interaction device 780 includes a physiological sensor.
- the physiological sensor can be a wearable sensor.
- the physiological sensor can provide information about a user through contact with the skin of the user or proximity to the skin of the user.
- the physiological sensor can include a heart rate sensor, a respiratory sensor, a thermal sensor, a blood pressure sensor, a hydration sensor, an oximetry sensor, an electrocardiograph, an electroencephalograph, and/or an electromyograph.
- Multiple interaction devices 780 may be included in a single electronics layer 107 of epidermal electronics device 100. It is also possible for multiple interaction devices 780 to be located on more than one epidermal electronics device 100. Multiple epidermal electronics devices 100 and corresponding multiple interaction devices 780 may be coordinated and controlled using communication device 750 on each epidermal electronics device 100 as well as control circuit 760 on each epidermal electronics device 100.
- Communications device 750 may be included in electronics assembly 1 13.
- Communications device 750 provides data transfer to and from the epidermal electronics device 100 through communications connection 753.
- Communications connection 753 may be a wire or wireless connection between communication device 750 and another source or receiver of data.
- communications connection 753 may be a connection over a wireless network (e.g. , WiFi, Zigbee, Bluetooth, etc.), a wired interface (e.g. , Ethernet, USB, Firewire, etc.), or other communications connection (e.g. , infrared, optical, ultrasound, etc.).
- communications device 750 is a wireless networking device or wired networking device which establishes communication connection 753 and transmits and/or receives data/signals through communications connection 753.
- Power connection 741 transfers power from power source 740 to other components in electronics layer 107. Power connection 741 provides power from power source 740 to communication device 750, control circuit 760, cells 120, and the components within cells 120 such as interaction devices 780 and sensors 770. Power connection 741 may be a wired or wireless connection. Power connection 741 may be a conductive wire (e.g. , copper, aluminum, etc.). Power connection 741 may be a semiconductor. Where power connection 741 is a wired
- power connection 741 is configured to maintain mechanical integrity when components of electronics layer 107 move relative to one another.
- power connection 741 may be a length of wire long enough to allow movement of the components without causing deformation of power connection 741 sufficient to break the connection.
- Power connection 741 may also be a wireless connection for delivering power (e.g. , direct induction, resonant magnetic induction, etc.).
- Power source 740 provides electrical power to components within electronics layer 107.
- power source 740 is a battery.
- power source 740 may be a disposable battery, rechargeable battery, and/or removable battery.
- power source 740 is configured to allow recharging of power source 740 without removing power source 740 from the electronics layer 107.
- power source 740 may be a rechargeable battery configured to be recharged through wireless changing (e.g. , inductive charging).
- power source 740 is configured to receive direct current from a source outside the electronics layer 107.
- power source 740 is configured to receive alternating current from a source outside the electronics layer 107.
- Power source 740 may include a transformer.
- power source 740 is configured to receive power from a wireless source (e.g. , such that power source 740 is a coil configured to receive power through induction).
- power source 740 can be a capacitor which may be configured to be charged by a wired or wireless source, one or more solar cells, or a
- metamaterial configured to provide power via microwaves.
- input/output connection 751 may be a wire connection between cell 120 and control circuit 760.
- Input/output connection 751 may be configured to allow the connection to flex and deform without suffering mechanical failure.
- input/output connection 751 is configured to maintain the connection between cell 120 and control circuit 760 during deformation of the epidermal electronics device 100 due to movement of the attachment surface 103.
- input/output connection 751 allows for deformation while maintaining mechanical integrity by including an additional length of wire which allows for connection points to separate from one another.
- input/output connection 751 may be a wire with slack to allow two or more components to move relative to one another and not cause mechanical degradation of the input/output connection.
- input/output connection 751 is a conductive wire (e.g. , copper, aluminum, etc.). Input/output connection 751 may be a semiconductor. In some embodiments, input/output connection 751 is a wireless connection.
- Input/output connection 751 allows the components within cell 120 to communicate data to control circuit 760.
- the component within cell 120 may output data to the control circuit through input/output connection 751 .
- sensor 770 located in cell 120 may output measurement data, in the form of a voltage, across input/output connection 751 to control circuit 760.
- Input/output connection 751 also allows for the control circuit to communicate with the component within cell 120.
- Control circuit 760 may send an input to a component within cell 120 through input/output connection 751 .
- control circuit 760 may send an input signal to interaction device 780 which causes interaction device 780 to deliver a drug or chemical to attachment surface 103.
- Cell 120 may also facilitate communication.
- Control circuit 760 may also send a calibration signal to sensor 770 or interaction device 780 using input/output connection 751 .
- power connection 741 and input/output connection 751 are integrated into a single connection.
- an integrated connection may provide power and input/output through a modulated or otherwise alterable signal.
- electronics assembly 1 13 includes control circuit 760.
- Control circuit 760 may further include multiplexer 765, processor 763, and memory 761 .
- Processor 763 may be implemented as a general-purpose processor, an application specific integrated circuit (ASIC), one or more field programmable gate arrays (FPGAs), a digital-signal-processor (DSP), a group of processing components, or other suitable electronic processing components.
- Memory 761 is one or more devices (e.g. , RAM, ROM, Flash Memory, hard disk storage, etc.) for storing data and/or computer code for facilitating the various processes described herein.
- Memory 761 may be or include non-transient volatile memory or non-volatile memory.
- Memory 761 may include database
- Memory 761 may be communicably connected to processor 763 and provide computer code or instructions to processor 763 for executing the processes described herein.
- Multiplexer 765 may be configured to allow multiple sensors 770 and/or interaction devices 780 to share an input/output connection 751 .
- cells 120 also facilitate multiplexing of signals from multiple components.
- control circuit 760 is configured to receive data from sensors 770.
- control circuit 760 may receive acceleration data in the form of a measured voltage from an acceleration sensor. This data may be received by control circuit 760 through multiplexer 765.
- Control circuit 760 may store sensor data in memory 761 .
- Control circuit 760 may output sensor data to communications device 750.
- control circuit 760 is also configured to send control signals to sensors 770.
- control circuit 760 may calibrate a sensor 770 by sending a control signal to the sensor.
- Control circuit 760 may also turn sensor 770 off or on.
- control circuit 760 may send a control signal which causes cell 120 to disconnect sensor 770 from power connection 741 .
- Control circuit 760 may also select which sensors to receive data from using processor 763 and memory 761 .
- Control circuit 760 may receive control signals from communication device 750.
- control circuit 760 also generates control signals with processor 763 and memory 761 .
- control circuit 760 may send a control signal to turn off a sensor 770 in response to abnormal data received from the sensor.
- Control circuit 760 may also send a control signal to turn off a sensor 770 in response to data from other sensors 770.
- some sensors 770 may be turned off in order to conserve power source 740 if minimal acceleration is detected. When using multiple sensors, one sensor 770 may be maintained in the on position. When increased acceleration activity is detected, control circuit 760 may reactivate, or turn on, the remaining sensors 770.
- control circuit 760 is also configured to receive data from interaction devices 780.
- control circuit 760 may receive drug delivery data from a drug delivery device. This data may be received by control circuit 760 through multiplexer 765. Control circuit 760 may store this data in memory 761 . Control circuit 760 may output interaction device data to
- Control circuit 760 is also configured to send control signals to interaction devices 780.
- control circuit 760 may send a control signal to a drug delivery device causing the device to administer a drug to attachment surface 103.
- Control circuit 760 may also turn off and on interaction devices 780.
- Control circuit 760 may receive signals from other components in
- control circuit 760 may receive signals from communications device 750. Control circuit 760 may also receive signals from power source 740. For example, control circuit 760 may receive a signal from power source 740 indicating how much power is available. Control circuit 760 may use this to take further action. For example, control circuit 760 may communicate this or other information to another device using communications device 750. Control circuit 760 may also take action by controlling components of the electronics layer 107 including cells 120, interaction devices 780, and/or sensors 770. In some embodiments, the functions of control circuit 760 are carried out by the circuitry of cells 120. For example, cells 120 may include transistors and/or additional components which allow cell 120 or a network of cells 120 to perform the above described functions of control circuit 760.
- control circuit 760 is located in an area not within electronics layer 107.
- communications device 750 may send and receive control signals and data.
- an external control circuit may perform the above described functions with communications device 750 relaying data between the components of the electronics layer 107 (e.g. , sensors 770 and interaction devices 780) and the external control circuit.
- Sensors 770 in electronics assembly 1 13 may include sensors configured to measure orientation data.
- Orientation data may include data regarding acceleration, orientation, movement, angular motion, and/or rotation of attachment surface 103.
- sensors 770 may include one or more of single-axis accelerometers, multi-axis accelerometers, single-axis gyroscopes, multi-axis gyroscopes, single-axis inclinometers, or multi-axis inclinometers. In some embodiments, combinations of these sensors are used to measure acceleration, orientation, movement, angular motion, and/or rotation.
- sensors 770 include sensors to measure characteristics of attachment surface 103.
- sensors 770 may be moisture sensors, electrodes,
- Interaction devices 780 may include devices configured to alter attachment surface 103 or provide data to control circuit 760.
- interaction devices 780 may include drug delivery devices, chemical delivery devices, electrodes, motion capture sensors, LEDs, etc.
- FIG. 4A illustrates an embodiment of another epidermal electronics device shown as epidermal electronics device 101 .
- epidermal electronics device 101 houses large components in a separate housing from sensors and/or interaction devices in electronics assembly 1 13. These large components may be located outside of the flexible patch which includes
- Epidermal electronics device 101 is shown with electronics module 610.
- Electronics module 610 may hold any or all of power source 740, communications device 750 and/or control circuit 760.
- electronics module 610 is separate from electronics layer 107 shown with view 1 10 (e.g. , electronics module 610 may house components outside of electronics assembly 1 13 and may provide for connection to electronics assembly 1 13).
- Electronics module 610 may be a housing containing the above mentioned components.
- electronics module 610 may be a plastic or polymer housing with access to the components housed within.
- Electronics module 610 may also be a film or other protective encasement.
- electronics module 610 allows for power source 740, communications device 750 and/or control circuit 760 to be on a larger scale than if they were within electronics layer 107.
- power source 740 may be a larger battery.
- Processing circuit 760 may be an integrated circuit or SOC.
- electronics module 610 is connected to electronics layer 107 by power connection 741 .
- Electronics module 610 may provide power from power source 740 to components of the electronics layer 107 (e.g. , sensors, interaction devices, etc.) through power connection 741 .
- electronics module 610 is also connected to the electronics layer 107 by input/output connection 751 .
- Electronics module 610 may be connected to electronics layer 107 and/or electronics assembly 1 13 by one or more input/output connections 751 . This may facilitate the use of additional components (e.g. , sensors, interactions devices, etc.). The use of multiple input/output connections 751 may reduce the need, partially or completely, for multiplexing.
- epidermal electronics devices 100 and/or 101 may measure the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position (e.g. , orientation data) at one point of the attachment surface using a combination of a multi-axis accelerometer 710, multi-axis gyroscope 715, and multi-axis inclinometer 713. Using a combination of these sensors, the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of the attachment surface may be determined with six degrees of freedom. Multiple combinations of sensors may be used to achieve measurement of six degrees of freedom.
- one type of sensor is used as a constraint on the measurements of another sensor.
- the data gathered from the multi- axis inclinometer 713 may be used as a constraint on the data gathered by the multi-axis accelerometer 710 or multi-axis gyroscope 715.
- the angle-relative to gravity measurements of the multi-axis inclinometer may be used as a constraint on accelerometer or gyroscope data integration.
- the sensors are integrating accelerometers.
- measurements from inclinometers may be used directly (e.g. , for angle relative to gravity).
- Inclinometer measurements may also be used as a check on orientation derived from the integration of data from multi-axis accelerometers 710 or from the integration of data from multi-axis gyroscopes 715. This may be used to limit error propagation. This may also include using inclinometer measurement data to verify data from other sensors and/or verify the orientation of the epidermal electronics device as determined using other data.
- Epidermal electronics devices 100 and/or 101 may measure the
- Epidermal electronics devices 100 and/or 101 may use these additional sensors (e.g. , multi-axis accelerometer, multi-axis gyroscope 715, and/or multi-axis inclinometer 713) to measure orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position at multiple points of the attachment surface 103 with one epidermal electronics device 100.
- additional sensors e.g. , multi-axis accelerometer, multi-axis gyroscope 715, and/or multi-axis inclinometer 713
- orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position are measured at multiple points using multiple epidermal electronics devices 100. Measurements from multiple epidermal electronics devices 100 and/or 101 (inter epidermal electronics device measurements) may be used as a constraint on other sensor measurements and integration. Constraints may be applied by the processing circuit 513. In some embodiments, constraints are applied by control circuit 760.
- multiple electronics layers 107 each with its own separate barrier layer 109 and substrate layer 105 (e.g. , multiple epidermal electronics patches), connect to the same electronics module 610. This may allow for measurement and interaction at multiple points on attachment surface 103 with a single supporting power source 740, communications device 750, and control circuit 610.
- electronics module 610 may be connected to data acquisition and processing device 510 via communications connection 753.
- Data acquisition and processing device 510 includes
- Communications device 750 allows data acquisition and processing device 510 to receive and send data and/or control signals to communications device 750 in electronics module 610.
- communication device 750 in data acquisition and processing device 510 may receive and send data and/or control signals to communications device 750 in electronics layer 107 of an epidermal electronics devices 100 and/or 101 .
- data acquisition and processing device 510 also includes processing circuit 513.
- Processing circuit 513 receives data from epidermal electronics devices 100 and/or 101 .
- Processing circuit 513 analyzes the data.
- processing circuit 513 may use algorithms to calculate or estimate the orientation, acceleration, movement, rotation, angular velocity, and/or position of the epidermal electronics devices 100 and/or 101 . These algorithms may include a Kalman filter, dynamic filter, a customized algorithm, etc.
- Processing circuit 513 may calculate or estimate the orientation, acceleration, movement, angular motion, angular acceleration, rotation, angular velocity, and/or position of one or more locations on an epidermal electronics device 100 and/or 101 or multiple epidermal electronic devices 100 and/or 101 .
- processing circuit 513 also sends control signals to epidermal electronics device 100.
- processing circuit 513 of data acquisition and processing device 510 may send a control signal to epidermal electronics device 100, using communication devices 750, to calibrate sensor 770.
- processing circuit 513 and/or data acquisition and processing device 510 may include one or more of processors and memory.
- Data acquisition and processing device 510 may output data, control signals, and/or estimations or calculations regarding orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position to additional computing devices. Data acquisition and processing device 510 may also output to one or more epidermal electronics devices 100 and/or 101 . This may include outputting data gathered by one epidermal electronics device 100 or 101 to a second epidermal electronics device 100 or 101 . In some embodiments, data acquisition and processing device 510 includes a user interface. In other embodiments, data acquisition and processing device 510 is controlled with an additional computer. In some embodiments, data acquisition and processing device 510 may also output data to another computer. In some embodiments, an epidermal electronics device 100 with power source 740, communications device 750, and control circuit 760 integrated in electronics layer 107 is connected to data acquisition and processing device 510.
- FIG. 5 illustrates an embodiment of epidermal electronics devices 100
- Two or more epidermal electronics devices 100 or 101 may communicate with one another through communications connection 753 and communication devices 750.
- Communications connection 753 may be a wireless connection or a wired one.
- Multiple epidermal electronics devices 100 may also communicate with data acquisition and processing device 510.
- Using two or more epidermal electronics devices 100 or 101 allows for multiple points to be measured simultaneously. For example, the orientation, acceleration, movement, rotation, angular velocity, angular acceleration, and/or position of one point may be measured relative to that of another through the use of two or more epidermal electronics devices 100.
- FIG. 6 illustrates one embodiment of multiple epidermal electronics devices 100 used with user 680.
- multiple epidermal electronics devices 100 are attached to user 680.
- Epidermal electronics devices 100 may communicate using wireless communications connection 753. Data may be communicated to data acquisition and processing device 510 which may include processing circuit 513.
- External sensing devices 550 may also be used to gather information about user 680 and/or epidermal electronics devices 100. External sensing devices 550 may also communicate data with wireless communication connection 753.
- epidermal electronics devices 100 are placed on various body parts of user 680.
- epidermal electronics devices may be placed on fingers, hands, forearms, upper arms, feet, legs, the head, etc.
- the attachment surface 103 of user 680 is his or her skin.
- Each epidermal electronics device may measure orientation with one of or a combination of single or multi-axis accelerometers, single or multi-axis
- Epidermal electronics devices 100 may communicate with one another and/or with data acquisition and processing device 510 using communications connection 753 and
- communications devices 750 In this embodiment, communications connection 753 is illustrated as a wireless connection.
- epidermal electronics devices 100 may form a network (e.g. , ad hoc network). The network of epidermal electronics devices 100 may communicate data and control signals to other networks of epidermal electronics devices 100. Multiple networks of epidermal electronics devices 100 may share information. This may allow data to be collected from multiple networks (e.g. , one network per user, with multiple users) by a single data acquisition and processing device 510.
- FIG. 6 further illustrates that two or more epidermal electronics devices 100 may be used to measure attachment surface parameters (e.g. , orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position) relative to one another.
- attachment surface parameters e.g. , orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position
- the attachment surface parameters of a forearm may be measured relative to the attachment surface parameters of an upper arm.
- the relative orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of one body part to another may be measured in this way.
- the orientation of a finger may be determined relative to a hand.
- Epidermal electronics devices 100 may also be used to measure a change in attachment surface parameters. Such changes may be used to determine motion of a user, such as gait, gestures, athletic motions (e.g. , golf swings, pitching motions, etc.), or the like. This measurement may be made absolutely by a single epidermal electronics device 100 or relative to an additional one or more epidermal electronics device 100. For example, as a user's leg moves, the change in orientation and angular velocity may be measured. This measurement may be made absolutely by epidermal electronics device 100. The measurement may also be made relative to the moving torso of user 680. In that case, measurements are collected by epidermal electronics device 100 on the torso and epidermal electronics device 100 on the leg.
- the relative orientation and angular velocity may be calculated by data acquisition and processing device 510.
- a single epidermal electronics device 100 may be used to measure attachment surface parameters at multiple locations. This may include multiple locations across multiple body parts. For example, a single epidermal electronics device 100 may measure the orientation of the torso and a leg of user 680.
- Data acquisition and processing device 510 may use a variety of techniques to determine or estimate the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of user 680. Data acquisition and processing device 510 may also use the same or other techniques to determine the posture and/or gestures of user 680. These techniques may include applying algorithms, Kalman filters, and/or other dynamic filters to measurements and/or applying constraints provided by one or more epidermal electronics devices 100. For example, a Kalman filter may be used to estimate the orientation of epidermal electronics device 100 attached to a body part of a user. The orientation can be described by various types of state vectors, such as Euler angles, quaternions, etc.
- physics-based dynamic filters e.g. , Kalman filters
- filters may incorporate additional state variables (such as angular velocity and/or angular acceleration), which are linked via a state propagation model (e.g. , continuous propagation via differential equations, discrete propagation via state transition matrices).
- the dynamic filter incorporates measurements related to the state variables (e.g.
- the dynamic filter can include estimates of the noise in such measurements, and hence in the uncertainty in its estimate of each state variable; these uncertainty estimates can be tracked throughout time by the filter.
- Dynamic filters can readily be formulated to handle different state vector representations (e.g. , angles vs quaternions), different measurement types (combinations of direct angular measurements and/or angular velocity and/or angular acceleration), and different sensors (e.g.
- Kalman filters used for 3D orientation estimation include: "Design, Implementation, and Experimental Results of a Quaternion-Based Kalman Filter for Human Body Motion Tracking", Xiaoping Yun, Eric Bachmann, IEEE Transactions on Robotics, Vol 22, No 6, 2006; "Kalman-Filter-Based Orientation Determination Using
- Inertial/Magnetic Sensors Observability Analysis and Performance Evaluation", Angelo Sabatini, Sensors, September 27, 201 1 ; "Using an Extended Kalman Filter for Rigid Body Pose Estimation", Kjartan Halvorsen, et al, Journal of
- constraints are supplied by other sources such as models of human movement, external sensing devices, etc.
- constraints may define ranges in which the measurements of epidermal electronics device 100 may be considered valid.
- Data acquisition and processing device 510 may combine various measurements and/or constraints using a Kalman or other dynamic filter. This may result in a better estimate of unknown variables than one based on one measurement or data point. Additionally, signal noise and inaccuracies may be reduced.
- Epidermal electronics devices 100 may also be used to measure the state of user 680.
- Epidermal electronics devices may be used to measure the posture of user 680. By measuring orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position at one or more locations, the user's posture may be determined. For example, it can be determined whether a user 680 is sitting, standing, or lying down using
- inclinometers and accelerometers measuring various body parts. If a person is sitting, inclinometers on the torso and on a leg will give different readings of the angle relative to gravity. Corresponding accelerometer or gyroscope readings indicating little or no acceleration could indicate that a user 680 is sitting.
- the posture measured includes the positioning of one or more body parts during movement or a particular type of movement.
- epidermal electronics devices 100 may measure the posture of a user 680 while running to ensure proper form or to be used to improve form.
- epidermal electronics devices 100 may measure the posture of a user 680 while swinging a golf club to ensure proper form or to be used to improve form.
- a single epidermal electronics device 100 may be used to measure attachment surface parameters at multiple locations.
- Multiple epidermal electronics devices 100 may be used to measure gestures made by user 680.
- the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of specific body parts along with the change in the same parameters may be measured.
- epidermal electronics devices 100 placed on the fingers, hands, and arms may be used to detect gestures made using those body parts.
- measuring the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of those body parts along with the change in the same parameters may allow for sign language to be interpreted.
- gestures are defined as any particular movement or movements of one or more body parts.
- Epidermal electronics device 100 may measure movements, and data acquisition and processing device 510 may compare the movements to a library of gestures.
- the library of gestures may contain the movements comprising gestures. Using the comparison, data acquisition and processing device 510 may estimate or determine if a gesture has been made.
- a human model may be used in conjunction with one or more epidermal electronics devices 100 and data acquisition and processing device 510.
- a human model may be a computer model of human movement and provide a way of checking measured movements against a model of all possible movements.
- a human model may include a human connectivity model, a musculoskeletal model, or other model of movement.
- the human connectivity model may model a human as an
- interconnectivities, and joints can be used to model postures and postural motions based upon orientation sensing epidermal electronics devices on one or more body parts.
- the model may be generic or may be personalized for an individual user. In some embodiments, a generic or personalized model is adjusted using measurements provided by epidermal electronics device 100.
- the human model may be used by the data acquisition and processing device to assist in
- a human connectivity model may be used as a constraint on sensor
- further constraints include measurements from additional sensors such as inclinometers.
- the measurements from one or more inclinometers or magnetometers may be used as a check on orientation estimated from an accelerometer. This technique may be used to limit error propagation.
- further constraints may also include inter epidermal electronics device measurements.
- external sensing device 550 may be used in conjunction with epidermal electronics device 100.
- external sensing device 550 is a device external to epidermal electronics device 100 used to measure orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position.
- External sensing device 550 may be a camera or motion capture image sensor.
- External sensing devices 550 may be used to intermittently make measurements to determine posture. For example, images from external cameras may be used to measure the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of a user 680.
- measurements from motion capture image sensors of active or passive interaction devices 780 are used to determine the orientation,
- Measurements from one or more external sensing devices 550 may be used to reset epidermal electronics device 100 based determinations. For example, measurements taken from an external sensing device 550 may be used to calibrate the sensors of one or more epidermal electronic devices 100. In some embodiments, the measurements from external sensing devices 550 may be used to update or individualize a human model for a user 680. The human model may also serve as a calibration point for the sensors of one or more epidermal electronics devices 100. Interaction devices 780 may also be calibrated in the same fashion.
- external sensing device 550 is connected to data acquisition and processing device 510 via communication connection 753. External sensing device 550 may include communications device 750 to facilitate communication via communication connection 753. In some embodiments, external sensing device 550 may be connected to control circuit 760 via communications connection 753 and communications device 750.
- an epidermal electronics device 100 determines its position and/or movement relative to another location using an antenna and a field source at the other location.
- Sensors 770 may be or include one or more antennas.
- the antenna or antennas may be one or more of a dipole antenna, loop antenna, plate antenna, magnetometer, vector magnetometer, and/or other types of antennas.
- Epidermal electronics device 100 may use one or more antennas to measure a field source. Based on the measurement of one or more field source, epidermal electronics device 100 may estimate the location, orientation, angular motion, rotation, and/or other movement of epidermal electronics device 100 relative to the field source.
- the field source may be a source of any measureable field.
- the field source may be a source of a magnetic field, electromagnetic radiation (e.g. , microwaves, radio waves, etc.), and/or other source of a measureable field.
- the field source may be a microwave generator and/or antenna, radio transmitter and/or antenna, or other combination of hardware configured to generate a measureable field.
- a natural field source can be used, for instance epidermal electronics device may use a magnetometer to measure the Earth's magnetic field, and hence determine one or more angular components of its orientation.
- Epidermal electronics device 100 may include one or more antennas for measuring the type of field generating by the field source.
- Epidermal electronics device 100 may include additional hardware for the reception and/or measurement of one or more field sources.
- epidermal electronics device 100 may include a receiver, signal processing hardware, and/or other hardware.
- the field source is emitted by a second epidermal electronics device 100. This may allow the first epidermal electronics device 100 to determine its location, orientation, angular motion, rotation, and/or other movement relative to the second epidermal electronics device 100 which emits the field source. Orientation information may be sent from the other location to epidermal electronics device 100 containing information about the field source, e.g. , type, spatial field pattern, frequency, orientation of the source, etc.
- the field source may be or be included in interaction device 780. In other embodiments, the field source may be fixed. For example, the field source may be a fixed emitter which generates a field encompassing one or more separate epidermal electronics devices 100.
- one or more epidermal electronics devices 100 may measure individual absolute location, orientation, angular motion, rotation, and/or other movement relative to the fixed field source.
- the fixed field source may be included in data acquisition and processing device 510 or another fixed device.
- one or more epidermal electronics devices 100 may determine their location, orientation, rotation, angular motion, and/or other movement relative to other epidermal electronics devices 100.
- the epidermal electronics device may estimate its absolute location, orientation, rotation, angular motion, and/or other movement by combining the relative information with corresponding absolute information for the other epidermal electronics devices.
- an epidermal electronics device 100 determines its position and/or orientation relative to another location (e.g., a second epidermal electronics device) using a range sensor and a range-determination source at the other location.
- Range sensors may include one or more receivers for detecting a range signal generated by the range-determination source.
- the range-determination source may generate range signals comprising pulsed ultrasound waves or pulsed electromagnetic waves.
- the range sensor an ultrasound or an electromagnetic detector respectively
- a single range sensor can be used to detect the range itself.
- epidermal electronics device 100 comprises multiple range sensors, and uses the differential ranges of each from the range-determination source, to determine the orientation of epidermal electronics device relative to the range determination source.
- Orientation information may be sent from the other location to epidermal electronics device 100 containing information about the range-determination source, e.g., pulse timing, wave frequency, emission pattern, orientation of the source, etc.
- the range-determination source e.g., pulse timing, wave frequency, emission pattern, orientation of the source, etc.
- two range sensors can be used to determine one angular component of the orientation
- three range sensors can be used to determine two angular components of the orientation.
- the roles of the range sensor and the range-determination sources can be reversed; here epidermal electronics device 100 can comprise multiple (e.g., 2 or 3) range- determination sources, and another location (e.g., a second epidermal electronics device) can comprise a range sensor. Differential range measurements by the range sensor can be used to determine the orientation of epidermal electronics device 100.
- epidermal electronics device 100 comprises both one or more range-determination sources and one or more range sensors, using reflectors (e.g., diffuse, specular, or retro) at another location to return range signals from the range-determination source to the range sensors, allowing determination of the range and/or orientation between epidermal electronics device 100 and the other location.
- a plurality of fields may be used to measure location, orientation, rotation, angular motion, and/or other movement relative to multiple field sources (fixed and/or moving).
- field sources may have different timings or frequencies in order to allow epidermal electronics devices 100 to distinguish between a plurality of field sources. This may allow for additional techniques for estimating the location, rotation, and/or other movement of one or more epidermal electronics devices.
- epidermal electronics device 100 may triangulate its location using a plurality of field sources.
- the estimation of absolute and/or relative position, orientation, rotation, angular motion, and/or other movement may be calculated by one or more epidermal electronics device 100.
- calculations may be performed using one or more control circuits on one or more epidermal electronics devices 100.
- Epidermal electronics devices 100 may communicate information for use in these calculations using one or more of the techniques described herein.
- calculations are performed remote from the epidermal electronics devices 100.
- one or more epidermal electronics devices 100 may communicate information (e.g. , field measurements) to data acquisition and processing device 510 which may perform the calculations described herein.
- Orientation, motion, and/or location may be used as a parameter to control one or more interaction devices 780.
- orientation, motion, or location may be used to control a drug delivery system. If user 680 is lying down (e.g. , as determined by epidermal electronics device 100 and/or data acquisition and processing device 510), a drug delivery system may be instructed not to deliver pain medication. Conversely, if a user 680 is moving, the drug delivery system may be instructed by data acquisition and processing device 510 and/or control circuit 760 to administer pain medication.
- the effect of the interaction may be measured. This may also allow the interaction device 780 to be calibrated. For example, if a measured parameter (e.g., posture of user 680 during movement) does not show improvement, a larger dose of a drug may be used next time the interaction device 780 is activated.
- a measured parameter e.g., posture of user 680 during movement
- orientation, motion, and/or location may be used to control sensors 770. For example, if a user is in a lying down position, sensors 770 and/or interaction devices 780 may be turned off to conserve power.
- any of the parameters described herein e.g., orientation, posture, acceleration, etc.
- Epidermal electronics device 100 may provide an alert when a certain parameter or parameters exceeds a threshold. For example, if rapid acceleration in an event such as a car crash is detected, LEDs on the epidermal electronics device may be illuminated, or illuminated in a particular color corresponding to severity, to alert a viewer as to possible injury. This type of configuration may be used in other settings as well (e.g., physical therapy).
- the alert is provided by data acquisition and processing device 510.
- Data acquisition and processing device 510 may provide the alert using a display.
- Data acquisition and processing device 510 may provide the alert to another device or computer (e.g., provide an alert to a mobile computing device or phone).
- method 810 of using one or more epidermal electronics devices to measure orientation is shown according to one
- Data regarding the orientation and/or angular motion of the surface to which the epidermal electronics device is attached is provided (812). This may be accomplished with any combination of sensors previously described.
- the sensor data is then collected (814). For example, a control circuit may
- the control circuit may collect/acquire the data using, in part, a multiplexer. In some embodiments, cells assist in multiplexing.
- the sensor data is then communicated to a data acquisition and processing device. This may be done using a combination of the control circuit and the communications device.
- An algorithm is applied to the sensor data (816).
- the data acquisition and processing device applies the algorithm.
- the control circuit applies the algorithm.
- One or more algorithms may be used, and the algorithms may perform a variety of functions. For example, algorithms may be used to reduce signal noise, eliminate extraneous data points, generate constraints for calculating the orientation and/or position of the attachment surface, etc.
- the algorithms used may include a Kalman filter, dynamic filter, or other custom filter.
- the orientation, motion, rotation, and/or position of the attachment surface and/or epidermal electronics device is estimated or calculated (818).
- the data acquisition and processing device uses the sensor data and/or constraints to estimate or calculate orientation, motion, rotation, and/or position of the
- control circuit uses the sensor data and/or constraints to estimate or calculate orientation, motion, rotation, and/or position of the attachment surface and/or epidermal electronics device.
- one or more algorithms are also used to perform calculations. Posture may be estimated in addition to or instead of orientation, rotation, and/or position of the attachment surface and/or epidermal electronics device.
- the location, orientation, motion, and/or rotation of a body part may be referenced to a position in/on the body part which differs from that of the attachment surface and hence epidermal electronics device 100 (for instance, the reference site of a forearm may be at the midpoint of the radius bone while the attachment surface is located on the outer skin surface near the wrist; in such cases, the locations, orientations, motions, and rotations at the two locations may differ by straightforwardly applied offsets.
- the data acquisition and processing device may use constraints or checks generated from other sources. For example, constraints may be supplied by the algorithms, additional sensors such as inclinometers, and/or external sensing devices such as motion capture image sensors.
- the epidermal electronics device may begin the cycle again by using sensors to produce data regarding the orientation and/or rotation of the surface to which the epidermal electronics device is attached.
- steps (812)- (818) are performed simultaneously as in data pipelining. For example, as a first set of data is being used to calculate orientation, a second set may be filtered using an algorithm, a third set may be collected by the control circuit, and a fourth set may be generated by the sensors. Simultaneously with the next cycle of steps, additional actions may be taken. In some embodiments the additional actions are taken before the next cycle of steps begins.
- the sensors and/or interaction devices may be calibrated (820).
- the data acquisition and processing device may determine that a sensor and/or interaction device needs to be calibrated. Using data from other sensors onboard the epidermal electronics device, data from external sensing devices, models, and/or calculated constraints, the data acquisition and processing device, in conjunction with the control circuit, may calibrate a sensor or interaction device. In some embodiments, the calibration is done solely by the control circuit.
- the data acquisition and processing device may be able to override a predetermined calibration algorithm run by the processing circuit.
- various types of data may be stored (822).
- data is stored by the data acquisition and processing device.
- data is stored by the control circuit.
- the data may be stored locally within the data acquisition and processing device or may be transferred to an additional computer, display device, mobile device, etc.
- the results and/or only a portion of the data is stored.
- the data is temporarily stored such that a device may display the data and/or a graphical representation of the data.
- one or more interaction devices may be controlled (824).
- the data acquisition and processing device, in conjunction with the control circuit, may activate one or more interaction devices. For example, upon determining a particular orientation of a user, the data acquisition device and control circuit may activate an interaction devices.
- interaction device to deliver a drug.
- interaction devices are controlled by the control circuit without input from a data acquisition and processing device.
- the epidermal electronics device is attached (902).
- the epidermal electronics device is attached to attachment surface 103 which may include skin, bone, muscle tissue, the heart, the lungs, etc.
- attachment surface 103 is a bandage attached or to be attached to the skin or other organ.
- Sensor data is acquired (904).
- Acquiring sensor data may include measuring one or more parameters of attachment surface 103.
- sensors 770 in epidermal electronics device 100 measure one or more parameters of attachment surface 103. For example, sensors 770 may measure the orientation of attachment surface 103 as approximated by the orientation of electronics layer 107 in epidermal electronics device 100.
- Sensors 770 may also measure the rate of change in the orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of attachment surface 103. In some embodiments, the rate of change of these parameters is calculated by either control circuit 760 or data acquisition and processing device 510.
- the sensor data is collected (906). For example, the sensor data is collected by control circuitry. This may be accomplished using multiplexer 765 within control circuit 760.
- the data is processed (908). For example, control circuit 760 may use processor 763 and memory 761 to calculate the orientation of epidermal electronics device 100.
- control circuit 760 may use a Kalman filter, dynamic filter, or other algorithm to calculate or estimate the orientation of epidermal electronics device 100.
- Control circuit 760 may also use constraints in making calculations such as data from other sensors 770 in epidermal electronics device 100, data from another epidermal electronics device 100, data from external sensing devices 550, and/or models. Control circuit 760 may also monitor sensors 770 for irregular measurements.
- control circuit 760 sends the data to data acquisition and processing device 510 to be displayed.
- data acquisition and processing device 510 displays the data.
- the data displayed may be one of or a combination of the raw sensor data, constraints, models, processed data, estimated orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of the attachment surface, graphical representations of position, orientation, gait, and/or posture, etc.
- the data is displayed on another computer or device to which data acquisition and processing device 510 sends the relevant information.
- Method 900 may begin again by measuring one or more parameters with sensors 770 of epidermal electronics device 100. In some embodiments, several iterations take place prior to the display of data. In some embodiments, only one iteration of the steps occurs.
- a control signal is sent (910) following the
- the control signal may be sent to sensor 770 and/or interaction device 780.
- the sensor 770 is controlled (912). This may include calibrating sensor 770. This may also include turning sensor 770 on or off.
- interaction device 780 is controlled (914). This may include activating interaction device 780, for example, delivering a drug with a drug delivery device. Controlling interaction device 780 may also include turning interaction device 780 on or off.
- the method may begin again by measuring one or more parameters with sensors 770 of epidermal electronics device 100.
- control circuit 760 outputs data using
- control circuit 760 may output
- the data may be output to data acquisition and processing device 510.
- the data is output to other devices.
- data may be output to other epidermal electronics devices 100 or to a computer other than data acquisition and processing device 510.
- the output data may be acquired and processed.
- data is acquired and processed by data acquisition and processing device 510.
- Data acquisition and processing device 510 may acquire the data through communications device 750 and
- the data may be processed by a variety of techniques to estimate or calculate orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position of epidermal electronics device 100.
- data acquisition and processing device 510 may use a Kalman filter, dynamic filter, or other algorithm to calculate or estimate the orientation of epidermal electronics device 100.
- Data acquisition and processing device 510 may also use constraints in making calculations such as data from other sensors 770 in epidermal electronics device 100, data from another epidermal electronics device 100, data from external sensing devices 550, and/or models.
- a control signal may be sent following the acquisition of the data from sensors 770 and processing of the data by data acquisition and processing device 510.
- Data acquisition and processing device 510 may send the control signal following the acquisition and processing of the data.
- the control signal may be sent to control circuit 760 using communication device 750 and communication connection 753.
- control circuit 760 uses the data or information transferred to send control signals as instructed by data acquisition and processing device 510.
- Control circuit 760 may also send a control signal to one or more interaction devices 780 and/or one of more sensors 770 based on a calculation by control circuit 760. For example, control circuit 760 may send a calibration control signal to sensor 770 to make a correction following an extraneous measurement detected by control circuit 760.
- FIGS. 7-8 provide various examples of operating epidermal electronics device 100, other steps and/or components may be used, and all such embodiments are within the scope of the present disclosure.
- the method 810 of using epidermal electronics device 100 may include additional steps or components.
- Sensors 770 may produce data regarding orientation, acceleration, movement, angular motion, rotation, angular velocity, angular acceleration, and/or position or any other measured
- cells 120 perform the function of multiplexing sensor output.
- the functions of control circuit 760 may be performed by cells 120 and/or data acquisition and processing device 510.
- the functions of data acquisition and processing device 510 are performed by control circuit 760.
- control circuit 760 may be configured to apply algorithms to the sensor data and to estimate or calculate orientation, rotation, and/or position of attachments surface 103.
- method 900 of operation of an epidermal electronics device may include additional steps or components. The individual steps of method 900 may be performed simultaneously (e.g., as in pipelining). Other steps and components may be used in the methods illustrated in FIGS. 7 and 8 consistent with the disclosure made herein with regards to components and their functions and the functions of the epidermal electronics device.
- a repetitive stress injury may include damage to tendons, nerves, and other soft tissues that is caused by the repetitive and forceful physical movements or vibrations and sustained positioning of body portions in a
- the systems and methods include generating sense signals from one or more physiological sensors and motion sensors positioned proximate to a body portion of a subject.
- the systems and methods described herein may be used to monitor and treat a medical condition through the generation of sense signals from one or more physiological sensors and motion sensors configured to monitor one or more physiological conditions of a subject and one or more movements or positions of a body portion of the subject and to provide an effect to the body portion through action of one or more effectors.
- the medical condition can include, but is not limited to, a joint-based non-inflammation condition (e.g., arthralgia, osteoarthritis), a joint-based inflammation condition (e.g., rheumatoid arthritis, psoriatic arthritis, arthritis, ankylosing spondylitis, juvenile idiopathic arthritis and systemic lupus erythematosus), an enthesis-based condition (e.g., enthesitis), a tendon- based condition (e.g., tendonitis, tenosynovitis), a ligament-based condition (e.g., strain), a nerve entrapment or compression based condition or syndrome (e.g., carpal tunnel entrapment, cubital tunnel entrapment, tarsal tunnel entrapment, radial nerve entrapment, meralgia paresthetica), and the like.
- a joint-based non-inflammation condition e.g
- carpal tunnel syndrome a type of carpal tunnel entrapment
- carpal tunnel syndrome relates to compression of the median nerve as it passes through the carpal tunnel into the wrist, and can be related to occupational factors (see, e.g., Palmer, Best Pract Res Clin Rheumatol. Feb 201 1 ; 25(1 ): 15-29, which is incorporated herein by reference).
- the systems and methods described herein employ one or more physiological sensors to monitor one or more physiological conditions of a subject and to generate a sense signal in response thereto.
- the physiological sensors include, but are not limited to, an electromyograph, a strain sensor, a temperature sensor, an optical sensor (e.g. , an LED), and an acoustic sensor.
- the systems and methods described herein employ one or more motion sensors to monitor a movement or position of a body portion of a subject and to generate a sense signal in response thereto.
- the motion sensors include, but are not limited to, sensors configured to measure a repeated motion of a body portion, sensors configured to measure a number of repetitions of a movement of a body portion, sensors configured to measure a speed of a movement of a body portion, sensors configured to measure a duration of movement of a body portion, sensors configured to measure a disposition of a body portion relative to a second body portion, and sensors configured to measure an angle of movement of a body portion.
- the systems and methods described herein employ one or more effectors to affect a body portion responsive to processing of sense signals generated by the sensor assembly.
- the effectors include, but are not limited to, tactile stimulators (e.g. , a tactile stimulator configured to provide a tactile indication regarding a position of a body portion) and nerve stimulators (e.g. , a nerve stimulator configured to provide therapeutic stimulation or electrical blockage of nerve conduction).
- a system 1000 is configured to monitor and treat a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- the system 1000 includes a substrate 1002, a sensor assembly 1004, a processor 1006, and an effector 1008.
- the system 1000 includes epidermal electronic systems (EES) to monitor EES
- EES describe classes of electronic systems that provide thicknesses, effective elastic moduli, and flexibility suitable for interfacing with a skin surface (see, e.g. , Kim et al., Epidermal Electronics, Science, Vol. 333, 838- 843 (201 1 ) and Yeo et al. , Multifunctional Epidermal Electronics Printed Directly Onto the Skin, Advanced Materials Vol. 25(20), 2773-2778 (2013), which are incorporated herein by reference) and can incorporate sensors (e.g. ,
- physiological, temperature, strain and associated circuity (e.g. , transistors, diodes, photodetectors, radio frequency components, capacitors, oscillators).
- circuity e.g. , transistors, diodes, photodetectors, radio frequency components, capacitors, oscillators.
- the substrate 1002 is a deformable (e.g. , flexible, stretchable) substrate configured to interface with a skin surface of a subject.
- the deformable nature of the substrate 1002 facilitates interaction/interfacing with the skin surface, a generally low-modulus and deformable natural surface.
- the substrate 1002 can include one or more of an elastomeric polymer, a hydrocolloid film, a nanomembrane (e.g. , silicon nanomembrane), or other deformable material.
- the substrate 1002 can include one or more coating.
- the substrate 1002 can be positioned in proximity with the skin surface according to various mechanisms including, but not limited to, affixed to the skin via an adhesive material, and held in place by an external pressure, such as pressure provided by a material wrapped around the body portion (e.g. , a fabric, a garment, etc.).
- the substrate 1002 is configured to reversibly deform to coordinate with a deformation of the skin surface of the body portion upon which the substrate 1002 is mounted.
- the substrate 1002 includes a gas-permeable elastomeric sheet on which electronic components of an EES reside (see, e.g. , Kim et al. , incorporated herein by reference) configured to interface with a skin surface.
- the substrate 1002 includes a microfluidic enclosure defined by opposing structured elastomeric substrates between which electronic components of an EES reside (see e.g. , Xu et al, Soft Microfluidic Assemblies of Sensors, Circuits, and Radios for the Skin, Science, Vol. 344, 70-74 (2014), which is incorporated herein by reference).
- the substrate 1002 can also be configured for interaction with a skin surface of a particular body portion.
- the body portion includes one or more of a finger, a hand, a wrist, a toe, a foot, an ankle, an arm, an elbow, a leg, a knee, a shoulder, a hip, a spinal portion (e.g. , a region proximate to one or more of a cervical spine, a thoracic spine, a lumbar spine, a sacral spine, and a coccygeal spine), a rib portion (e.g.
- the substrate 1002 can conform to a tubular structure to facilitate interaction with a finger or toe (see, e.g. , Ying et al. , Silicon nanomembranes for fingertip electronics, Nanotechnology, Vol. 23, No. 34, 1 -7 (2012) which is incorporated herein by reference). In an embodiment, shown in FIG.
- the system 1000 is positioned on a wrist 1 100 of the subject for monitoring, preventing, and treating a medical condition associated with a repetitive stress injury, arthritis, or other medical condition associated with the wrist or other body portion in close proximity to the wrist, including, but not limited to, the hand, one or more fingers, and the arm.
- the sensor assembly 1004 includes a motion sensor 1010 and a physiological sensor 1012.
- the sensor assembly 1004 is configured to generate one or more sense signals based on detection of a movement of a body portion by the motion sensor 1010 and a physiological parameter of the body portion by the physiological sensor 1012.
- the motion sensor 1010 includes one or more of an accelerometer (e.g. , accelerometer 1400) and a proximity sensor (e.g. , proximity sensor 1402) to detect a movement of a body portion and generate a sense signal in response thereto.
- the proximity sensor can include one or more of an infrared sensor (e.g. , infrared sensor 1404) and an optical sensor (e.g. , optical sensor 1406).
- the proximity sensor is configured to sense a second body portion proximate the body portion on which the system 1000 is positioned.
- the system 1000 can be positioned on a wrist of a subject and the motion sensor 1010 can include a proximity sensor configured to detect one or more of a presence, a position, an angle, and a movement of another body portion proximate the wrist, such as a hand, a palm, an arm, a finger, a shoulder, and so forth.
- the proximity sensor is configured to sense a device interfacing with another portion of the skin surface or with another body portion.
- the system 1000 can be positioned on a body portion of a subject and a second system 1000 is positioned proximate the body portion or on another body portion, where the proximity sensor of the motion sensor 1010 of the system 1000 can sense one or more of a presence, a position, an angle, and a movement of the second system 1000.
- the motion sensor 1010 is configured to detect one or more of a movement of a body portion and a position of the body portion.
- the body portion can be the portion with which the system 1000 interfaces or can be a portion proximate the portion with which the system 1000 interfaces.
- the motion sensor 1010 generates a sense signal based on a repeated motion of the body portion.
- the system 1000 can be positioned on a wrist of a subject and the motion sensor 1010 measures a repeated flexing or bending of the wrist, such as to move the hand or one or more fingers.
- the motion sensor 1010 measures a number of repetitions of a movement of a body portion.
- the system 1000 can be positioned on a finger of a subject and the motion sensor 1010 measures the number of repetitions that the particular finger is flexed or bent. Measuring the number of repetitions can include, but is not limited to, measuring that zero repetitions have occurred, measuring a finite number of repetitions, measuring the number of repetitions taken over a specified time period, and determining that the number of repetitions exceeds a threshold number (e.g. , a threshold at which a subject is at risk for a repetitive strain injury).
- the motion sensor 1010 measures a speed of a movement of a body portion.
- the system 1000 can be positioned on an ankle of a subject and the motion sensor 1010 measures the speed of movement of the ankle, such as one or more of a speed of movement during a flexing of the ankle during a walking motion, a speed of movement relative to a ground surface during a walking motion, or other movement.
- the motion sensor 1010 measures a duration of a movement of a body portion. The duration can include one or more of a total duration of movement within a period of time (e.g. , duration encompassing multiple repetitions of movement) and a total duration of movement for a single repetition of movement.
- the system 1000 can be positioned on a finger of a subject and the motion sensor 1010 measures one or more of the duration of motion of bending or flexing the finger over a period of time and the duration of motion of a single repetition of movement of the finger, such as relative to the palm, hand, or wrist.
- the period of time over which the movement is measured can include, but is not limited to, a minute, an hour, a portion of a day during which a subject is awake and active, a day, or longer duration.
- the sensor assembly 1004 is configured to measure the disposition of the body portion over a period of time.
- the sensor assembly 1004 may measure a disposition of the body portion over time while the body portion is one or more of at rest, while in motion, and while held in a position that is not a rest position (e.g. , tensed).
- the motion sensor 1010 measures a disposition of a body portion on which the system 1000 is positioned relative to a second body portion during a movement of one or more of the body portion and the second body portion.
- the system 1000 can be positioned on a phalange of a subject and the motion sensor 1010 measures a disposition of the phalange relative to a wrist or ankle of the subject during motion of the phalange or wrist/ankle.
- the motion sensor 1010 measures an angle of movement of a body portion.
- the system 1000 can be positioned on an arm of a subject and the motion sensor 1010 measures an angle of movement of the arm (e.g. , relative to the torso, relative to a rest position of the arm, relative to another body portion, and so forth).
- the motion sensor 1010 measures an angle of movement of the arm (e.g. , relative to the torso, relative to a rest position of the arm, relative to another body portion, and so forth).
- Measurement by the motion sensor 1010 of one or more of a repeated motion of a body portion, a number of repetitions of the movement of the body portion, a speed of the movement of the body portion, a duration of the movement of the body portion, a disposition of the body portion relative to a second body portion, and an angle of movement of the body portion provides information that can aid in the determination by the system 1000 of whether the subject has a repetitive stress injury or is at risk for a repetitive stress injury, and can provide data regarding actions to treat or avoid a particular repetitive stress injury with the system 1000.
- the physiological sensor 1012 is configured to detect a physiological parameter of the subject on which the system 1000 is positioned.
- the physiological sensor 1012 detects a localized physiological parameter provided by one or more of a body portion with which the system 1000 interfaces and a body portion proximate the portion with which the system 1000 interfaces.
- the physiological sensor 1012 can also be configured to detect systemic physiological parameters of the subject on which the system 1000 is positioned.
- the physiological sensor 1012 includes an electromyograph (EMG) (FIG. 13 shows electromyograph 1408), such as sensor electrodes configured to monitor the electrophysiological activity of muscle tissue proximate to the body portion on which the system 1000 is positioned.
- EMG electromyograph
- the physiological sensor 1012 includes a strain sensor (e.g. , strain sensor 1410).
- the strain sensor may be a silicon nanomembrane- based sensor positioned over the skin surface to measure a strain-based physiological parameter (see, e.g. , Son et al. , Multifunctional wearable devices for diagnosis and therapy of movement disorders, Nature Nanotechnology, Vol. 9, 397-404 (2014), which is hereby incorporated by reference).
- the physiological sensor 1012 includes a temperature sensor (e.g. , temperature sensor 1412).
- the temperature sensor can include, but is not limited to, a single point temperature sensor, a spatial imaging temperature sensor, and a microscale temperature sensor configured as a microscale heating element or actuator, such as one or more microscale temperature sensors incorporating thin serpentine features of thin metal or PIN diodes with nanoscale membranes (see, e.g. , Webb et al. , Ultrathin conformal devices for precise and continuous thermal characterization of human skin, Nature Materials, Vol. 12, 938-944 (2013), which is incorporated herein by reference).
- the physiological sensor 1012 includes an optical sensor (e.g. , optical sensor 1414) configured to measure an optical characteristic of a body portion on which the system 1000 is positioned.
- the optical sensor can include, but is not limited to, a light-emitting diode (LED) (e.g. , light-emitting diode 1416), an LED coordinates with a
- LED light-emitting diode
- photosensor an imaging device, such as a camera, and so forth.
- imaging device such as a camera
- the physiological sensor 1012 includes an acoustic sensor (e.g. , acoustic sensor 1418).
- the acoustic sensor may provide data regarding motion of a joint including, but not limited to, a wrist, an elbow, a shoulder, an ankle, a knee, and a hip.
- the processor 1006 is configured to receive one or more sense signals from the sensor assembly 1004 and to process the sense signals in order to provide control signals to portions of the system 1000, such as to the effector 1008.
- the processor 1006 is a resident device component that is coupled to the substrate 1002.
- the processor 1006 can be located remotely from the substrate 1002 and can send and receive signals via associated wireless communication methods including, but not limited to acoustic
- the processor 1006 can include a microprocessor, a central processing unit (CPU), a digital signal processor (DSP), an application-specific integrated circuit (ASIC), a field programmable gate entry (FPGA), or the like, or any combinations thereof, and can include discrete digital or analog circuit elements or electronics, or combinations thereof.
- the computing device includes one or more ASICs having a plurality of predefined logic components.
- the computing device includes one or more FPGAs having a plurality of programmable logic commands.
- the effector 1008 is operably coupled to the processor 1006 and affects a body portion responsive to control by the processor 1006 to one or more of prevent and treat a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- the effector 1008 includes one or more of a tactile stimulator (e.g. , tactile stimulator 1420) and a nerve stimulator (e.g. , nerve stimulator 1422).
- a tactile stimulator can provide a subject an indication regarding a position of a body portion.
- the sensor assembly 1004 can generate one or more sense signals regarding a position of a body portion on which the system 1000 is positioned, where the processor 1006 receives the sense signals and instructs the effector 1008 (e.g.
- the processor 1006 determines that the position of the body portion is a biomechanically detrimental position. For example, the processor 1006 can compare the one or more sense signals generated by the sensor assembly 1004 to reference data indicative of a strain injury stored in a resident or remote memory device. The processor 1006 can then instruct the tactile stimulator to affect the body portion, such as by providing a vibrational effect, to provide an indication that the position of the body portion is a biomechanically detrimental position. In an embodiment, the processor 1006 determines that the body portion has maintained the current position for a duration longer than a threshold duration.
- the processor 1006 can compare the one or more sense signals generated by the sensor assembly 1004 regarding a duration of the body portion in a particular position to a threshold duration stored in a resident or remote memory device.
- the threshold duration can be based on biomechanical data indicative of when a repetitive stress injury is likely to occur.
- the processor 1006 can then instruct the tactile stimulator to affect the body portion, such as by providing a vibrational effect, to provide an indication that the body portion has maintained the current position for a duration longer than the threshold duration.
- the effector 1008 can include a nerve stimulator configured to provide an electrical stimulation to one or more nerves in the subject on which the system 1000 is positioned.
- the nerve stimulator generates an electrical current or impulse to therapeutically stimulate a nerve proximate to the body portion on which the system 1000 is positioned.
- the therapeutic stimulation can be utilized to treat or avoid a repetitive stress injury of the subject.
- the nerve stimulator is configured to stimulate a nerve conduction of a nerve proximate to the body portion on which the system 1000 is positioned. Stimulating the nerve conduction induces movement of the body portion or sensation of the body portion.
- the sensor assembly 1004 generates one or more sense signals based on detection of a movement or position of the body portion by the motion sensor 1010 and a physiological parameter of the body portion by the physiological sensor 1012, where the processor 1006 receives the one or more sense signals and directs the effector 1008 to affect the body portion by generating an electrical current or impulse to stimulate a nerve conduction of a nerve proximate to the body portion on which the system 1000 is positioned, such as to cause movement of the body portion or to induce a sensation of the body portion.
- the nerve stimulator is configured to stimulate the nerve conduction after a threshold period of time during which the body portion is retained in a particular position.
- the motion sensor 1010 may provide one or more sense signals regarding the position of the body portion over a temporal duration.
- the system 1000 may infer that the body portion remains within a particular position when the one or more sense signals do not significantly deviate over a period of the temporal duration that corresponds to a threshold duration of time.
- the threshold duration of time can correspond to a time at which a body portion becomes subject to a risk of strain injury or to an increased risk of strain injury.
- the nerve stimulator is configured to electrically block a nerve conduction of a nerve proximate to the body portion on which the system 1000 is positioned.
- the nerve stimulator generates an electrical current or impulse to interfere with, block, alter, and the like, a nerve conduction of a nerve. Blocking the nerve conduction can inhibit a pain receptor of the subject.
- the sensor assembly 1004 generates one or more sense signals based on detection of a movement of the body portion by the motion sensor 1010 and a physiological parameter of the body portion by the physiological sensor 1012, where the processor 1006 receives the one or more sense signals and directs the effector 1008 affect the body portion by generating an electrical current or impulse to block a nerve conduction of a nerve proximate to the body portion on which the system 1000 is positioned, such as to inhibit a pain receptor of the subject.
- the blockage of the nerve conduction can inhibit a movement of the body portion.
- the sensor assembly 1004 generates one or more sense signals indicating that the body portion is
- the processor 1006 can control the effector 1008 to block a nerve conduction of a nerve proximate to the body portion to inhibit movement of the body portion from maintaining or repositioning into the biomechanically detrimental position.
- Other indicators for inhibiting the movement of the body portion include, but are not limited to, repetitive movements indicative of a repetitive stress injury, maintaining the body portion in a position that exceeds a threshold duration, and the like.
- the system 1000 includes a power supply 1200 configured to provide power to one or more components of the system 1000 including, but not limited to, the sensor assembly 1004, the processor 1006, and the effector 1008.
- the power supply 1200 is a resident device component that is coupled to the substrate 1002. Examples of resident device components include, but are not limited to, batteries (e.g. , a thin film battery) and solar cells (e.g. , silicon-based solar cells) configured to convert light energy into electrical energy for use by the components of the system 1000.
- the power supply 1200 includes one or more components positioned remotely from the substrate 1002 that transmit power signals via associated wireless power methods including, but not limited to, inductive coupling of power signals.
- the system 1000 includes one or more components positioned on the substrate 1002 configured to one or more of receive, process, and distribute the power signals that originate from components positioned remotely from the substrate 1002.
- the system 1000 can include a wireless power coil coupled to the substrate 1002 that is configured to receive a remote power signal, such as a remote power signal originating from a remote transmission coil (see, e.g. , Kim et al., incorporated herein by reference).
- the system 1000 includes a comparison module 1300 accessible by the processor 1006 to compare the movement of the body portion, detected by the motion sensor 1010 of the sensor assembly 1004, and the physiological parameter of the body portion, detected by the physiological sensor 1012 of the sensor assembly 1004, to reference data indicative of a strain injury.
- the processor 1006 accesses the comparison module 1300 by accessing a computer memory 1302, which can include, but is not limited to, random-access memory (RAM), read-only memory (ROM), electrically erasable programmable read-only memory (EEPROM), flash memory, or other memory technology, CD-ROM, digital versatile disks (DVD), or other optical disk storage, magnetic cassettes, magnetic tape, magnetic disk storage, or other magnetic storage devices, or any other medium which can be used to store the desired information maintained by the comparison module 1300 and which can be accessed by the processor 1006 or other accessing device.
- the reference data may be stored by the computer memory 1302 of the system 1000, can be accessible by the processor 1006 via wireless means, or can be available to the processor 1006 through another method.
- the reference data may include physiological and biomechanical information pertaining to an acute or traumatic injury that include, but is not limited to, a strain, a sprain, or a tear of a muscle or soft tissue (e.g. , ligament, tendon, enthesis, or other connective tissue).
- the reference data may include physiological and biomechanical information pertaining to a long-term or chronic medical condition that can include, but is not limited to, a joint-based non-inflammation condition (e.g. , arthralgia, osteoarthritis), a joint-based inflammation condition (e.g.
- rheumatoid arthritis psoriatic arthritis, arthritis, ankylosing spondylitis, juvenile idiopathic arthritis and systemic lupus erythematosus
- an enthesis-based condition e.g. , enthesitis
- a tendon- based condition e.g. , tendonitis, tenosynovitis
- a ligament-based condition e.g. , chronic strain
- a nerve entrapment or compression based condition or syndrome e.g. , carpal tunnel entrapment, cubital tunnel entrapment, tarsal tunnel entrapment, radial nerve entrapment, meralgia paresthetica
- the processor 1006 may compare the movement, position, and physiological data pertaining to the body portion obtained by the sensor assembly 1004 to reference data indicative of a strain injury and make a determination regarding the risk or likelihood of a strain injury occurring for the body portion.
- the processor 1006 further determines an action to be executed by the effector 1008 based upon the comparison made between the data received from the sensor assembly 1004 and the reference data. For example, where the processor 1006 determines that the body portion is at a relatively high risk for incurring a strain injury, the processor 1006 may control the effector 1008 to take a first action (e.g.
- the processor 1006 may control the effector 1008 to take a second action (e.g. , provide a visible, audible, or tactile warning to the subject).
- a second action e.g. , provide a visible, audible, or tactile warning to the subject.
- the system 1000 further includes a reporter 1500 configured to convey information from the system 1000.
- the information from the reporter 1500 may be provided one or more of visually (e.g. , visual information), audibly (e.g. , auditory information), and as data (e.g. , one or more data signals associated with the information to convey).
- the reporter 1500 reports one or more of an actuation of the effector 1008, a detected movement or position of the body portion, and a detected physiological condition.
- the reporter 1500 can provide warnings or instructions regarding the movement, position, and the physiological condition of the body portion.
- the reporter 1500 may be configured to report a warning of a risk of a biomechanically detrimental positioning of the body portion.
- the biomechanically detrimental positioning may influence the risk for a repetitive strain injury (e.g. , as determined by the processor 1006 implementing the comparison module 1300).
- the reporter 1500 is configured to report an instruction to move the body portion.
- the reporter 1500 may function in combination with the effector 1008 to provide visual or auditory context to the subject upon action of the effector 1008, such as when a tactile stimulation occurs via a tactile stimulator of the effector 1008.
- the reporter 1500 includes a display 1502 configured to report, communicate, or otherwise provide information to the subject utilizing the system 1000.
- the display 1502 may include, but is not limited to, a graphical user interface (GUI), a touchscreen assembly (e.g.
- the reporter 1500 includes a transmitter 1504 configured to transmit information from the system 1000 to a remote location 1506 (e.g. , a remote entity, a remote device, and so forth).
- a remote location includes a communication device, such as one or more of a mobile communication device and a computer system including, but not limited to, mobile computing devices (e.g. , hand-held portable computers, Personal Digital Assistants (PDAs), laptop computers, netbook computers, tablet computers, and so forth), mobile telephone devices (e.g.
- the reporter 1500 can communicate (e.g. , send and receive communication signals) with the remote location 1506 via one or more connected and wireless communication mechanisms (FIG. 14 displays a wireless
- communication signals optical communication signals, radio communication signals, infrared communication signals, ultrasonic communication signals, and the like.
- the remote location 1506 includes a computer system configured to store and execute one or more computer-executable programs, whereby the reporter can interact with (e.g. , remotely access, execute, and so forth) and modify the programs stored on the computer system.
- FIG. 14 displays the remote location 1506 including a computer system 610 having a computer-executable program 612 stored thereon.
- the information provided to the computer system 610 by the reporter 1500 is used to populate fields of the program, such as fields associated with risks of repetitive stress injury.
- the program 612 includes scheduling software configured to provide personnel scheduling functionality, such as to schedule personnel to particular tasks within an organizational structure while considering the risks for repetitive stress injuries associated with the various tasks engaged by the personnel and including actual data, provided by the reporter 1500, of actual risks of repetitive stress injuries of individuals interfacing with the system 1000.
- the scheduling software can include instructions that, when executed by a computer processor on the computer system 610, causes the computer system 610 to provide real-time personnel scheduling.
- the reporter 1500 can provide information associated with risks for repetitive stress injuries for one or more individuals interfacing with the system 1000 based on measured movements, positions, and physiological conditions in order for the program 612 to make real-time personnel scheduling assignments, such as to make
- the scheduling software can include instructions, that when executed by a computer processor on the computer system 610, causes the computer system 610 to provide long-term personnel scheduling.
- the reporter 1500 can provide information associated with risks for repetitive stress injuries for one or more individuals interfacing with the system 1000 based on measured movements, positions, and physiological conditions in order for the program 612 to make long-term personnel scheduling assignments, such as to make
- the scheduling software can include instructions, that when executed by a computer processor on the computer system 610, causes the computer system 610 to provide personnel tracking.
- the reporter 1500 can provide information associated with risks for repetitive stress injuries for one or more individuals interfacing with the system 1000 based on measured
- the information provided by the reporter 1500 can be used to track an individual's propensity for risk of repetitive stress injury as compared to a group of individuals, such as to determine whether the particular individual engages in more
- biomechanically detrimental activities than the group to determine whether the particular individual engages in more biomechanically detrimental positioning than the group (e.g. , the individual has improper form for performing the various tasks associated with specific job assignments), and so forth.
- FIG. 15A illustrates an example environment in which embodiments of the system 1000 may be implemented.
- the system 1000 is positioned on a finger 1600a of a subject.
- the system 1000 further includes a second device configured to generate one or more sense signals based on detected movements, positions, and physiological parameters of the body portion on which the second device is positioned. The second device can then affect the body portion on which it is positioned, as described herein with respect to the effector 1008 of the system 1000. For example, as shown in FIG.
- the system 1000 includes a second device 1602 positioned on another finger 1600b of the same hand of the subject, although other positional configurations can be utilized, including but not limited to, positioning the second device 1602 on a different portion of the same finger 1600a, or positioning the second device 1602 on a hand, a wrist, a toe, a foot, an ankle, an arm, an elbow, a leg, a knee, a shoulder, a hip, a spinal portion (e.g. , a region proximate to one or more of a cervical spine, a thoracic spine, a lumbar spine, a sacral spine, and a coccygeal spine), a rib portion (e.g. , a region proximate to a rib, such as where the rib attaches the spine), a torso, a neck, and a head region (e.g. , face, scalp).
- a spinal portion e.g. , a region proximate to
- the second device 1602 includes a deformable substrate 1604, a sensor assembly 1606, a processor 1608, and an effector 1610.
- the second device 1602 incorporates epidermal electronic systems (EES) to monitor physiological, positional, and movement conditions for monitoring, preventing, and treating a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- the deformable substrate 1604 is a deformable (e.g. , flexible, stretchable) substrate configured to interface with a skin surface of a subject.
- the deformable nature of the substrate 1604 facilitates interaction/interfacing with the skin surface, a generally low-modulus and deformable natural surface.
- the structure of the substrate 1604 is similar to, or the same as, the structure of the substrate 1002 described herein, with corresponding functionalities.
- the sensor assembly 1606 of the second device 1602 includes a motion sensor 1612 and a physiological sensor 1614.
- the sensor assembly 1606 is configured to generate one or more sense signals based on detection of a movement or position of a body portion by the motion sensor 1612 and a physiological parameter of the body portion by the physiological sensor 1614.
- the structures of the sensor assembly 1606, the motion sensor 1612, and the physiological sensor 1614 are similar to, or the same as, the structures of the sensor assembly 1004, the motion sensor 1010, and the physiological sensor 1012, respectively, described herein, including but not limited to, accelerometers, proximity sensors, electromyographs (EMG), strain sensors, temperature sensors, optical sensors, and acoustic sensors, with corresponding functionalities.
- EMG electromyographs
- the processor 1608 is configured to receive one or more sense signals from the sensor assembly 1606 and to process the sense signals in order to provide control signals to portions of the second device 1602, such as to the effector 1610.
- the structure of the processor 1608 is similar to, or the same as, the structure of the processor 1006 described herein, with corresponding functionalities.
- the effector 1610 is operably coupled to the processor 1608 and affects a body portion responsive to control by the processor 1608 to one or more of prevent and treat a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- the effector 1610 affects the finger 1600b under the control of the processor 1608, based on the processing of the one or more sense signals from the sensor assembly 1606.
- the structure of the effector 1610 is similar to, or the same as, the structure of the effector 1008 described herein, including but not limited to, tactile stimulators and nerve stimulators, with corresponding functionalities.
- one or more components of the system 1000 interact with the second device 1602.
- One or more components of the system 1000 and the second device 1602 are configured to detect the presence of the respective other of the components of the system 1000 and the second device 1602.
- the motion sensor 1010 of the system 1000 may sense one or more properties of the second device 1602 to detect a presence of the second device on the finger 1600b, and the motion sensor 1612 of the second device 1602 may sense one or more properties of the system 1000, such as the presence of the substrate 1002 positioned on the finger 1600a, to detect a presence of the system 1000.
- the motion sensor 1010 of the system 1000 may sense one or more properties of the finger 1600b to detect one or more of the presence of the finger 1600b, the proximity of the finger 1600b relative to the finger 1600a, and the disposition of the finger 1600b relative to the finger 1600a.
- the motion sensor 1612 of the second device may sense one or more properties of the finger 1600a to detect one or more of the presence of the finger 1600a, the proximity of the finger 1600a relative to the finger 1600b, and the disposition of the finger 1600a relative to the finger 1600b.
- the second device 1602 includes a communications interface 1616 to send communication signals from the second device 1602 and to receive communication signals from a remote location or device via one or more connected (e.g. , wired connections) and wireless communication mechanisms including, but not limited to acoustic communication signals, optical communication signals, radio communication signals, infrared communication signals, ultrasonic communication signals, and the like.
- FIG. 15B shows an embodiment where the communications interface 1616 includes a reporter 1618 configured to convey information from the second device 1602.
- the information from the reporter 1618 may be provided one or more of visually (e.g. , visual information), audibly (e.g. , auditory information), and as data (e.g. , one or more data signals associated with the information to convey).
- the structure and functionality of the reporter 1618 is similar to, or the same as, the structure and functionalities of the reporter 1500 described herein.
- the communications interface 1616 of the second device 1602 facilitates communication and interaction between the second device 1602 and other components of the system 1000, including but not limited to, the processor 1006 and the reporter 1500. Accordingly, the communications interface 1616 facilitates the transfer of data between the second device 1602 and other components of the system 1000.
- the data can include, but is not limited to, data associated with one or more of an actuation of an effector (e.g. , effector 1008, effector 1610), a detected movement or position of the body portion (e.g.
- the environment 1700 includes a first system 1702, a second system 1704, and a communications interface 1706 coupled between the first system 1702 and the second system 1704.
- the first system 1702 and the second system 1704 are configured to monitor, prevent, and treat a medical condition associated with a repetitive stress injury, arthritis, or other medical condition, and employ epidermal electronic systems (EES) to monitor physiological, positional, and movement conditions for monitoring, preventing, and treating a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- EES epidermal electronic systems
- the communications interface 1706 facilitates the transfer of one or more communication signals between the first system 1702 and the second system 1704.
- the first system 1702 includes a deformable substrate 1708 configured for interaction with a skin surface of a particular body portion, a sensor assembly 1710 including a motion sensor 1712 and a physiological sensor 1714 configured to generate one or more sense signals based on detection of a movement of a body portion by the motion sensor 1712 and a physiological parameter of the body portion by the
- physiological sensor 1714 a processor 1716 configured to receive one or more sense signals from the sensor assembly 1710 and to process the sense signals in order to provide control signals to portions of the first system 1702, and an effector 1718 operably coupled to the processor 816 to affect a body portion responsive to control by the processor 1716 to one or more of prevent and treat a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- the substrate 1708, the sensor assembly 1710, the processor 1716, and the effector 1718 may correspond to the substrate 1002, the sensor assembly 1004, the processor 1006, and the effector 1008, respectively.
- the second system 1704 includes a deformable substrate 1720 configured for interaction with a skin surface of a particular body portion, a sensor assembly 1722 including a motion sensor 1724 and a physiological sensor 1726 configured to generate one or more sense signals based on detection of a movement of a body portion by the motion sensor 1724 and a physiological parameter of the body portion by the physiological sensor 1726, a processor 1728 configured to receive one or more sense signals from the sensor assembly 1722 and to process the sense signals in order to provide control signals to portions of the second system 1704, and an effector 1730 operably coupled to the processor 1728 to affect a body portion responsive to control by the processor 1728 to one or more of prevent and treat a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- the substrate 1720, the sensor assembly 1722, the processor 1728, and the effector 1730 may correspond to the substrate 1604, the sensor assembly 1606, the processor 1608, and the effector 1610, respectively.
- the communications interface 1706 facilitates communication between the first system 1702 and the second system 1704 and may facilitate communication from one or more of the first system 1702 and the second system 1704 with a remote device or location.
- the communications interface 1706 includes a reporter associated with one or more of the first system 1702 and the second system 1706, such as described with reference to the reporter 1500 and the reporter 1618.
- the example the example
- a power supply in power communication with one or more of the first system 1702, the second system 1704, and the communications interface 1706.
- a power supply may be positioned remotely from the first system 1702, the second system 1704, and the communications interface 1706 and provide one or more wireless power signals to the first system 1702, the second system 1704, and the communications interface 1706.
- FIG. 17 illustrates a method 1800 for monitoring, preventing, and treating a medical condition associated with a repetitive stress injury, arthritis, or other medical condition.
- Method 1800 shows detecting, via an epidermal electronic system (EES), at least one of a position and a movement of a body portion in block 1802.
- EES epidermal electronic system
- the motion sensor 1010 provided on an EES-based system, such as system 1000 can detect at least one of a position and a movement of a body portion, as described herein.
- Method 1800 also includes generating one or more sense signals based on detection of the at least one of a position and a movement of a body portion in block 1804.
- the motion sensor 1010 can generate one or more sense signals based on detecting at least one of a position and a movement of a body portion, as described herein.
- Method 1800 further includes processing the one or more sense signals to determine a risk of inducing a repetitive stress injury in block 1806.
- the processor 1006 can receive the one or more sense signals generated from the motion sensor 1010 of the sensor assembly 1004, and can process the one or more sense signals to determine a risk of inducing a repetitive stress injury, such as by accessing and executing the comparison module 1300, as described herein.
- Method 1800 further includes executing an action to reduce the risk of inducing the repetitive stress injury in block 1808.
- the processor 1006 can provide one or more control signals to the effector 1008 to affect the body portion to reduce the risk of inducing the repetitive stress injury, as described herein.
- FIG. 18 depicts further aspects of the method 1800 illustrated in FIG. 17.
- Block 1806 shows processing the one or more sense signals to determine a risk of inducing a repetitive stress injury and includes optional block 1900 that shows comparing the one or more sense signals to reference data indicative of a strain injury to determine the risk of inducing the strain injury.
- the processor 1006 can access and execute the comparison module 1300 to compare the one or more sense signals generated by the sensor assembly 1004 to reference data indicative of a strain injury.
- Block 1900 also includes optional block 1902 that shows determining the action to execute based upon comparing the one or more sense signals to reference data indicative of a strain injury.
- the processor 1006 can determine which action for the effector 1008 to take based on a comparison of the one or more sense signals to reference data indicative of a strain injury: where immediate action is warranted, the processor 1006 may determine to stimulate a nerve conduction via the effector 1008 to induce movement of the body portion; where the risk of the repetitive stress injury is lesser, the processor 1006 may determine to provide a tactile simulation via the effector 1008.
- FIG. 19 depicts further aspects of the method 1800 illustrated in FIG. 17.
- Block 1806 shows executing an action to reduce the risk of inducing the repetitive stress injury and includes optional block 2000 that shows reporting the
- Block 2000 includes optional block 2002 that shows providing a tactile indication of the risk.
- Block 2002 includes optional block 2004, which shows providing a vibration-based indication of the risk and optional block 2006, which shows providing a tactile indication regarding a position of the body portion.
- Block 2006 includes optional block 2008, which shows providing a tactile indication that the position is a biomechanically detrimental position, and block 2010, which shows providing a tactile indication that the body portion has been in the position longer than a threshold duration.
- FIG. 20 depicts further aspects of the method 1800 illustrated in FIG. 19.
- Block 1806 shows executing an action to reduce the risk of inducing the repetitive stress injury and includes optional block 2000 that shows reporting the
- Block 2000 includes optional block 2100 that shows providing a visual indication of the risk.
- Block 2100 includes optional block 2102 that shows providing a visual indication regarding a position of the body portion.
- Block 2102 includes optional block 2104, which shows providing a visual indication that the position is a biomechanically detrimental position, and optional block 2106, which shows providing a visual indication that the body portion has been in the position longer than a threshold duration.
- FIG. 21 depicts further aspects of the method 1800 illustrated in FIG. 19.
- Block 1806 shows executing an action to reduce the risk of inducing the repetitive stress injury and includes optional block 2000 that shows reporting the determination of the risk of inducing the repetitive strain injury to reduce the risk.
- Block 2000 includes optional block 2200 that shows providing an auditory indication of the risk.
- Block 2200 includes optional block 2202 that shows providing an auditory indication regarding a position of the body portion.
- Block 2202 includes optional block 2204, which shows providing an auditory indication that the position is a biomechanically detrimental position, and optional block 2206, which shows providing an auditory indication that the body portion has been in the position longer than a threshold duration.
- FIG. 22 depicts further aspects of the method 1800 illustrated in FIG. 19.
- Block 1806 shows executing an action to reduce the risk of inducing the repetitive stress injury and includes optional block 2000 that shows reporting the
- Block 2000 includes optional blocks 2300, 2302, 2304, and 2306.
- Block 2300 shows reporting at least one of an actuation of an effector configured to execute the action, a detected movement of the body portion, or a detected physiological condition.
- Block 2302 shows providing a warning of a risk of a biomechanically detrimental positioning of the body portion.
- Block 2304 shows providing an instruction to move the body portion.
- Block 2306 shows communicating the determination to a remote location and includes optional block 2308, which shows interacting with a program stored on the computer system, and optional block 2310, which shows modifying a program stored on the computer system.
- FIG. 23 depicts further aspects of the method 1800 illustrated in FIG. 17.
- Block 1808 shows executing an action to reduce the risk of inducing the repetitive stress injury and includes optional block 2400 that shows stimulating a nerve proximate to the body portion.
- Block 2400 includes optional block 2402 that shows inducing at least one of a movement or a sensation of the body portion by stimulating the nerve conduction of the nerve proximate to the body portion.
- Block 2402 includes optional block 2404 that shows inducing at least one of a
- FIG. 24 depicts further aspects of the method 1800 illustrated in FIG. 17.
- Block 1808 shows executing an action to reduce the risk of inducing the repetitive stress injury and includes optional block 2500 that shows electrically blocking a nerve conduction of a nerve proximate to the body portion.
- Block 2500 includes optional block 2502, which shows electrically blocking a nerve conduction of a nerve proximate to the body portion to inhibit a pain receptor, and optional block 2504, which shows electrically blocking a nerve conduction of a nerve proximate to the body portion to inhibit a movement of the body portion.
- FIG. 25 depicts further aspects of the method 1800 illustrated in FIG. 17.
- Block 1802 shows detecting, via an epidermal electronic system (EES), at least one of a position and a movement of a body portion and includes optional blocks 2600, 2602, 2604, 2606, 2608, and 2610.
- Block 2600 shows measuring, via an epidermal electronic system (EES), a repeated motion of the body portion.
- Block 2602 shows measuring, via an epidermal electronic system (EES), a number of repetitions of the movement of the body portion.
- Block 2604 shows measuring, via an epidermal electronic system (EES), a speed of the movement of the body portion.
- Block 2606 shows measuring, via an epidermal electronic system (EES), a duration of the movement of the body portion.
- Block 2608 shows measuring, via an epidermal electronic system (EES), a disposition of the body portion relative to a second body portion.
- Block 2610 shows measuring, via an epidermal electronic system (EES), an angle of movement of the
- FIG. 26 depicts further aspects of the method 1800 illustrated in FIG. 17 and includes optional block 2700, which shows detecting, via an epidermal electronic system (EES), a physiological parameter of the body portion, and optional block 2702, which shows generating one or more sense signals based on detection of the physiological parameter of the body portion.
- optional block 2700 which shows detecting, via an epidermal electronic system (EES), a physiological parameter of the body portion
- EES epidermal electronic system
- 2702 which shows generating one or more sense signals based on detection of the physiological parameter of the body portion.
- FIG. 27 depicts further aspects of the method 1800 illustrated in FIG. 26.
- Block 2700 shows detecting, via an epidermal electronic system (EES), a physiological parameter of the body portion and includes optional blocks 2800, 2802, 2804, 2806, and 2808.
- Block 2800 shows detecting a temperature of the body portion.
- Block 2802 shows detecting a strain of the body portion.
- Block 2804 shows detecting a blood flow of the body portion.
- Block 2806 shows detecting a blood oxygenation level of the body portion.
- Block 2808 shows detecting an electrical activity of the body portion.
- FIG. 28 depicts further aspects of the method 1800 illustrated in FIG. 17 and includes optional block 2900, which shows detecting, via an epidermal electronic system (EES), a disposition of the body portion.
- EES epidermal electronic system
- Block 2900 includes optional block 2902, which shows detecting, via an epidermal electronic system (EES), an angle of a joint proximate the body portion, and optional block 2904, which shows detecting, via an epidermal electronic system (EES), a disposition of the body portion over a period of time.
- EES epidermal electronic system
- FIG. 29 depicts further aspects of the method 1800 illustrated in FIG. 17 and includes optional block 3000, which shows detecting, via an epidermal electronic system (EES), a device interfacing with at least one of the body portion and another body portion, and optional block 3002, which shows transmitting a communication signal to the device.
- Block 3002 includes optional block 3004 that shows transmitting the one or more sense signals generated based on detection of at least one of the position and the movement of the body portion to the device.
- FIG. 30 depicts further aspects of the method 1800 illustrated in FIG. 17 and includes optional block 3100, which shows detecting, via an epidermal electronic system (EES), at least one of a position and a movement of a second body portion proximate the body portion.
- EES epidermal electronic system
- Pain can be attributed to numerous variables.
- a pain state includes a pain type, a pain level, a pain quality, or combinations thereof.
- the pain states can include a pain-free state, an onset of pain, a pain pattern, chronic pain, acute pain, mixed pain state, a hyperalgesic pain state, an allodynic pain state, a breakthrough pain state, a neuropathic pain state, a nociceptive pain state, a non-nociceptive pain state, combinations thereof, or the like.
- Pain types can include, for example, nociceptive pain (e.g. , due to
- pain types can include spontaneous pain (e.g. , occurring in the absence of stimuli), evoked pain (e.g., occurring in response to stimuli), continuous pain, or intermittent pain.
- pain levels can include intensity, severity, or magnitude of pain.
- Pain quality can include, but is not limited to, intensity, sharpness, dullness, burning, cold, tenderness, itch, cramping, radiating, tingling, throbbing, aching, tiring, deepness, shocking or electrical, stinging, etc., and combinations thereof.
- Assessment tools to evaluate a pain state can, for example, include instruments or combinations of instruments and related software designed to monitor physiological responses including chemical changes, biopotentials, muscle activation, and changes thereof.
- Assessment tools to evaluate a pain state can, for example, include instruments or combinations of instruments (e.g., motion sensor(s), physiological sensor(s), or combinations thereof) and related software designed to monitor autonomic responses as described herein.
- Assessment tools to evaluate a pain state for example, can include subjective tools such as the Pain Quality Assessment Scale and the McGill Pain Questionnaire. In an embodiment, the subjective tools can provide the system 1000 with data
- a baseline or comparative pain level which in turn can serve as a threshold pain level or other comparative pain indicator.
- the systems, devices, and methods described herein generate sense signals from one or more physiological sensors and motion sensors positioned proximate a body portion of a subject to provide indicators of a physiological state (e.g., a pain state) of the individual subject.
- the systems and methods described herein may be used to monitor and treat pain experienced by an individual subject via the generation of sense signals from one or more
- physiological sensors and motion sensors configured to monitor one or more physiological parameters of the individual subject and one or more movements or positions of a body portion of the individual subject and to provide an effect to the body portion through action of one or more effectors.
- the systems, devices, and methods can employ an ultrasound transducer as the effector to affect the individual subject, such as to treat the pain associated with movement of the body portion, pain associated with the physiological parameter, or
- movement of the body portion can be indicative of pain experienced by the individual.
- the conscious or unconscious fear that a motion will induce pain can alter the motion of a body portion, indicating acute or chronic pain.
- physiological adaptation to acute pain or chronic pain can cause short-term or long-term changes in motor function of a body portion (e.g., increased or inhibited muscle activation), and as such can be indicative of pain.
- Alterations in movement of a body portion can present, for example, as pronounced minimalization of motion or agitation of affecting a body site (e.g., a muscle) a guarding motion, an awkward gait, a limp, redistribution of activity or stress, modifications in loading, pronounced use of non-dominant limb, reduced force output, lack of use of a body portion, respiratory dysfunction, splinting, etc.
- a body site e.g., a muscle
- a guarding motion e.g., an awkward gait, a limp, redistribution of activity or stress, modifications in loading, pronounced use of non-dominant limb, reduced force output, lack of use of a body portion, respiratory dysfunction, splinting, etc.
- conscious or unconscious coping mechanisms e.g., grimacing, pronounced rubbing or massage of a body portion, etc.
- involuntary responses e.g., reflex, spasm, etc.
- movement of the body portion of the individual can be a source of, a cause of, or induce or worsen pain, and, as such, a particular movement can be determined to be associated with the pain.
- a certain motion can be repeatedly associated temporally with an increase in pain (e.g., as indicated by changes in autonomic responses, measured by chemical sensors, electrophysiological sensors, biopotential sensors, etc. or by subjective reporting).
- movement of the body portion of the individual can be a preventative treatment or therapeutic treatment of pain. For example, lack of movement or repetition of a movement can be indicative of an increased risk for pain, while sensed and recorded motions indicative of
- muscle fatigue can be associated with, can induce, or can be an indicator of muscle pain.
- the motion of the body portion can provide an indication as to when treatment by the effector can be employed or should be employed.
- the systems, devices, and methods may employ the effector to provide treatment to the individual subject when the body portion is undergoing motion determined (e.g., previously or simultaneously) to be associated with an increase in pain, e.g., as a palliative treatment.
- the systems, devices, and methods may employ the effector to provide treatment to the individual subject when there has been a lack of motion in the body portion of the individual subject or the individual subject has been at rest for a time period above a threshold time period.
- Treatment of the individual subject to induce movement can be a preventative measure (e.g., to induce movement to prevent onset of arthralgia, myalgia, or pressure sores).
- the systems, devices, and methods may employ the effector to provide treatment to the individual subject when the individual subject is at rest (e.g., not currently undergoing substantial movement, such as exercising, walking, signing, etc.).
- Treatment of the individual subject during a rest state can provide a convenient and non-interruptive mechanism to treat pain (e.g., chronic or long-term pain) experienced by the individual subject.
- the systems and methods described herein employ one or more physiological sensors to monitor one or more physiological conditions of a subject and to generate a sense signal in response thereto.
- the physiological sensors can include, but are not limited to, an electrophysiological sensor, an electrocardiograph, an electrooculograph, a microneurography electrode, a myograph, an electromyograph (e.g., a surface electromyograph), an acoustic myography sensor, a mechanomyography sensor, an accelerometer myography sensor, a strain sensor, a pressure sensor, a temperature sensor, an optical sensor (e.g., an LED, a pulse oximeter, etc.), a near infrared sensor, a skin conductance sensor, a bioimpedance sensor, a pH sensor, an acoustic sensor, a chemical sensor.
- an electrophysiological sensor an electrocardiograph
- an electrooculograph e.g., a microneurography electrode
- a myograph e.g., an electromyograph (e.g.
- the systems and methods described herein employ one or more motion sensors to monitor a movement or position of a body portion of an individual subject and to generate a sense signal in response thereto.
- the motion sensors can include, but are not limited to, an orientation sensor, an
- the motion of the body portion can be indicative of pain experienced by the individual, can be indicative of risk of pain, can be indicative of a source of pain, can provide an indication as to when treatment can be employed, or combinations thereof.
- the systems and methods described herein employ one or more effectors to affect a body portion responsive to processing of sense signals generated by the sensor assembly.
- the one or more effectors can include one or more ultrasound transducers, including, but not limited to, an array of ultrasound transducers, an ultrasound transducer configured to generate low intensity ultrasound signals, an ultrasound transducer configured to generate high intensity focused ultrasound signals, an ultrasound transducer configured to generate ultrasound signals as low dose, high frequency ultrasound signals, an ultrasound transducer configured to generate ultrasound signals on a pulsed basis, an ultrasound transducer configured to generate ultrasound signals on a continuous basis, an ultrasound transducer configured to generate
- the one or more effectors can include, but are not limited to, an electrode, a magnetic stimulator, an optical stimulator (e.g. , an optical stimulator configured to generate infrared light, an optical stimulator configured to generate low-intensity, pulsed infrared light, etc. , and combinations thereof), a thermal stimulator, and combinations thereof.
- the 1000 (or pain therapy device) is configured for monitoring and treating pain experienced by an individual subject.
- the system 1000 includes the substrate 1002, the sensor assembly 1004, the processor 1006, and the effector 1008 for placement on the individual subject to monitor the individual subject for indications of pain and for treating the pain through action of the effector 1008.
- the system 1000 includes epidermal electronic systems (EES) or devices incorporating epidermal electronics to monitor physiological, positional, and movement conditions for monitoring, preventing, and treating pain
- the substrate 1002 is configured to conform to a contour of a body portion of an individual subject (e.g. , the curvature of a limb), to interface with a skin surface of the body portion, or combinations thereof.
- the substrate 1002 can comprise a deformable (e.g. , conformable, flexible, stretchable, etc.) material configured to interface with, and conform to, the body portion, including, but not limited to a skin surface of the body portion.
- the body portion is shown in FIG.
- the system 100 can be positioned on any body portion, including but not limited to, an arm, an elbow, a wrist, a hand, a finger, a leg, a hip, a knee, an ankle, a foot, a toe, a facial region, a head region (e.g. , proximate one or more cranial muscles of the face or head), a neck region, a torso region, a spinal portion, a sacroiliac joint, or the like, or a skin portion thereof.
- the pliable nature of the substrate 1002 e.g. , flexibility and stretchability
- the substrate 1002 can include one or more of a stretchable/flexible fabric, paper, or polymer (e.g. , a natural or synthetic
- elastomeric polymer polyimide, polyvinyl, an organic polymer such as PDMS, xylylene, parylene, an inorganic polymer, a biopolymer, a composite material, or any combination thereof), a film (e.g. , a hydrocolloid film), a membrane (e.g. , a nanomembrane, such as a silicon nanomembrane), a gas-permeable elastomeric sheet, or other deformable (e.g. , stretchable, flexible, pliable) material.
- a film e.g. , a hydrocolloid film
- membrane e.g. , a nanomembrane, such as a silicon nanomembrane
- gas-permeable elastomeric sheet e.g. , stretchable, flexible, pliable
- the substrate 1002 can be positioned in proximity with the skin surface according to various mechanisms including, but not limited to, affixed to the skin via an adhesive material, held in place by an external pressure, such as pressure provided by a material wrapped around or about a body portion (e.g. , a fabric, a garment, a glove, a bandage, etc.), affixed in a textile, fabric, garment, accessory (e.g. , a glove, a sock, a finger cot, etc.), or so forth.
- a body portion e.g. , a fabric, a garment, a glove, a bandage, etc.
- accessory e.g. , a glove, a sock, a finger cot, etc.
- the system 1000 includes at least one flexible or stretchable electronic component.
- the sensor assembly 1004 e.g. , motion sensor 1010, physiological sensor 1012, etc. as described herein
- the processor (and associated circuitry) 1006, or the effector 1008 can include or be formed of flexible or stretchable electronics coupled to the substrate 1002.
- interconnects (not illustrated) between these components or within the circuitry can include or be formed of flexible or stretchable electronics (e.g. , serpentine conducting tracings allowing for stretchable interconnects) and coupled to the substrate 1002.
- a power source e.g. , power supply 1200 described herein
- the at least one flexible or stretchable electronic component includes at least one of a wavy, bent, mesh (e.g. , open mesh), buckled, or serpentine geometry.
- the at least one flexible or stretchable electronic component includes at least one nanowire, at least one nanoribbon, or at least one nanomembrane.
- the system 1000 can include one or more multifunctional electronic units comprising a stretchable/flexible system including a sensor assembly (e.g. , sensor assembly 1004), effector (e.g. , effector 1008), and power source (e.g., power supply 1200) in communication via associated circuitry (e.g. , with processor 1006), including interconnects, residing in or on a deformable substrate (e.g. , substrate 1002).
- the system 1000 can include at least one ultrathin electronic component.
- an ultrathin (e.g. , less than 20 micrometers) electronic component can include a thinned wafer (e.g. , thinned silicon wafer bonded to a polymer substrate), an ultrathin chip, or the like.
- ultrathin circuitry can include conductive layers formed on a deformable substrate (e.g. , substrate 1002) such as parylene by evaporation deposition with ultraviolet (UV) lithography and etching.
- at least one of the sensory assembly 1004, the processor 1006, or the effector 1008 can include ultrathin electronics.
- the system 1000 can include at least one electrically conductive thread, yarn, or textile.
- the sensory assembly 1004, the processor 1006, or the effector 1008 can include at least one electrically conductive thread or yarn.
- Electrically conductive threads, yarns, or textiles can be configured to provide sufficient current to induce at least one of a wired or wireless coupling, e.g. , between electronic components.
- electronically conductive threads, yarns, or textiles may form the processor 1006 (or circuitry thereof) or other circuitry configured to function in communication between one or more sensor assemblies 1006, one or more effectors 108, or other circuitry of the system 1000.
- electronically conductive threads, yarns, or textiles may form at least a portion of circuitry configured to function in communication between a plurality of multifunctional electronic units each comprising one or more sensor assemblies 1006, one or more effectors 1008, and processor 1006.
- Electrically conductive fibers, threads, and yarns can include a metallic material, semi-metallic material, semi-insulative material, semi-conductive material (e.g. , silicon and a gallium arsenide), or transparent conductive material (e.g. , an indium-tin-oxide (ITO) material).
- Electrical threads or yarns can be embedded in textiles using weaving, knitting or embroidery, for example, or can be attached using nonwoven production techniques such as adhesion.
- electrically conductive yarns having curved configuration can be attached to an elastic textile (e.g. , by sewing or by adhesion) and can form all or part of a sensor assembly 1004 that measures one or more physical characteristics of an individual, e.g. , as the curved configuration is altered, such as due to particular skin topography or the like.
- the sensor assembly 1004 is coupled to the substrate 1002 and includes the motion sensor 1010 and the physiological sensor 1012.
- the sensor assembly 1004 is configured to generate one or more sense signals based on detection of a movement of the body portion by the motion sensor 1010 and upon detection of a physiological parameter of the body portion by the physiological sensor 1012.
- the one or more sense signals can be associated with one or more movements of the body portion, one or more physiological parameters of the body portion, or combinations thereof.
- the motion sensor 1010 includes one or more of an orientation sensor 3200 (e.g. , cells 120 described with reference to FIGS. 1 A through 8), an accelerometer (e.g. , accelerometer 1400), and a proximity sensor (e.g.
- the orientation sensor 3200 can include one or more of a single-axis accelerometer, a pair of oppositely aligned single-axis accelerometers, an antenna configured to measure a field source, a range sensor, a multi-axis accelerometer, a gyroscope, an inclinometer, or combinations thereof, as described herein, to measure a movement of the body portion based on an orientation or change of orientation of the body portion.
- the proximity sensor 1402 can include one or more of an infrared sensor (e.g. , infrared sensor 1404) and an optical sensor (e.g. , optical sensor 1406).
- the proximity sensor is configured to sense a second body portion proximate the body portion on which the system 1000 is positioned.
- the system 1000 can be positioned on a wrist of the individual subject and the motion sensor 1010 can include a proximity sensor configured to detect one or more of a presence, a position, an angle, and a movement of another body portion proximate the wrist, such as a hand, a palm, an arm, a finger, a shoulder, and so forth.
- the proximity sensor 1402 is configured to sense a device interfacing with another portion of the skin surface or with another body portion.
- the system 1000 can be positioned on a body portion of the individual subject and a second system 1000 is positioned proximate the body portion or on another body portion, where the proximity sensor of the motion sensor 1010 of the system 1000 can sense one or more of a presence, a position, an angle, and a movement of the second system 1000.
- the motion sensor 1010 includes a pressure sensor, which can be an individual sensor, or
- the pressure sensor can provide an indication (e.g. , via sense signals) regarding whether an individual, or a body portion thereof, has been idle for a period of time that exceeds a threshold duration, which in turn can provide an indicator for operation of the effector 1008.
- treatment of the individual subject to induce movement can be a preventative measure (e.g., to induce movement to prevent onset of arthralgia, myalgia, or pressure sores).
- the motion sensor 1010 is configured to detect one or more of a movement of a body portion and a position of the body portion.
- the movement of the body portion, the position of the body portion, or combinations thereof can be indicative of a pain state of the individual subject. For example, the conscious or
- unconscious fear that a motion will induce pain can alter the motion of a body portion, indicating acute or chronic pain.
- physiological adaptation to acute pain or chronic pain can cause short-term or long-term changes in motor function of a body portion (e.g., increased or inhibited muscle activation), and as such can be indicative of pain.
- Alterations in movement of a body portion can present, for example, as pronounced minimalization of motion or agitation of affecting a body site (e.g., a muscle) a guarding motion, an awkward gait, a limp, redistribution of activity or stress, modifications in loading, pronounced use of non- dominant limb, reduced force output, lack of use of a body portion, respiratory dysfunction, splinting, etc.
- conscious or unconscious coping mechanisms e.g., grimacing, pronounced rubbing or massage of a body portion, etc.
- involuntary responses e.g., reflex, spasm, etc.
- movement of the body portion of the individual can be a source of, a cause of, or induce or worsen pain, and, as such, a particular movement can be determined to be associated with the pain.
- the movement of the body portion, the position of the body portion, or combinations thereof can be indicative of a risk of increased pain experienced by the individual subject, for example, when the movement has been determined to be temporally associated with pain (e.g., as indicated by changes in autonomic responses) or when a movement (e.g., a lack of movement) or repetition of movement indicates a risk of pain. Detection of these movements can facilitate determination by the processor 1006 of a physiological state of the individual subject, which can aid in determining whether to treat the individual subject through action of the effector 1008. Further, the motion of the body portion can provide an indication as to when treatment by the effector 1008 can be employed.
- the processor 1006 can instruct the effector 1008 (e.g., via one or more control signals, such as electric control signals) to provide treatment to the individual subject when the individual subject is at rest (e.g. , not currently undergoing substantial movement, such as exercising, walking, signing, etc.).
- the processor 1006 can instruct the effector 1008 to provide treatment to the individual subject when the body portion is undergoing motion determined (e.g. , previously or simultaneously) to be associated with an increase in pain, e.g. , as a palliative treatment.
- the processor 1006 can instruct the effector 1008 to provide treatment to the individual subject when there has been a lack of motion in the body portion of the individual subject or the individual subject has been at rest for a time period above a threshold time period.
- Treatment of the individual subject to induce movement can be a preventative measure (e.g. , to induce movement to prevent onset of arthralgia, myalgia, or pressure sores).
- the body portion can be the portion with which the system 1000 interfaces or can be a portion proximate the portion with which the system 1000 interfaces.
- the motion sensor 1010 generates a sense signal based on a repeated motion of the body portion.
- the system 1000 can be positioned on a wrist of a subject and the motion sensor 1010 measures a repeated flexing or bending of the wrist, such as during movement of the hand or one or more fingers.
- the motion sensor 1010 measures a number of repetitions of a movement of a body portion.
- the system 1000 can be positioned on a finger of a subject and the motion sensor 1010 measures the number of repetitions that the particular finger is flexed or bent.
- Measuring the number of repetitions can include, but is not limited to, measuring that zero repetitions have occurred, measuring a finite number of repetitions, measuring the number of repetitions taken over a specified time period, and determining that the number of repetitions exceeds a threshold number (e.g. , a threshold at which a subject is at risk for pain).
- the measurement of the number of repetitions can be facilitated by, for example, one or more of a counter 3202 or a timer 3204 present in the motion sensor 1010, in the processor 1006, or combinations thereof.
- the motion sensor 1010 measures a speed of a movement of a body portion.
- the system 1000 can be positioned on an ankle of a subject and the motion sensor 1010 measures the speed of movement of the ankle, such as one or more of a speed of movement during a flexing of the ankle during a walking motion, a speed of movement relative to a ground surface during a walking motion, or other movement.
- the motion sensor 1010 measures a duration of a movement of a body portion. The duration can include one or more of a total duration of movement within a period of time (e.g. , duration encompassing multiple
- the timer 3204 can facilitate such duration measurements.
- the system 1000 can be positioned on a cheek or proximate a facial muscle of the individual subject, and the motion sensor 1010 measures the duration of a contraction of the cheek or facial muscle (e.g. , such as to indicate a grimace or other pain-related movement of the body portion).
- the period of time over which the movement is measured can include, but is not limited to, seconds (e.g.
- the sensor assembly 1004 is configured to measure the disposition of the body portion over a period of time.
- the sensor assembly 1004 may measure a disposition of the body portion over time while the body portion is one or more of at rest, in motion, and held in a position that is not a rest position (e.g. , tensed).
- the motion sensor 1010 measures a disposition of a body portion on which the system 1000 is positioned relative to a second body portion during a movement of one or more of the body portion and the second body portion.
- the system 1000 can be positioned on a phalange of a subject and the motion sensor 1010 measures a disposition of the phalange relative to a wrist or ankle of the subject during motion of the phalange or wrist/ankle.
- the motion sensor 1010 measures an angle of movement of a body portion.
- the system 1000 can be positioned on an arm of a subject and the motion sensor 1010 measures an angle of movement of the arm (e.g.
- Measurement by the motion sensor 1010 of one or more of a repeated motion of a body portion, a number of repetitions of the movement of the body portion, a speed of the movement of the body portion, a duration of the movement of the body portion, a disposition of the body portion relative to a second body portion, and an angle of movement of the body portion provides information that can aid in the determination by the system 1000 of whether the subject is experiencing pain or is at risk of experiencing pain (e.g. , delayed onset pain or repetitive injury pain), such as whether the movement is symptomatic of pain or a causal factor of pain.
- the motion sensor 1010 is configured to transmit one or more sense signals to the processor 1006 indicative of a motion state of the individual subject, a rest state of the individual subject, or a duration of a rest state of the individual subject.
- the motion state of the individual subject can indicate that the individual subject (or body portions thereof) is currently moving, whereas the rest state of the individual subject can indicate that the individual subject (or body portions of thereof) are not moving, or are moving at a rate or between orientations that does not exceed a threshold rate.
- the processor 1006 determines a rest state of the individual based on the sense signals from the motion sensor 1010.
- the processor 1006 can compare the sense signals from the motion sensor 1010 to reference data indicative of a body portion at rest to determine whether the body portion of the individual subject is experiencing a rest state (e.g. , at or under a motion threshold relative to the reference data) or an active state (e.g. , exceeding a motion threshold relative to the reference data).
- the processor 1006 is configured to activate the effector 1008 to affect the body portion (e.g. , via ultrasound, electric, magnetic, optical, or thermal stimulation, as described further herein) only when the body portion is at rest.
- the processor 1006 can instruct the effector 1008 (e.g.
- the effector 1008 may operate only when the individual subject, or the particular body portion to treat, is at rest, such as when the individual subject is asleep, resting on furniture, driving or riding in a vehicle, or the like. As another example, the effector 1008 may operate after the individual subject, or the particular body portion to treat, has been at rest, or in the same position, for a period that exceeds a predetermined length of time.
- the processor 1006 is configured to activate the effector 1008 to affect the body portion responsive to a predetermined amount of movement of the body portion.
- the processor 1006 can instruct the effector 1008 (e.g. , via one or more electric control signals) to activate to affect the body portion when the sense signals from the motion sensor 1010 indicate that the body portion met or exceeded a predetermined amount of movement, such as by exceeding a threshold distance of travel of the body portion, a threshold period of time of movement of the body portion, a threshold orientation of the body portion, or the like.
- the processor 1006 is configured to activate the effector 1008 to affect the body portion responsive to a predetermined type of movement of the body portion.
- the processor 1006 can instruct the effector 1008 (e.g.
- the sense signals from the motion sensor 1010 might indicate that the body portion experienced a particular type of movement, such as a predetermined high velocity of movement, a high level of force output, a too-rapid step (e.g. , indicating tripping), a movement in a particular direction (e.g. , indicating a twisting of a joint), or the like, which can indicate an increased risk of pain.
- the sense signals from the motion sensor 1010 might indicate pronounced minimalization of motion or agitation affecting a body site (e.g. , a muscle), e.g.
- the sense signals from the motion sensor 1010 might indicate that the body portion experienced a particular type of movement such as experiencing a predetermined velocity of movement (e.g. , the individual subject is slowing down), a grimace, an awkward gait, a limp, pronounced use of non-dominant limb, pronounced rubbing or massage of a body portion (e.g. , repeated or deep massage), or the like, which can indicate a level of discomfort or pain experienced by the individual subject.
- a predetermined velocity of movement e.g. , the individual subject is slowing down
- a grimace e.g. , an awkward gait, a limp, pronounced use of non-dominant limb, pronounced rubbing or massage of a body portion (e.g. , repeated or deep massage), or the like
- Such occurrences can serve as an indicator to the processor 1006 that the effector 1008 should be activated.
- the physiological sensor 1012 is configured to detect one or more physiological parameters of the individual subject on which the system 1000 is positioned, where such physiological parameters can provide an indication as to whether the individual subject is experiencing pain, or to what degree the individual subject is experiencing pain.
- the physiological sensor 1012 detects a localized physiological parameter provided by one or more of a body portion with which the system 1000 interfaces and a body portion proximate the portion with which the system 1000 interfaces.
- the physiological sensor 1012 can also or instead be configured to detect systemic physiological parameters of the subject on which the system 1000 is positioned.
- the physiological sensor 1012 can include an electrophysiological sensor 3300, an electrocardiograph 3302, an
- electrooculograph 3304 a microneurograph 3306, a myograph 3308, an electromyograph (EMG) 3310, a surface electromyograph 3312, an acoustic myography sensor 3314, a mechanomyography sensor 3316, an accelerometer myography sensor 3318, a strain sensor 3320, a temperature sensor 3322, an optical sensor 3324, a light emitting diode (LED) 3326, an oximeter 3328, a near infrared sensor 3330, a skin conductance sensor 3332, a bioimpedance sensor 3334, a pH sensor 3336, an acoustic sensor 3338, a chemical sensor 3340, a pressure sensor 3342, or combinations thereof.
- EMG electromyograph
- EMG electromyograph
- surface electromyograph 3312 a surface electromyograph 3312
- an acoustic myography sensor 3314 a mechanomyography sensor 3316
- an accelerometer myography sensor 3318 a strain sensor 3320, a temperature sensor
- the physiological sensor 1012 can include a plurality of sensors, such as a plurality of a single sensor type or a combination of different sensor types, arranged in an array or otherwise communicatively coupled (e.g. , via one or more leads and/or wireless coupling, such as between sensor locations).
- a plurality of sensors such as a plurality of a single sensor type or a combination of different sensor types, arranged in an array or otherwise communicatively coupled (e.g. , via one or more leads and/or wireless coupling, such as between sensor locations).
- the electrophysiological sensor 3300 can generate one or more sense signals based upon detection of a physiological parameter of the body portion, for example, by detecting one or more electrical properties associated with biological cells or tissues, and can include one or more of an electroencephalograph (EEG) (e.g. , for measuring electrical activity of the brain), an amplified sensor electrode that incorporates silicon metal oxide semiconductor field effect transistors
- EEG electroencephalograph
- an amplified sensor electrode that incorporates silicon metal oxide semiconductor field effect transistors
- EMG electrocardiograph
- EOG electrooculograph
- EMG electromyograph
- EMG electromyograph
- the microneurograph 3306 e.g. , for electrical activity measurements in nerve fibers
- the skin conductance sensor 3332 the skin conductance sensor
- an electrophysiological sensor such as an EEG, ECG, EOG, or EMG (e.g. , surface EMG) can include one or more capacitive sensors or silicon metal oxide semiconductor field effect transistors (MOSFETs).
- the electrophysiological sensor 3300 can include a measurement electrode, a reference electrode capacitively coupled with the measurement electrode, and a ground electrode, whereby displacement currents induced in the electrodes provide data associated with ECG, EMG, EOC, etc.
- one or more of the electrodes includes a filamentary serpentine mesh structure insulated from the skin surface of the individual, such as with an insulating layer having high permittivity, stretchability, and adhesion (e.g.
- an electrophysiological sensor such as an ECG can include one or more dry electrodes or a conducting polymer comprising adhesive polymer (e.g. , polydimethylsiloxane) mixed with a conducting material such as silver microspheres, silver nanowires, or carbon structures (e.g. , including carbon nanostructures).
- the EOG 3304 can be a skin-resident device configured to detect activity in muscles controlling eye and eyelid movement.
- a surface EMG can include a
- the electrophysiological sensor 3300 can be an array of electrophysiological sensors.
- the electrophysiological sensor 3300 measures a muscle activity of a body portion on which the system 1000, such as during a movement of the body portion, during lack of movement, or combinations thereof.
- the system 1000 can be positioned on a phalange of a subject and the electrophysiological sensor 3300 (e.g. , EMG 3310) measures a muscle activity of the phalange during motion or lack of motion of the phalange or wrist/ankle.
- the myograph 3308 can generate one or more sense signals based upon detection of a physiological parameter of the body portion, for example by detecting one or more properties associated with one or more muscles, and can include one or more of the EMG 3310, the surface EMG 3312, the acoustic myography sensor 3314 (e.g. , for measuring sound in muscle movement), the mechanomyography sensor 3316 (e.g. , for measuring oscillations in muscle contraction), the accelerometer myography sensor 3318, or the like.
- the mechanomyography sensor 3316 can include as a detector a condenser microphone, accelerometer, laser-based instrument, and the like.
- the acoustic myographic sensor 3314 can include an acoustic transducer.
- the acoustic myographic sensor 3314 can include an acoustic sensor having a microphone.
- the physiological sensor 1012 includes
- electrophysiological sensor 3300 e.g. , EEG, ECG 3302
- EOG 3304 e.g., EOG 3304
- microneurograph 3306 EMG 3310, surface EMG 3312, acoustic myography sensor 3314, mechanomyography sensor 3316, accelerometer myography sensor 3318, etc.
- bioelectrical signal can be indicative of a pain state of the individual subject.
- the electrophysiological sensor 3300 includes an EMG for detecting a bioelectrical signal in a muscle as a localized or systemic indicator of pain.
- a surface EMG e.g. , surface EMG 3312
- a surface EMG positioned on the zygomaticus muscle of the subject's face can detect the bioelectrical signals of the muscle when it contracts as the subject feels pain somewhere in the body, e.g. , during a grimace or jaw clenching.
- trazpezius muscle can measure high bioelectrical activity, which is an indication of a high stress level associated with experiencing pain.
- a surface EMG positioned on a biceps muscle can measure bioelectric activity indicating over use and fatigue associated with pain or the risk of pain.
- a surface EMG positioned on a muscle during repetitive work can measure bioelectric activity indicative of repetitive injury stress and related pain or risk of pain.
- a surface EMG positioned on a muscle during exercise can detect bioelectric signal indicative of a sustained muscle contraction (e.g. , a muscle spasm or cramp) with associated pain.
- a surface EMG e.g.
- the electrophysiological sensor 3300 includes an EMG for detecting a bioelectrical signal in a muscle positioned relative to a second body portion during a movement of one or more of the body portion and the second body portion.
- the system 1000 can be positioned on a wrist of the individual subject and the electrophysiological sensor 3300 can include an electromyograph (not shown) configured to detect movement in one or more fingers.
- the sensor assembly 1004 includes the electrophysiological sensor 3300, microneurograph 3306, or myograph 3308 configured to distinctly measure electrical activity mediated by A delta ( ⁇ ) nerve fibers (e.g. , indicative of sharp, localized pain).
- the sensor assembly 1004 includes the electrophysiological sensor 3300, microneurograph 3306, or myograph 3308 configured to distinctly measure electrical activity mediated by C nerve fibers (e.g. , indicative of diffuse pain, such as that associated with inflammation).
- the electrophysiological sensor 3300, microneurograph 3306, or myograph 3308 is configured to measure electrical activity mediated by A delta ( ⁇ ) fibers and C fibers, where the one or more sense signals from the sensor assembly 1004 are transmitted to the processor 1006 only when the one of the A delta ( ⁇ ) fibers or the C fibers are inactive when the other of the A delta ( ⁇ ) fibers or the C fibers are active.
- the sensor assembly 1004 can transmit the one or more sense signals when each of the A delta ( ⁇ ) fibers and C fibers are active, whereby the processor 1006 is configured to disregard portions of the sense signals
- the physiological sensor 1012 includes a myograph (e.g. , EMG 3310, surface EMG 3312, acoustic myography sensor 3314, mechanomyography sensor 3316, the accelerometer myography sensor 3318, etc.) configured to measure a signal (e.g. , an acoustic signal or a mechanical signal) associated with a muscle contraction, wherein the signal associated with a muscle contraction can be indicative of a pain state of the individual subject.
- the acoustic myography sensor 3314 can measure sound waves arising from muscle fiber contractions to assess muscle activity to determine when a muscle or muscle group is being misused, leading to pain and injury.
- the strain sensor 3320 can include, but is not limited to, one or more of a metallic stack strain sensor, a silicon nanomembrane strain sensor, a
- the piezoresistor strain sensor is configured to measure a physiological characteristic of the body portion including, but not limited to, inflammation, swelling, or the like.
- the metallic stack strain sensor can include a first metallic material positioned on a second metallic material, where differences between electrical resistivity between the first metallic material and the second metallic material experienced during flexing or bending of the materials while mounted to a surface of interest can provide an indication of strain experienced by the surface.
- the metallic stack strain sensor includes a titanium / gold stack (Ti/Au) stack with a thickness of 10 nanometers of titanium per 60 nanometers of gold.
- Ti/Au stack can provide an electrical resistance of between about 305 ohms and 330 ohms for a strain percentage of between about 0.5% and 3.0%, which can be used to associate the change in electrical resistance of the stack to a strain experienced by the the body portion.
- the silicon nanomembrane strain sensor can include a thin strip of silicon to provide a thin crystalline semiconductor strip, where changes in the relative resistance of the silicon nanomembrane experienced during flexing or bending of the silicon while mounted to a surface of interest can provide an indication of strain experienced by the surface.
- the silicon nanomembrane strain sensor includes a silicon nanomembrane having a thickness from about 100 nm to about 400 nm, a width from about 10 pm to about 100 pm, and a length from about 100 pm to about 1000 pm.
- Multiple strips of silicon nanomembrane can be utilized to monitor strain associated with the body portion along differing axes, such as by employing a silicon nanomembrane along a longitudinal axis of the body portion and employing a silicon nanomembrane along a transverse axis of the body portion (e.g. , the longest dimension of the silicon nanomembrane being parallel to the respective axis).
- the silicon nanomembranes can be arranged in an array.
- the piezoresistor strain sensor can include a material that generates electricity upon deformation.
- the piezoresistor strain sensor includes strip of material (e.g. , a silicon nanomembrane, semiconducting material, metallic material, etc.) that tapers near a midpoint of the material (e.g. , to provide a "dog-bone” shaped structure) that provides a change in electrical resistance upon experiencing mechanical strain (e.g. , bending, flexing, etc.).
- the piezoresistor strain sensor can include a tapered silicon nanomembrane coupled to the body portion to associate the generated electricity of the silicon nanomembrane to a strain experienced by the body portion.
- the piezoresistor strain sensor includes a nanoribbon of lead zirconate titanate (PZT) coupled between gold and platinum electrodes, where the nanoribbon generates electricity upon deformation.
- PZT lead zirconate titanate
- the piezoresistor strain sensor includes a lead zirconate titanate nanoribbon coupled to the body portion to associate the generated electricity of the nanoribbon to a strain experienced by the body portion.
- the bonded metallic strain sensor can include a metallic material arranged in a grid on a substrate.
- the metallic material can be structured as a fine wire or foil.
- at least a portion of the grid is affixed directly to the body portion.
- the grid can exhibit a linear change in electrical resistance upon experiencing mechanical strain (e.g., bending, flexing, etc.)
- the bonded metallic strain sensor is applied to the body portion to associate the change in electrical resistance of the metallic grid to a strain experienced by the body portion.
- the wave-structured strain sensor can include a relatively brittle wave- structured material (e.g., single-crystalline silicon) bonded on an elastic support material.
- the wave-structured material includes a substantially planar base layer to mechanically couple to the elastic support material in a substantially continuous manner.
- the wave-structured material mechanically couples to elastic support material at discontinuous bonding portions (e.g., at a "valley" of a wave).
- the wave-structured material can be micro-scale or nano-scale structures (e.g., ribbons, membranes, wires, etc.), where amplitudes and wavelengths of the wave-structure material can change in response to mechanical strains.
- the wave-structured strain sensor is applied to the body portion to associate the change in electrical resistance of the wave-structured material to a strain experienced by the body portion.
- the open-mesh structured strain sensor includes an open-mesh material having mesh connections at bridging elements, which can provide in-plane rotations of the mesh material(s) upon experiencing mechanical strain (e.g., bending, flexing, etc.). Tensile strains can be applied to ends of the open-mesh material to cause in-plane rotations at the bridging elements, which can alter a shape of the openings within the mesh (e.g. , transitioning between open squares and open rhombuses). For example, strains applied in a direction not aligned to connecting bridges of the open-mesh material can lead to rotation of the connecting bridges about the connection points, providing a stretchable strain sensor.
- the open-mesh structured strain sensor is applied to the body portion to associate the change in electrical resistance of the open-mesh material to a strain experienced by the body portion.
- the interlocked metallic-coated nanofiber strain sensor can include interlocked arrays of metallic-coated nanofibers, each array supported by a substrate material to providing differing levels of interconnection and electric resistance between the arrays when external strains are applied.
- the interlocked metallic-coated nanofiber strain sensor can include two arrays of high-aspect-ratio platinum-coated polymeric nanofibers each supported on a thin polydimethylsiloxane (PDMS) substrate, where when mechanical strain is applied, the degree of interconnection of the nanofibers and the electrical resistance of the sensor changes in a reversible, directional manner.
- the interlocked metallic-coated nanofiber strain sensor is applied to the body portion to associate the change in electrical resistance of the arrays to a strain
- the physiological sensor 1012 includes the temperature sensor 3322.
- the temperature sensor 3322 can include, but is not limited to, a single point temperature sensor, a spatial imaging temperature sensor, and a microscale temperature sensor configured as a microscale heating element or actuator, such as one or more microscale temperature sensors incorporating thin serpentine features of thin metal or PIN diodes with nanoscale membranes.
- temperature sensors comprising thermal and/or optical sensors can detect increased tissue temperatures (e.g. , in muscle or adjacent skin) associated with delayed onset muscle soreness (DOMS) (sometimes referred to as exercise-induced muscle damage), e.g. , within the first 24 hours post-exercise.
- DOMS delayed onset muscle soreness
- the physiological sensor 1012 includes the acoustic sensor 3338 configured to measure one or more acoustical signatures of a physiological event.
- the acoustic sensor 3338 can include at least one microphone or acoustic transducer.
- the acoustic sensor 3338 can be configured to detect an articular noise (e.g. , creaking or popping) in an arthritic joint experiencing pain associated with movement.
- the acoustic sensor 3338 can include an acoustic sensor (e.g. , acoustic myographic sensor 3314) configured to detect musculoskeletal acoustic signature.
- the acoustic sensor 3338 can be configured to detect a vocal event (e.g. , a groan, vocalization, or speech), such as a vocal event indicative of pain.
- a vocal event e.g. , a groan, vocalization, or speech
- the acoustic sensor 3338 can be configured to detect an acoustic signature of a physiological event indicative of an autonomic response, e.g. , a heartbeat, valve closure, blood flow, respiration, etc.
- the physiological sensor 1012 includes the optical sensor 3324 configured to measure an optical characteristic of a body portion on which the system 1000 is positioned.
- the optical sensor 3324 is configured to measure a blood flow characteristic associated with the body portion.
- the optical sensor 3324 is configured to measure a temperature characteristic associated with the body portion.
- the optical sensor 3324 is configured to measure a pressure, strain, or
- the optical sensor 3324 is configured to measure a heart rate or respiratory rate. In an embodiment, the optical sensor 3324 is configured to measure at least one of transmitted light or reflected light.
- the optical sensor 3324 can include, but is not limited to, a photodiode, a light-emitting diode (LED) (e.g. , light-emitting diode 3326), an LED coordinated with a photosensor (e.g. , photodetector), a fiber optic sensor (e.g.
- the fiber optic sensor can include intrinsic fiber optic sensors (e.g. , the fiber optic sensor represents the sensing element) and extrinsic fiber optic sensors (e.g. , conveyor of light whose characteristics are affected or modulated by the measurand to be received by a separate detector) and can provide measurement of physical parameters such as, but not limited to, temperature, force, torque, strain, position, and the like.
- the fiber optic sensor is configured for measurement of one or more of cardiac tissue or respiratory tissue, such as for sensing of temperature, strain, deformation (e.g., swelling) of the respective tissue, which can serve as an indicator for pain.
- the fiber optic sensor e.g., single fiber optic line, multiple fiber optic lines in parallel, multiple fiber optic lines in matrix, spiral, honeycomb or other configuration, etc., or combinations thereof
- the body portion such as via a textile, tape, or ribbon
- light emitted from the fiber optics can be collected by a controller as reflections or transmissions (e.g., from the body portion, from the textile, etc.) for determination of the light characteristics thereof (e.g., wavelength, intensity, etc.).
- the optical sensor 3324 includes one or more optoelectronics to generate one or more sense signals based on measurement or sensing of one or more physical characteristics of the individual subject.
- the optoelectronics can include, but are not limited to, one or more polymer light-emitting diodes (PLEDs), one or more organic photodetectors (OPDs), or combinations thereof.
- the optoelectronics include a plurality of polymer light-emitting diodes (PLEDs) configured to emit light of differing wavelengths (e.g., green, red, blue, etc.), which in combination with one or more organic photodetectors (e.g., having an active layer of poly(3- hexylthiophene) (P3HT):(6,6)-phenyl-C61 -butyric acid methyl ester (PCBM)) are arranged as an ultraflexible reflective pulse oximeter.
- PLEDs polymer light-emitting diodes
- P3HT poly(3- hexylthiophene)
- PCBM poly(6,6)-phenyl-C61 -butyric acid methyl ester
- the physiological sensor 1012 includes the near infrared sensor 3300 configured to measure a physiological characteristic of the body portion such as, but not limited to, tissue oxygenation, a blood analyte, such as oxygen, carbon monoxide, methemoglobin, total hemoglobin, glucose, a protein, or a lipid, or to measure brain activity (prefrontal cortex activity associated with nociception).
- a physiological characteristic of the body portion such as, but not limited to, tissue oxygenation, a blood analyte, such as oxygen, carbon monoxide, methemoglobin, total hemoglobin, glucose, a protein, or a lipid
- brain activity prefrontal cortex activity associated with nociception
- hypoxemia in muscle detectable by NIR oximetry
- the physiological sensor 1012 can measure oxygenation in an earlobe, such as by configuring the substrate 1002 to wrap around the earlobe or other portion of the ear, whereby the physiological sensor can measure oxygenation via transmittance.
- the pressure sensor 3342 is configured to sense one or more of swelling or rigor of the body portion, which can be associated with pain.
- at least one of the physiological sensor 1012 or the processor 1006 includes circuitry configured to determine a risk of ischemia for the body portion, such as through a comparison of the one or more sense signals (e.g. , from pressure sensor 3342 or other physiological sensor) to reference data indicative of ischemic risk factors.
- at least one of the physiological sensor 1012 or the processor 1006 includes circuitry configured to determine a risk of prolonged pressure exerted on the body portion, such as through a comparison of the one or more sense signals (e.g. , from pressure sensor 3342 or other physiological sensor) to reference data indicative of pressure-based risk factors.
- the pressure sensor 3342 can stimulate the body portion with one or more of pressure (e.g. , via a mechanical probe) or electrical signal (e.g. , via electrode operation) to measure a tenderness or rigidity of the body portion, which can be associated with pain.
- pressure e.g. , via a mechanical probe
- electrical signal e.g. , via electrode operation
- the physiological sensor 1012 is configured to detect changes in one or more physiological parameters indicative of autonomic nervous system responses, including, but not limited to changes in biopotentials, electrophysiological signals, heart rate, heart rate variability, arterial blood pressure, plethysmograph wave amplitude, skin conductance level, number of skin conductance fluctuations and their time derivatives, etc. Changes in the autonomic nervous system, including changes in biopotentials and
- electrophysiological signals can be indicators of the presence of pain.
- ECG 3302 can be configured to measure heart rate variability; a reduction of the heart rate variability power in the high frequency band (i.e. , 0.15- 0.4 Hz) can be indicative of pain onset.
- the oximeter 3328 e.g. , a pulse oximeter or photo-plethysmograph
- the oximeter 3328 can be configured to assess
- skin conductance sensor 3320 can be configured to detect changes in skin conductance; changes in electro-galvanic skin properties, which can be measured by changes in the level and number of skin conductance fluctuations, can be indicative of the presence of pain.
- surface EMG 3312 can be configured to detect changes in the bioelectric signal in the corrugator muscle; changes in muscle tone, which are directed by the autonomic nervous system, can be indicative of the presence of pain.
- one or more of the sensor assembly 1004 or the processor 1006 can be configured to extract information from the detected signal, e.g. , a detected electrophysiological signal, such as to process, analyze, receive, or transmit a subset of the total information included in the detected signal.
- a detected electrophysiological signal such as to process, analyze, receive, or transmit a subset of the total information included in the detected signal.
- ECG 3302 can capture an electrophysiological signal from the heart and the signal includes features such as heart rate, interbeat interval, and heart rate variability that can be independently assessed; e.g. , a reduction of the heart rate variability can be indicative of pain onset.
- EMG 3312 can capture a signal from the corrugator muscle, and the signal includes such features as amplitudes, frequency, etc. that can be independently assessed; e.g. , changes in the amplitude and entropy of an EMG signal can be indicative of the presence of pain.
- one or more physiological sensors 1012 are configured to combine two or more physiological parameters (e.g. , autonomic response parameters) and provide a single multi-parameter sense signal. In an embodiment one or more physiological sensors 1012 are configured to provide signals on two or more physiological parameters to the processor 1006 and the processor 1006 combines the information into a single multi-parameter signal.
- the system 1000 is configured to assess a multi-parameter composite of autonomic signals to determine an indication of the presence of pain.
- the physiological sensor 1012 is configured to detect changes in one or more physiological parameters indicative of responses in the autonomic nervous system for use in quantifying a pain state. For example, quantifiable changes in biopotentials and electrophysiological signals can be indicators of pain intensity.
- the physiological sensor 1012 includes the chemical sensor 3340 configured to measure an analyte, where such analyte can be indicative of a pain state of the individual subject.
- the chemical sensor 3340 can include a sensor for detecting an analyte in sweat.
- the chemical sensor 3340 can include a sensor for detecting increased levels in sweat of a saccharide such as glucose, of a salt such as lactate or glutamate.
- the chemical sensor 3340 can include a sensor for detecting a hormone (e.g. , Cortisol or adrenaline).
- the chemical sensor 3340 can include a sensor for detecting inflammatory mediators (e.g. , a prostaglandin (e.g. , PGE2), bradykinin, serotonin, adenosine triphosphate, pyruvate, etc.) or a proinflammatory cytokine (IL-1 a, IL- ⁇ , IL-6, TNFa, IL-8).
- the chemical sensor 3340 can include a sensor for detecting a change in pH.
- the chemical sensor 3340 can include a sensor for detecting an ion or electrolyte (e.g. , hydrogen, sodium, potassium, chloride, calcium, magnesium, phosphate, etc.).
- the chemical sensor 3340 includes a multiplexed sweat sensor array fabricated on a mechanically flexible polyethylene terephthalate (PET) substrate.
- PET mechanically flexible polyethylene terephthalate
- amperometric glucose sensor an amperometric lactate sensor, or combinations thereof, which can include glucose oxidase and lactate oxidase immobilized within a permeable film (e.g. , a film of polysaccharide chitosan) with a silver/silver chloride (Ag/AgCI) electrode to facilitate a reference electrode and counter electrode for the amperometric glucose sensor, the amperometric lactate sensor, or combinations thereof.
- the sensors can generate current signals proportional to the abundance of the metabolites (e.g. , glucose, lactate, etc.) between the working electrode and the silver/silver chloride reference electrode.
- multiplexed sweat sensor array can additionally or alternatively include ion- selective electrodes (e.g. , for determination of sodium and potassium levels) with a reference electrode, which can include a polyvinyl butyral (PVB)-coated electrode.
- the multiplexed sweat sensor array can additionally or alternatively include a temperature sensor, including but not limited to a resistance-based temperature sensor (e.g. , a chromium/gold (Cr/Au) microwires supported by an insulating layer, such as a parylene layer).
- the chemical sensor 3340 includes a graphene-based sweat sensor having a serpentine bilayer of gold mesh and gold-doped graphene (e.g.
- the graphene-based sweat can also include a water-proof film (e.g. , a silicone layer), a humidity sensor (e.g. , a poly(3,4-ethylenedioxythiophene electrode), a glucose sensor (e.g. , a Prussian blue charge-based transfer sensor), a pH sensor (e.g. , polyaniline), a counter electrode (e.g. , Ag/AgCI), a tremor sensor (e.g. , graphene), a sweat uptake layer (e.g. , a Nafion layer), or combinations thereof.
- a water-proof film e.g. , a silicone layer
- a humidity sensor e.g. , a poly(3,4-ethylenedioxythiophene electrode)
- a glucose sensor e.g. , a Prussian blue charge-based transfer sensor
- a pH sensor e.g. , polyaniline
- a counter electrode e.g.
- the chemical sensor 3340 can include a sensor for detecting in sweat a protein (e.g. , of a proinflammatory cytokine, inflammatory mediator, hormone, etc.) or peptide thereof.
- the chemical sensor 3340 can include a transdermal sensor for sensing an analyte in tissue fluids (e.g. , blood).
- the chemical sensor 3340 can include a sensor configured for reverse iontophoresis (e.g. , reverse iontophoretic extraction) to draw an analyte (e.g. , glucose) from an interstitial space without puncturing the skin.
- the chemical sensor 3340 can include microneedles to access a tissue space.
- the chemical sensor 3340 can facilitate determination of a pain state of the individual subject. For example, changes in levels of physiological chemicals have been associated with increased muscle use or the presence of a pain condition. For instance, increases in lactate levels or in glucose levels (e.g. , in response to released hormones), measureable in sweat or bodily tissues (e.g. , interstitial tissues), have been associated with increased muscle use or the presence of pain. For example, increased levels of one or more hormones (e.g. , Cortisol, pregnenolone, DHEA, adrenocorticotrophic hormone (ACTH), a catcholamine (e.g.
- hormones e.g. , Cortisol, pregnenolone, DHEA, adrenocorticotrophic hormone (ACTH)
- ACTH adrenocorticotrophic hormone
- catcholamine e.g.
- neuropeptides e.g. , neuropeptide Y, substance P and calcitonin-gene-related peptide (CGRP)
- neurotransmitters e.g. , glutamate
- pain e.g. , tenderness, allodynia, and hyperalgesia
- ATP adenosine triphosphate
- electrolytes as well as low pH
- ATP and hydrogen ions are irritants that activate nerve endings by binding to receptor molecules
- pathological and pathophysiological changes of skeletal muscle are accompanied by a drop in pH.
- increased tissue metabolism during exercise leads to decreased oxygen levels (detectable by oximetry), causing a drop in pH and accumulation of hydrogen atoms (detectable as above), which in turn can activate nerve endings to induce pain.
- muscle spasm persistent, involuntary muscle contraction
- muscle ischemia which leads to a drop in pH and the release of pain-producing substances such as bradykinin, ATP, and hydrogen ions.
- an alteration in the levels of an electrolyte might be associated with an ion channel (e.g. , Transient Receptor Potential family members) in the activation of nociceptive receptors.
- the chemical sensor 3340 includes an electrochemical sensor.
- the electrochemical sensor can include, but is not limited to, an amperometric enzymatic electrode, which utilizes glucose oxidase to detect glucose or lactate oxidase to detect lactate, or one or more ion-selective
- the electrochemical sensor utilizes reverse iontophoresis.
- the electrochemical sensor utilizes reverse iontophoresis.
- electrochemical can include a pair of reverse iontophoresis electrodes (e.g. , Ag/AgCI), a reference electrode (Ag/AgCI), and a working electrode (e.g. ,
- the electrochemical sensor includes a ligand, such as an aptamer.
- a gold such as an aptamer.
- the chemical sensor 3340 includes microfluidic fluid transport, such as through microfluid channels (e.g. , formed in or by the substrate 1002 or other supporting substrate).
- the microfluid channels can transport an analyte of interest from the body portion to a detector positioned on the substrate 1002, or for containment by the system 1000 for subsequent remote analysis.
- the system 1000 can include one or more of a dolorimeter or algesiometer.
- the physiological sensor 1012 can include one or more of a dolorimeter or algesiometer to provide indications as to pain
- the processor 1006 is configured to receive one or more sense signals
- the processor 1006 includes circuitry configured to identify a physiological state (e.g. , a pain state) of the individual subject based on analysis of the one or more sense signals.
- the processor 1006 includes circuitry configured to identify a physiological state (e.g. , a pain state) of the individual subject based on the movement of the body portion detected by the motion sensor 1010.
- the processor 1006 includes circuitry configured to identify a physiological state (e.g.
- the processor 1006 includes circuitry configured to identify a physiological state (e.g. , a pain state) of the individual subject based on each of the movement of the body portion detected by the motion sensor 1010 and the one or more physiological parameters detected by the physiological sensor 1012.
- the processor 1006 is operably coupled to the sensor assembly 1004 such that the processor 1006 is configured to receive the one or more sense signals from one or more of the motion detector 1010 or the physiological sensor 1012.
- the system 1000 includes a comparison module 1300 accessible by the processor 1006 to compare one or more of the movement of the body portion, detected by the motion sensor 1010 of the sensor assembly 1004, or the one or more physiological parameters of the body portion, detected by the one or more physiological sensors 1012 of the sensor assembly 1004, to reference data indicative of a physiological state.
- the physiological state includes at least one of a pain state, a pain type, a pain level, or a pain quality.
- the reference data can include one or more of motion data or physiological parameter data, where such data can be associated with, but not limited to, a pain state, such as a pain-free state, an onset of pain, a pain pattern, chronic pain, acute pain, mixed pain state, a hyperalgesic pain state, an allodynic pain state, a breakthrough pain state, a neuropathic pain state, a nociceptive pain state, a non-nociceptive pain state, combinations thereof, or the like.
- a pain state such as a pain-free state, an onset of pain, a pain pattern, chronic pain, acute pain, mixed pain state, a hyperalgesic pain state, an allodynic pain state, a breakthrough pain state, a neuropathic pain state, a nociceptive pain state, a non-nociceptive pain state, combinations thereof, or the like.
- the reference data can include one or more of motion reference data indicative of short-term or long-term changes in motor function of a body portion (e.g., increased or inhibited muscle activation as a result of physiological adaptation to acute pain or chronic pain), a guarding motion, a grimace, an awkward gait, a limp, redistribution of activity or stress, modifications in loading, pronounced use of non-dominant limb,
- physiological reference data including, but not limited to, heart rate (including changes in heart rate or heart rate variation indicative of pain), blood pressure (including changes in blood pressure indicative of pain), electrophysiological data (including, but not limited to, electrical activity of the heart, electrical activity of the eye (e.g., corneo-retinal standing potential, pupil diameter, etc.)), nerve impulses, muscular-skeletal pressure forces or electrical activity (including, but not limited to, electric potential generated by muscle cells, muscular-skeletal acoustic or mechanical properties (e.g., vibrations), etc.), strain data (e.g., associated with muscle), temperature (including changes in
- analytes of sweat including but not limited to, analytes of sweat, analytes of tissue, a saccharide (e.g., glucose), a salt (e.g., sodium chloride), lactate, an electrolyte (e.g., sodium, chloride, potassium, etc.), a hormone (e.g., Cortisol, adrenaline, pregnenolone, DHEA, testosterone, progesterone, estrogen, triiodothyronine (T3), and thyroxine (T4)), a neuropeptide (e.g.
- neuropeptide Y neuropeptide Y
- substance P and calcitonin-gene-related peptide (CGRP)
- CGRP calcitonin-gene-related peptide
- a peptide a protein, or a nucleotide or modified nucleotide (e.g. , adenosine triphosphate), an
- the reference data can include one or more of motion data or physiological parameter data associated with pain types, where such data can be associated with, but not limited to, nociceptive pain (e.g. , due to mechanical, thermal, and/or chemical interactions), somatic pain, neuropathic pain, visceral pain, superficial pain, and psychogenic pain.
- the reference data can include one or more of motion data or physiological parameter data associated with pain levels, where such data can be associated with, but not limited to, pain intensity, pain severity, or magnitude of pain.
- the reference data can include one or more of motion data or physiological parameter data associated with pain quality or pain quantity, where such data can be associated with, but not limited to, a subjective characteristic of the pain (e.g. , a subjective pain threshold or tolerance threshold), such as those identified by the individual subject. Pain types can also include spontaneous pain (e.g. , occurring in the absence of stimuli), evoked pain (e.g. , occurring in response to stimuli), continuous pain, or intermittent pain.
- the motion sensor 1010, the physiological sensor 1012, or combinations thereof can include a stimulator for evaluating evoked responses from the individual subject.
- the stimulator can include an electrical stimulator, a thermal stimulator, an optical stimulator, or the like.
- Pain types can also include cephalalgia or headache, which can include, but are not limited to, tension headaches, cervicogenic headaches, migraines, or combinations thereof.
- the reference data can include user-specific threshold or tolerance information.
- the individual can indicate to the system 1000 (e.g. , via user interface 3600 described herein) when the individual feels pain.
- the system 1000 can then take a snapshot of one or more of the
- the system 1000 can monitor the individual and receive additional individual input regarding whether the pain intensifies, dissipates, differs in type, location, chronology, etc.
- the processor 1006 is configured to activate the effector 1008 to affect the body portion responsive to the physiological state
- the system 1000 can identify (via the processor 1006, the sensor assembly 1004, or combinations thereof) a physiological state of the individual subject, where a physiological state corresponding to a particular pain state is used as a trigger for the processor 1006 to activate the effector 1008 to treat the body portion.
- the processor 1006 can compare the physiological state to reference data indicative of a trigger condition to activate the effector 1008, where such trigger condition can be a specified pain state, including but not limited to, a pain- free state, an onset of pain, a pain pattern, chronic pain, acute pain, mixed pain state, a hyperalgesic pain state, an allodynic pain state, a breakthrough pain state, a neuropathic pain state, a nociceptive pain state, a non-nociceptive pain state, combinations thereof.
- the processor 1006 is configured to activate the effector 1008 responsive to the physiological state corresponding to a pain level experienced by the individual subject, a pain type experienced by the individual subject, a pain quality experienced by the individual subject, or combinations thereof.
- the processor 1006 can compare the physiological state to reference data indicative of a trigger condition to activate the effector 1008, where such trigger condition can be a specified pain level, pain type, or pain quality, including but not limited to nociceptive pain (e.g. , due to mechanical, thermal, and/or chemical interactions), somatic pain, neuropathic pain, visceral pain, superficial pain, psychogenic pain, pain intensity, pain severity, magnitude of pain, myofascial pain syndrome or condition, sharpness, dullness, burning, cold, tenderness, itch, cramping, radiating, tingling, throbbing, aching, tiring, deepness, shocking or electrical, stinging, or combinations thereof.
- nociceptive pain e.g. , due to mechanical, thermal, and/or chemical interactions
- somatic pain e.g. , due to mechanical, thermal, and/or chemical interactions
- somatic pain e.g. , due to mechanical, thermal, and/or chemical interactions
- somatic pain e.g. , due to mechanical, thermal
- the processor 1006 is configured to activate the effector 1008 to affect the body portion responsive to information from the physiological sensor 1012 regarding the location of the pain on the body portion.
- the processor 1006 can activate the effector 1008 responsive to information from one or more EMG 3310 or surface EMG 3312 to determine activation in a specific muscle, e.g. , a muscle known anatomically or historically to induce a regional pain.
- the processor 1006 can activate the effector 1008 responsive to information from a subset of two or more EMG 3310 or surface EMG 3312 sensors indicative of which muscle is experiencing pain.
- the processor 1006 accesses one or more of the comparison module or the reference data by accessing computer memory 1302 which can include, but is not limited to, random-access memory (RAM), read-only memory (ROM), electrically erasable programmable read-only memory
- computer memory 1302 can include, but is not limited to, random-access memory (RAM), read-only memory (ROM), electrically erasable programmable read-only memory
- EEPROM electrically erasable programmable read-only memory
- flash memory or other memory technology
- CD-ROM compact disc-read only memory
- DVD digital versatile disks
- magnetic cassettes magnetic tape
- magnetic disk storage or other magnetic storage devices, or any other medium which can be used to store the desired information maintained by the comparison module 1300 or memory manager and which can be accessed by the processor 1006 or other associated accessing device.
- the processor 1006 includes components to process the one or more sense signals from the sensor assembly 104 and to provide instruction to one or more components of the system 1000, such as the effector 1008.
- the processor 1006 can include a microprocessor, a central processing unit (CPU), a digital signal processor (DSP), an application-specific integrated circuit (ASIC), a field programmable gate entry (FPGA), or the like, or any combinations thereof, and can include discrete digital or analog circuit elements or electronics, or combinations thereof.
- the processor 1006 includes one or more ASICs having a plurality of predefined logic components.
- the processor 1006 includes one or more FPGAs having a plurality of
- the computer memory device can be integrated with the system 1000, can be associated with an external device and accessible by the system 1000 through wireless or wired communication protocols, or a combination thereof.
- the reference data can be stored by the computer memory 1302 coupled to the substrate 1002 of the system 1000, can be accessible by the processor 1006 via wireless means, can be available to the processor 1006 through another method, such as through a remote network, a cloud network, and so forth, or combinations thereof.
- the processor 1006 includes, or is operably coupled to, a receiver 3400 or transceiver 3402 (e.g. , antenna, etc.), or combinations thereof, to receive the reference data information or other information (e.g.
- the receiver 3400 can receive one or more communication signals from an external device 3406 associated with but not limited to, control programming, reference data, a query (e.g. , a query to transmit information from the system 1000 to the external device 3406, a query to determine a motion state of the individual subject, a query to determine a current physiological state (e.g. , pain state) of the individual subject, etc.), or combinations thereof.
- the processor 1006 can additionally or alternatively include a transmitter 3404 or transceiver 3402 (e.g.
- the external device 3406 can include one or more of a receiver 3408, a transceiver 3410, or a transmitter 3412 to facilitate
- the external device 3406 can include but is not limited to, a communication device or electronic equipment, such as one or more of a mobile communication device or a computer system including, but not limited to, one or more mobile computing devices (e.g. , hand-held portable computers, Personal Digital Assistants (PDAs), laptop computers, netbook computers, tablet computers, or so forth), mobile telephone devices (e.g. , cellular telephones and smartphones), devices that include functionalities associated with smartphones and tablet computers (e.g.
- a communication device or electronic equipment such as one or more of a mobile communication device or a computer system including, but not limited to, one or more mobile computing devices (e.g. , hand-held portable computers, Personal Digital Assistants (PDAs), laptop computers, netbook computers, tablet computers, or so forth), mobile telephone devices (e.g. , cellular telephones and smartphones), devices that include functionalities associated with smartphones and tablet computers (e.g.
- PDAs Personal Digital Assistants
- smartphones e.g. cellular telephones and smartphones
- wearable or portable devices e.g., including sensors positioned on the same body portion as system 1000, sensors positioned on different body portions than system 1000, sensors positioned remotely from the individual subject, sensors positioned on different individual subjects, etc.
- portable game devices portable media players, multimedia devices, augmented or virtual reality (VR) systems (e.g. , VR headsets, VR immersive experience systems, etc.) satellite navigation devices (e.g. , Global Positioning System (GPS) navigation devices), e- book reader devices (eReaders), Smart Television (TV) devices, surface computing devices (e.g. , table top computers), Personal Computer (PC) devices, and other devices that employ touch-based human interfaces.
- VR virtual reality
- satellite navigation devices e.g. , Global Positioning System (GPS) navigation devices
- eReaders e- book reader devices
- TV Smart Television
- surface computing devices e.g. , table top computers
- PC Personal Computer
- PC Personal Computer
- system 1000 can utilize
- communications from the external device 3406 as an operational indicator e.g. , when to engage the effector 1008, when to begin sensing via the sensor assembly 1004, etc.
- the processor 1006 can coordinate operations of the system 1000 based on the one or more sense signals and identification of a physiological state (e.g. , pain state) of the individual subject based on the one or more sense signals. For example, the processor can coordinate operation of the effector 1008 based upon identification of the physiological state (e.g. , pain state) of the individual subject and conditions experienced by the individual subject (e.g. , rest state, motion state, etc.).
- the effector 1008 is operably coupled to the processor 1006 and is configured to a body portion of the individual subject responsive to control by the processor 1006. In an embodiment, shown in FIG.
- the effector can include, but is not limited to, an ultrasound transducer 3500, an electrode 3502, a magnetic stimulator 3504, an optical stimulator 3506, a thermal stimulator 3508, an acoustic stimulator 3510, a mechanical stimulator 3512, a vibration stimulator 3514, or combinations thereof.
- the ultrasound transducer 3500 generates ultrasound waves (or signals) directed toward the body portion of the individual subject, such as for therapeutic treatment of the body portion.
- the effector 1008 includes an array of ultrasound transducers.
- the effector 1008 can include a first ultrasound transducer configured for placement on a first location on the body portion of the individual subject and a second ultrasound transducer configured for placement on a second location on the body portion of the individual subject.
- the array of ultrasound transducers can provide localized treatment based on differing locations of the transducers, based on differing patterns of ultrasound waves generated by the ultrasound transducers, or the like.
- the ultrasound transducer 3500 is configured to generate low intensity ultrasound waves (e.g.
- the ultrasound transducer 3500 can generate ultrasound waves from about 30 to about 1000 mW/cm 2 , where such low intensity can be applied to the body portion of the individual subject for up to about eight hours.
- the ultrasound transducer 3500 can include a diverging-wave transducer that operates from about 2.5 to about 3 MHz with about 0.03 to about 2 W/cm 2 ultrasound intensity for less than about 18 hours of treatment.
- the low intensity ultrasound waves correspond to a spatial temporal average intensity of about 90 mW/cm 2 at the transducer face, where a one-hour treatment provides about 1795 J of ultrasonic energy to the body portion, and where a six-hour treatment provides about 9596 J of ultrasonic energy to the body portion.
- a one-hour treatment provides about 1795 J of ultrasonic energy to the body portion
- a six-hour treatment provides about 9596 J of ultrasonic energy to the body portion.
- greater acoustic energy deposition can provide better clinical outcomes, where it has been found that deposition of an average of 4228 J per treatment session provided clinically significant outcomes, whereas deposition of an average of 2019 J did not provide statistically or clinically significant differences from a control or sham treatment.
- the ultrasound transducer 3500 includes a power controller and two ultrasound transducers, having 3 MHz frequency, 0.132 W/cm 2 intensity per transducer providing a cumulative ultrasound energy deposition of about 18720 J for a four-hour treatment session.
- the ultrasound transducer 3500 includes a divergent lens to scatter the ultrasound waves to a divergent acoustic treatment field.
- the ultrasound transducer 3500 is configured to generate high intensity focused ultrasound waves (e.g. , HIFU).
- the ultrasound transducer 3500 can generate the high intensity focused ultrasound waves at about 2.5 to about 3 MHz at about 1900 to about 2810 W/cm 2 for a duration from about 3 to about 15 seconds.
- the high intensity focused ultrasound waves can provide a nerve conduction block.
- a treatment can lead to localized coagulative necrosis and structural disruption in tissue, such that a focused treatment area of the HIFU ultrasound transducer 3500 can confine the biological effects to a particular, targeted region of the body portion for treatment (e.g. , to provide a nerve conduction block, etc.).
- the focused treatment area is about 1 mm x 10mm.
- the effector 1008 includes an imaging device to facilitate targeting of the targeted region of the body portion.
- the imaging device can include, for example, an ultrasound imaging transducer with a broadband frequency of about 5 to about 10 MHz to provide a hyperechoic region at the focus of the ultrasound transducer 3500 during synchronous operation with the ultrasound imaging transducer, which can facilitate viewing of the target region via a bright or light region.
- the ultrasound transducer 3500 is configured to generate low dose, high frequency ultrasound.
- the ultrasound transducer 3500 can generate low dose, high frequency ultrasound between about 0.5 to about 3 W/cm 2 at about 1 MHz frequency with a pulsed pattern of about 1 :4.
- the treatment duration for low dose, high frequency ultrasound includes a five minute treatment per day, for about 20 sessions.
- the ultrasound transducer 3500 is operated at a frequency of about 8 MHz at about 0.15 W/cm 2 for a period of about 15 seconds, with a duty cycle of about 0.01 % and a target region of the posterior frontal cortex. In an embodiment, the ultrasound transducer 3500 is operated at a frequency of about 0.5 MHz at about 5.9 W/cm 2 for a period of about 500 milliseconds, with a duty cycle of about 36% and a target region of the primary somatosensory cortex S1 .
- the ultrasound transducer 3500 is operated at a frequency of about 0.25 MHz at about 0.3 to about 2.5 W/cm 2 for a period of about 300 milliseconds, with a duty cycle of about 50% and a target region of the primary somatosensory cortex S1 .
- the ultrasound transducer 3500 is configured to generate ultrasound signals on a pulsed basis, a continuous basis, or combinations thereof.
- the ultrasound transducer 3500 is configured to generate ultrasound signals according to at least a first treatment pattern and a second treatment pattern.
- the treatment pattern can relate to a spatial pattern (e.g. , varying the location of the treatment, varying the depth of treatment, etc.), a timing pattern, an intensity pattern, or the like.
- the processor 1006 directs the ultrasound transducer 3500 to alternate generation of the ultrasound signals according to the first treatment pattern and the second treatment pattern on a dynamic basis.
- the first treatment pattern differs from the second treatment pattern according to at least one of a target site of the body portion of the individual subject (e.g.
- the ultrasound transducer 3500 generates ultrasound signals according to a plurality of ultrasound frequencies, where the frequency can be tuned or adjusted responsive to control by the processor 1006 or internal ultrasound transducer controller.
- the effector 1008 includes a first ultrasound transducer 3500 configured for placement on a first location on the body portion of the individual subject and a second ultrasound transducer 3500 configured for placement on a second location on the body portion of the individual subject.
- the first ultrasound transducer 3500 and the second ultrasound transducer 3500 can be spaced apart relative to each other (e.g. , on different body portions, on different regions of the same body portion, on opposing sides of the same body portion, etc.), where the transducers can receive different sourced frequencies to provide treatment to the individual subject.
- the optical stimulator 3506 is configured to generate infrared light.
- the optical stimulator 3506 can generate the infrared light as low-intensity, pulsed infrared light.
- the optical stimulator 3506 generates light at about 0.3 to about 0.4 J/cm 2 , which is about two and a half times less than a threshold at which histological tissue damage can occur (e.g. , about 0.8 to about 1 .0 J/cm 2 ).
- the optical stimulator 3506 can include a laser to facilitate treatment, where the laser can include, but is not limited to, a
- the optical stimulator 3506 generates light to provide a skin surface temperature increase of about 6 to about 10 degrees centigrade (e.g. , to provide stimulation of a peripheral nerve).
- the processor 1006 can direct the optical stimulator 3506 to generate light to provide a photothermal effect from transient tissue heating (e.g. , having a temporally and spatially mediated temperature gradient at the axon level of about 3.8 to about 6.4 degrees centigrade).
- the effector 1008 and stimulations therefrom can engage proprioceptors,
- mechanoreceptors, or light touch receptors stimulating such nerves can produce sensations to the nervous system that compete with signals from pain receptors (e.g. , nociceptors) and thereby decrease pain nerve perception by the individual.
- the effector 1008 and stimulations therefrom can engage body portions in or on the ear (e.g. , vagal stimulation).
- the effector 1008 and stimulations therefrom can engage one or more myofascial trigger points.
- the processor 1006 is configured to activate the effector
- the effector 1008 when the individual subject is in a rest state (e.g. , seated, prone, or the like while sleeping, reading, watching TV or other electronic device, etc.).
- the effector 1008 can include the ultrasound transducer 3500 configured for high-power pain threshold ultrasound (HPPTUS) to desensitize latent myofascial trigger points (e.g. , pathlogical alteration of muscle fibers that evoke local and referred pain, and does not elicit spontaneous local pain) for pain therapy.
- HPPTUS high-power pain threshold ultrasound
- a plurality of HPPTUS applications are applied to the body portion in a treatment session (e.g. , while the individual subject is stationary or at rest).
- the number of HPPTUS applications can include, but are not limited to, three to ten treatments at the latent myofascial trigger point(s).
- a single HPPTUS application can include, but is not limited to, application of ultrasound energy at 1 MHz, 0.5 to 1 .2 W/cm 2 , continuous wave for about five minutes.
- the system 1000 also includes a user interface 3600.
- the user interface 3600 can be operably coupled to the processor 1006 to facilitate operations of the system 1000.
- the processor 1006 is operably coupled to the user interface 3600 and is configured to generate one or more communication signals for display by the user interface 3600.
- the communication signals for display can include, for example, a request for user input regarding an operation state of the effector 1008.
- the system 1000 can seek approval or disapproval by a user (e.g. , the individual on which the system 1000 is positioned, a health care professional, etc.) to operate certain functionalities of the system, including but not limited to the functionalities of the effector 1008.
- the processor 1006 is configured to prevent activation of the effector 1008 responsive to a user command via the user interface 3600.
- the processor 1006 can direct the user interface 3600 to display a request for user input regarding whether the effector 1008 should activate. The user can select a deny activation
- the processor 1006 is configured to activate the effector 1008 responsive to a user command via the user interface 3600.
- the processor 1006 can direct the user interface 3600 to display a request for user input regarding whether the effector 1008 should activate.
- the user can select an activate or allow activation command to allow the effector 1008 to activate at that time, or to schedule a time or motion state during which the effector 1008 is permitted to activate.
- the individual can direct a user command via the user interface 3600 to activate the effector 1008 only during a rest period, such as when the individual subject would be sleeping or resting.
- the user interface 3600 can include, but is not limited to, a graphical user interface (GUI), a touchscreen assembly (e.g. , a capacitive touch screen), a liquid crystal display (LCD), a light-emitting diode (LED) display, or projection-based display, or combinations thereof.
- GUI graphical user interface
- touchscreen assembly e.g. , a capacitive touch screen
- LCD liquid crystal display
- LED light-emitting diode
- projection-based display or combinations thereof.
- the system 1000 includes a timer
- the processor 1006 is configured to stop activation of the effector 1008 responsive to a duration of treatment by the effector.
- the processor 1006 can access a maximum duration reference time (e.g. , stored in memory 1302, or otherwise accessible by the processor 1006), whereby the processor 1006 can compare a time of treatment tracked by the timer 3700. When the time of treatment tracked by the timer 3700 meets the maximum duration reference time, the processor 1006 directs the effector 1008 to cease activation.
- the processor 1006 is configured to stop activation of the effector 1008 responsive to an intensity of treatment by the effector 1008.
- the processor 1006 can access a maximum intensity of treatment reference intensity (e.g. , stored in memory 1302, or otherwise accessible by the processor 1006), whereby the processor 1006 can compare an intensity of treatment provided by operation of the effector 1008 (e.g. , during a single treatment session, over multiple treatment sessions, etc.), which can depend on the power output of the effector 1008, the duration of treatment by the effector 1008, the frequency of treatment by the effector 1008, or the like. When the intensity of treatment determined by the processor 1006 meets the maximum intensity of treatment reference intensity, the processor 1006 directs the effector 1008 to cease activation.
- a maximum intensity of treatment reference intensity e.g. , stored in memory 1302, or otherwise accessible by the processor 1006
- the effector 1008 is configured to affect the body portion for treatment of at least one of arthritis (e.g. , osteoarthritis, rheumatoid arthritis, psoriatic arthritis, etc.), arthralgia, myalgia, neuralgia, enthesitis, myalgia, fibromyalgia, cephalalgia, or traumatic pain.
- arthritis e.g. , osteoarthritis, rheumatoid arthritis, psoriatic arthritis, etc.
- arthralgia myalgia, neuralgia, enthesitis, myalgia, fibromyalgia, cephalalgia
- the effector 1008 is configured to affect the body portion with an active treatment.
- the processor 1006 can direct the effector 1008 to affect the body portion when the individual subject is experiencing a pain state.
- the effector 1008 is configured to affect the body portion with a preventative treatment.
- the processor 1006 can direct the effector 1008 to affect the body portion prior to the individual subject experiencing a pain state, when the pain state of the individual subject is less than a threshold pain state, or to induce individual subject to move to prevent a pain state.
- the effector 1008 is configured to affect the body portion with a palliative treatment.
- the system 1000 is configured to determine or receive an identification of the individual subject on which the system 1000 is positioned to determine whether to provide or enable certain functionalities.
- the system 1000 can be configured to operate only for certain authorized individuals, whereby certain features or functionalities are disabled if an unidentified or unauthorized individual attempts to use the system 1000.
- the system 1000 is configured to identify the individual subject on which the system 1000 is positioned, whereby the system 1000 permits operation of certain system components upon a positive identification of an individual authorized to use the particular system 1000.
- the sensor assembly 1004 can detect physical characteristics of the individual subject on which the system 1000 is positioned to generate one or more identity sense signals associated with the physical characteristic. The physical characteristics can include, but are not limited to, skin topography features (e.g.
- the processor 1006 or other system component compares the identity sense signals to reference data associated with individual(s) authorized to use the system 1000. When the identity sense signals have a positive
- the system 1000 can permit operation of certain system functionalities including, but not limited to, permitting operation of the sensor assembly 1004 for pain monitoring, permitting operation of the effector 1008 (e.g. , only upon positive association of an individual, such that the individual becomes authorized to operate the system 1000), selecting a particular treatment protocol (e.g. , the reference data can include a correspondence between an identity and a particular treatment protocol, whereby upon confirmation of an identity, the particular treatment protocol is selected for operation of the effector 1008), permitting the transmission of information associated with operation of the system 1000 or the status of the individual subject to a record (e.g. , an electronic health record or other health diary), or the like.
- a record e.g. , an electronic health record or other health diary
- the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware.
- the processes and/or devices and/or other technologies described herein can be effected, none of which is inherently superior to the other in that any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g., speed, flexibility, or predictability) of the implementer, any of which may vary.
- Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware.
- implementations can include software or other control structures. Electronic circuitry, for example, may have one or more paths of electrical current constructed and arranged to implement various functions as described herein.
- one or more media can be configured to bear a device- detectable implementation when such media hold or transmit a device detectable instructions operable to perform as described herein.
- implementations can include an update or modification of existing software or firmware, or of gate arrays or programmable hardware, such as by performing a reception of or a transmission of one or more instructions in relation to one or more operations described herein.
- an implementation can include special-purpose hardware, software, firmware components, and/or general-purpose components executing or otherwise invoking special-purpose components. Specifications or other implementations can be transmitted by one or more instances of tangible transmission media as described herein, optionally by packet transmission or otherwise by passing through distributed media at various times.
- implementations may include executing a special-purpose instruction sequence or otherwise invoking circuitry for enabling, triggering, coordinating, requesting, or otherwise causing one or more
- operational or other logical descriptions herein may be expressed directly as source code and compiled or otherwise invoked as an executable instruction sequence.
- C++ or other code sequences can be compiled directly or otherwise implemented in high-level descriptor languages (e.g. , a logic-synthesizable language, a hardware description language, a hardware design simulation, and/or other such similar mode(s) of expression).
- high-level descriptor languages e.g. , a logic-synthesizable language, a hardware description language, a hardware design simulation, and/or other such similar mode(s) of expression.
- some or all of the logical expression may be
- FPGAs Programmable Gate Arrays
- DSPs digital signal processors
- FPGAs Programmable Gate Arrays
- FPGAs digital signal processors
- some aspects of the embodiments disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g. , as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g. , as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure.
- the mechanisms of the subject matter described herein are capable of being distributed as a program product in a variety of forms, and that an illustrative embodiment of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution.
- electro-mechanical system includes, but is not limited to, electrical circuitry operably coupled with a transducer (e.g.
- an actuator e.g. , a motor, a piezoelectric crystal, a Micro Electro Mechanical System (MEMS), etc.
- electrical circuitry having at least one discrete electrical circuit electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g. , a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a
- microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein
- electrical circuitry forming a memory device e.g. , forms of memory (e.g. , random access, flash, read only, etc.)
- electrical circuitry forming a communications device e.g. , a modem, communications switch, optical-electrical equipment, etc.
- any nonelectrical analog thereto such as optical or other analogs.
- electro-mechanical systems include but are not limited to a variety of consumer electronics systems, medical devices, as well as other systems such as motorized transport systems, factory automation systems, security systems, and/or communication/computing systems.
- electro-mechanical as used herein is not necessarily limited to a system that has both electrical and mechanical actuation except as context may dictate otherwise.
- electrical circuitry includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of memory (e.g., random access, flash, read only, etc.)), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, optical-electrical equipment, etc.).
- a memory device e.g., forms of memory (e.g., random access, flash, read only, etc.)
- communications device e.g., a modem, communications switch, optical-electrical equipment, etc.
- a typical image processing system generally includes one or more of a system unit housing, a video display device, memory such as volatile or non- volatile memory, processors such as microprocessors or digital signal processors, computational entities such as operating systems, drivers, applications programs, one or more interaction devices (e.g., a touch pad, a touch screen, an antenna, etc.), control systems including feedback loops and control motors (e.g., feedback for sensing lens position and/or velocity; control motors for moving/distorting lenses to give desired focuses).
- An image processing system can be implemented utilizing suitable commercially available components, such as those typically found in digital still systems and/or digital motion systems.
- a data processing system generally includes one or more of a system unit housing, a video display device, memory such as volatile or non-volatile memory, processors such as microprocessors or digital signal processors, computational entities such as operating systems, drivers, graphical user interfaces, and applications programs, one or more interaction devices (e.g. , a touch pad, a touch screen, an antenna, etc.), and/or control systems including feedback loops and control motors (e.g. , feedback for sensing position and/or velocity; control motors for moving and/or adjusting components and/or quantities).
- a data processing system can be implemented utilizing suitable commercially available components, such as those typically found in data computing/communication and/or network computing/communication systems.
- a typical mote system generally includes one or more memories such as volatile or non-volatile memories, processors such as microprocessors or digital signal processors, computational entities such as operating systems, user interfaces, drivers, sensors, actuators, applications programs, one or more interaction devices (e.g. , an antenna USB ports, acoustic ports, etc.), control systems including feedback loops and control motors (e.g. , feedback for sensing or estimating position and/or velocity; control motors for moving and/or adjusting components and/or quantities).
- a mote system may be implemented utilizing suitable components, such as those found in mote computing/communication systems. Specific examples of such components entail such as Intel Corporation's and/or Crossbow Corporation's mote components and supporting hardware, software, and/or firmware.
- use of a system or method may occur in a territory even if components are located outside the territory.
- use of a distributed computing system may occur in a territory even though parts of the system may be located outside of the territory (e.g. , relay, server, processor, signal-bearing medium, transmitting computer, receiving computer, etc. located outside the territory).
- a sale of a system or method may likewise occur in a territory even if components of the system or method are located and/or used outside the territory.
- implementation of at least part of a system for performing a method in one territory does not preclude use of the system in another territory.
- any two components so associated can also be viewed as being “operably connected,” or “operably coupled,” to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable,” to each other to achieve the desired functionality.
- operably couplable include but are not limited to physically mateable and/or physically interacting components, and/or wirelessly interactable, and/or wirelessly interacting components, and/or logically interacting, and/or logically interactable components.
- one or more components can be referred to herein as
- any tangible, non-transitory computer-readable storage medium may be utilized, including magnetic storage devices (hard disks, floppy disks, and the like), optical storage devices (CD-ROMs, DVDs, Blu-ray discs, and the like), flash memory, and/or the like.
- These computer program instructions may be loaded onto a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions that execute on the computer or other programmable data processing apparatus create a means for implementing the functions specified.
- These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture, including implementing means that implement the function specified.
- the computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer-implemented process, such that the instructions that execute on the computer or other programmable apparatus provide steps for implementing the functions specified.
- the terms "comprises,” “comprising,” and any other variation thereof are intended to cover a non-exclusive inclusion, such that a process, a method, an article, or an apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, system, article, or apparatus.
- the system is integrated in such a manner that the system operates as a unique system configured specifically for function of the pain therapy device or system (e.g., system 1000), and any associated computing devices of the system operate as specific use computers for purposes of the claimed system, and not general use computers.
- at least one associated computing device of the system operates as a specific use computer for purposes of the claimed system, and not a general use computer.
- at least one of the associated computing devices of the system is hardwired with a specific ROM to instruct the at least one computing device.
- the pain therapy device or system e.g., system 1000
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Physiology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Artificial Intelligence (AREA)
- Signal Processing (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Dentistry (AREA)
- Neurology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Electrotherapy Devices (AREA)
- Magnetic Treatment Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/361,953 US10279200B2 (en) | 2014-07-17 | 2016-11-28 | Monitoring and treating pain with epidermal electronics |
US15/361,999 US10279201B2 (en) | 2014-07-17 | 2016-11-28 | Monitoring and treating pain with epidermal electronics |
PCT/US2017/063243 WO2018098417A1 (en) | 2016-11-28 | 2017-11-27 | Monitoring and treating pain with epidermal electronics |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3544681A1 true EP3544681A1 (en) | 2019-10-02 |
EP3544681A4 EP3544681A4 (en) | 2020-06-10 |
Family
ID=62195587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17875036.0A Withdrawn EP3544681A4 (en) | 2016-11-28 | 2017-11-27 | Monitoring and treating pain with epidermal electronics |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3544681A4 (en) |
JP (1) | JP2020512846A (en) |
CN (1) | CN110290834A (en) |
TW (1) | TW201825045A (en) |
WO (1) | WO2018098417A1 (en) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US10583287B2 (en) | 2016-05-23 | 2020-03-10 | Btl Medical Technologies S.R.O. | Systems and methods for tissue treatment |
US10556122B1 (en) | 2016-07-01 | 2020-02-11 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
LU100021B1 (en) | 2017-01-13 | 2018-07-30 | Adapttech Ltd | Socket fitting system |
TWI676788B (en) * | 2018-10-12 | 2019-11-11 | 研能科技股份有限公司 | Health monitoring device |
TWI699783B (en) * | 2018-11-08 | 2020-07-21 | 佛教慈濟醫療財團法人 | Intelligent medical treatment auxiliary system and method thereof |
US11642081B2 (en) | 2019-02-01 | 2023-05-09 | X Development Llc | Electrode headset |
US11583231B2 (en) | 2019-03-06 | 2023-02-21 | X Development Llc | Adjustable electrode headset |
WO2020209846A1 (en) * | 2019-04-09 | 2020-10-15 | Somniferum Labs LLC | Pain level determination method, apparatus, and system |
JP7125033B2 (en) * | 2019-04-11 | 2022-08-24 | ビーティーエル メディカル ソリューションズ エー.エス. | Methods and devices for aesthetic treatment of biological structures with radio frequency and magnetic energy |
TR201917004A2 (en) * | 2019-11-04 | 2021-05-21 | Zorluteks Tekstil Ticaret Ve Sanayi Anonim Sirketi | AN ELECTRIC STIMULATING SYSTEM |
TWI730503B (en) * | 2019-11-19 | 2021-06-11 | 奇異平台股份有限公司 | Physiological and biochemical monitoring device |
CN110840412A (en) * | 2019-12-09 | 2020-02-28 | 苏州大学 | Pain signal detection device based on animal body communication and detection method thereof |
US20210196201A1 (en) * | 2019-12-27 | 2021-07-01 | RichHealth Technology Corporation | Wearable sensing device |
JP2021129891A (en) * | 2020-02-21 | 2021-09-09 | 住友電気工業株式会社 | Terminal device, emotion analysis device, emotion analysis system, and emotion analysis method |
CN111319320B (en) * | 2020-02-27 | 2021-09-10 | 电子科技大学 | Multifunctional electronic fabric and construction method and application thereof |
KR102355171B1 (en) * | 2020-03-02 | 2022-01-26 | 고려대학교 산학협력단 | High Voltage Microcurrent Diagnostic Device |
TWI799740B (en) * | 2020-03-05 | 2023-04-21 | 緯創資通股份有限公司 | Optical sensing device |
TWI773972B (en) * | 2020-03-05 | 2022-08-11 | 緯創資通股份有限公司 | Optical sensing device |
US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
WO2021224678A1 (en) | 2020-05-04 | 2021-11-11 | Btl Medical Technologies S.R.O. | Device and method for unattended treatment of a patient |
CN111568382B (en) * | 2020-05-21 | 2023-04-07 | 中国计量科学研究院 | Intelligent measurement system for intra-thyroid irradiation iodine measurement |
CN111714354B (en) * | 2020-06-09 | 2021-11-26 | 北京航空航天大学 | Intelligent ultrasonic pain relieving device |
CN114077301B (en) * | 2020-08-20 | 2023-10-10 | 鹏鼎控股(深圳)股份有限公司 | Virtual reality glove and manufacturing method thereof |
CN112023265B (en) * | 2020-09-28 | 2022-01-07 | 杭州神络医疗科技有限公司 | Electrical stimulation device |
US20220339461A1 (en) * | 2021-04-22 | 2022-10-27 | Innolux Corporation | Electronic device and operation method thereof |
CN113288419A (en) * | 2021-05-28 | 2021-08-24 | 常州纵慧芯光半导体科技有限公司 | Laser device and appearance that moults |
CN113243892A (en) * | 2021-06-28 | 2021-08-13 | 遵义医科大学附属医院 | Multifunctional pain assessment mold |
WO2023285494A1 (en) * | 2021-07-12 | 2023-01-19 | Cortery AB | Wearable device for generating extracorporeal shock waves |
US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
CN116649972B (en) * | 2023-07-04 | 2024-03-29 | 珠海美华医疗科技有限公司 | Blood collection auxiliary device for blood culture bottle |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090076343A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Energy Management for Adherent Patient Monitor |
BR112016015426B1 (en) * | 2013-12-31 | 2022-07-12 | Iftech Inventing Future Technology Inc | WEAR DEVICES, SYSTEMS, METHODS AND ARCHITECTURES FOR SENSORY STIMULATION AND MANIPULATION AND PHYSIOLOGICAL DATA ACQUISITION |
US20160015280A1 (en) * | 2014-07-17 | 2016-01-21 | Elwha Llc | Epidermal electronics to monitor repetitive stress injuries and arthritis |
AU2015296139B2 (en) * | 2014-08-01 | 2019-11-07 | Lifelens Technologies, Llc | Modular physiologic monitoring systems, kits, and methods |
US20160129274A1 (en) * | 2014-11-10 | 2016-05-12 | Sam Boong Park | Wearable energy delivery system |
EP3253282A4 (en) * | 2015-02-05 | 2018-09-26 | Mc10, Inc. | Method and system for interacting with an environment |
WO2017007518A1 (en) * | 2015-07-07 | 2017-01-12 | Obma Padraic R | Noninvasive medical monitoring device, system and method |
-
2017
- 2017-11-22 TW TW106140457A patent/TW201825045A/en unknown
- 2017-11-27 EP EP17875036.0A patent/EP3544681A4/en not_active Withdrawn
- 2017-11-27 CN CN201780084773.4A patent/CN110290834A/en active Pending
- 2017-11-27 WO PCT/US2017/063243 patent/WO2018098417A1/en active Application Filing
- 2017-11-27 JP JP2019528460A patent/JP2020512846A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3544681A4 (en) | 2020-06-10 |
JP2020512846A (en) | 2020-04-30 |
WO2018098417A1 (en) | 2018-05-31 |
CN110290834A (en) | 2019-09-27 |
TW201825045A (en) | 2018-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10279200B2 (en) | Monitoring and treating pain with epidermal electronics | |
US10279201B2 (en) | Monitoring and treating pain with epidermal electronics | |
US10390755B2 (en) | Monitoring body movement or condition according to motion regimen with conformal electronics | |
US10383550B2 (en) | Monitoring body movement or condition according to motion regimen with conformal electronics | |
EP3544681A1 (en) | Monitoring and treating pain with epidermal electronics | |
WO2018118673A2 (en) | Monitoring body movement or condition according to motion regimen with conformal electronics | |
JP7296344B2 (en) | Conformal sensor system for detection and analysis of cardiac activity | |
US20220249022A1 (en) | Modular physiologic monitoring systems, kits, and methods | |
US10099053B2 (en) | Epidermal electronics to monitor repetitive stress injuries and arthritis | |
AU2015296139B2 (en) | Modular physiologic monitoring systems, kits, and methods | |
US20160015280A1 (en) | Epidermal electronics to monitor repetitive stress injuries and arthritis | |
US9884179B2 (en) | Neural sleeve for neuromuscular stimulation, sensing and recording | |
US11779761B2 (en) | Non-invasive nerve stimulation | |
US20200129762A1 (en) | Detection and treatment of obstructive sleep apnea | |
JP7434163B2 (en) | non-invasive nerve stimulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190614 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200512 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/026 20060101ALN20200506BHEP Ipc: A61N 5/067 20060101ALI20200506BHEP Ipc: A61B 5/11 20060101ALN20200506BHEP Ipc: A61N 1/36 20060101ALI20200506BHEP Ipc: A61N 5/06 20060101ALI20200506BHEP Ipc: A61B 5/0488 20060101ALN20200506BHEP Ipc: A61N 1/04 20060101ALI20200506BHEP Ipc: A61B 5/0205 20060101ALN20200506BHEP Ipc: A61B 5/0402 20060101ALN20200506BHEP Ipc: A61N 2/00 20060101ALN20200506BHEP Ipc: A61B 5/024 20060101ALN20200506BHEP Ipc: A61B 5/00 20060101ALI20200506BHEP Ipc: A61N 7/00 20060101AFI20200506BHEP Ipc: A61B 5/08 20060101ALN20200506BHEP |
|
18W | Application withdrawn |
Effective date: 20200513 |